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PREFACE 
The search for novel oxidants has been ongoing due to the advancements in 
the synthesis of complex organic molecules under different reaction conditions. Most 
oxidation reactions employ inorganic oxidants with metal ions of Cr(VI), Mn(VII), 
Ce(IV), Fe(III), Ru(IV), V(V) etc. However, the poor solubility of these inorganic 
oxidants in nonaqueous media restricts their use for the oxidation of water insoluble 
organic substrates. To undertake reactions of organic substrates in organic 
homogeneous media, tailor made lipopathic oxidants are of much interest. Onium ions 
(generally refer to hypervalent ammonium, phosphonium, arsonium, tellurium ions 
etc,) having alkyl groups are attached as counterions to carry the oxidant from 
aqueous medium into organic medium. Due to amphipathic characteristics of these 
onium ions and resultant ion pair characteristics with the anionic counterpart the 
solubility, reactivity, and redox potentials of the oxidants vary significantly. These 
reagents are found to be mild, chemoselective and regioselective. 
With an objective  to develop new efficient, selective and mild oxidation 
protocols, the oxidizing ability of some lipopathic oxidants namely 
cetyltrimethylammonium dichromate (CTADC), cetyltrimethylammonium 
permanganate (CTAP) and cetyltrimethylammonium cericnitrate (CTACN) has been 
explored by our research group using cetyltrimethylammonium (CTA) ion as the 
onium counterion for anionic dichromate, permanganate and cericnitrate. The CTA 
ion is well known for its amphipathicity, which is having the characteristics of being 
solubilized in both aqueous and non-aqueous media. Unlike other quaternary 
ammonium ions (tetrabutyl or tetraoctyl ammonium ions), the CTA ion has a 
relatively small head group with more exposed charge and a well-balanced 
hydrophobic group to carry the ions to both water and organic media and thus is a 
magic amphiphile. Its balanced amphiphilic system makes it capable to form various 
artificial organized assemblies such as micelles, reverse micelles, microemulsions, 
vesicles etc. The preliminary reports on oxidation of various mono- and bi-functional 
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organic substrates by CTADC and CTAP show their mildness and chemoselectivity. 
The present research work aims at employing CTADC and CTAP to study the 
oxidative metabolism of some established drugs such as acetaminophen, epinephrine, 
isoniazid, carbamazepine and norfloxacin having multiple functional groups in 
nonaqueous medium. 
To achieve the objectives, the oxidation product(s) were isolated and 
characterized. The reaction kinetics was studied using UV-vis spectrophotometric 
method in different media with varied polarities and also in micro-heterogeneous 
systems generated due to the presence of surfactants. Suitable mechanisms have been 
proposed and supplemented by proper evidences such as deuterium kinetic isotope 
effect, solvent kinetic isotope effect, effect of medium, effect of temperature, effect of 
surfactants etc. The selectivity, mildness and biomimetic characteristics of the 
oxidative cleavage have been discussed and compared with that of the existing 
literature reports. Possibilities to utilize these oxidants as biomimetic chemical 
oxidation model have been explored primarily to synthesize the selective metabolites 
of drug candidates and to study the mechanism of oxidation at lipid-solution 
interfaces. 
The present thesis entitled, “Oxidation of some biologically important 
organic substrates by lipopathic Cr(VI) and Mn(VII) : Kinetics and mechanistic 
study” comprises of seven chapters. Brief summary of the chapters are as follows. 
A brief introduction on lipopathic oxidants has been presented in Chapter 1. 
Synthesis and applications of various lipopathic Cr(VI) and Mn(VII) oxidants have 
been discussed in this chapter with special reference to their mildness, selectivity and 
mechanism. Scope of the work along with the objective of the present thesis has also 
been presented in this chapter. 
Chapter 2 deals with the oxidative cleavage of a well-known analgesic and 
antipyretic drug acetaminophen by a lipopathic oxidant, cetyltrimethylammonium 
dichromate (CTADC), in nonpolar medium and also in the presence of surfactants.  
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Oxidation of acetaminophen by CTADC in acetonitrile in the presence of acetic acid 
was found to produce p-benzoquinone and acetamide. Michaelis-Menten type kinetics 
was observed with respect to the substrate. An analysis of the reaction kinetics reveals 
the existence of a multistep complex mechanism, the first step of which involves a 
very fast formation of association complex (1) between acetaminophen and CTADC, 
followed by a  rate-determining dissociation of the complex proceeding via a polar 
transition state (2) to form N-acetyl-p-benzoquinone iminium ion intermediate (3) 
(Scheme 1). Subsequent deprotonation and hydrolysis of the intermediate affords the 
final products. The proposed mechanism gets support from the effect of solvent 
polarity, isotope effect (solvent kinetic isotope effect and deuterium kinetic isotope 
effect) and the effect of temperature on the reaction rate.   
Complex
O
Cr
O
O O CrO2 O
-CTA+
NH C
O
CH3 O
Cr
O
O O CrO2 O
-CTA+
N
H
C
O
CH3

O N+ C
O
CH3 + Cr(IV)
Transition State
H
Intermediate
1 2 3
 (Scheme 1) 
Effect of various surfactants such as cetyltrimethylammonium bromide 
(CTAB), sodium dodecylsulphate (SDS) and triton-100 (TX-100) on the reaction rate 
proposes the formation of mixed reverse micelle type aggregates having different 
solubilization pockets for reactants. The substrate and the oxidant are thus partitioned 
into different types of environments, and accordingly the reaction is controlled. 
Chapter 3 of the thesis describes the oxidation of a neurotransmitter 
epinephrine (adrenaline), by CTADC.  CTADC oxidizes epinephrine (4) to 
adrenochrome (9) selectively without affecting the secondary hydroxyl group present 
in the side chain of epinephrine. The rate of the reaction was measured by monitoring 
the product at 455 nm. A suitable ionic mechanism has been proposed (Scheme 2) 
basing on the experimental findings where epinephrine is first converted to 
epinephrine quinone (6). Intramolecular cyclization followed by aromatization 
through proton transfer affords leucochrome (7) which further oxidizes to the product 
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adrenochrome through the rate-determining decomposition of the complex C2 (8) via 
a less polar transition state. 
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Complex (C1)
4 5 6
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7 8 9  
(Scheme 2) 
The proposed mechanism gets support from the rate retarding effect in the 
presence of acetic acid and surfactant. The decrease in rate constant due to the 
increase in polarity and hydrogen bond acceptor (HBA) ability of the solvent indicates 
the existence of a less polar transition state and stabilization of the reactants through 
strong intermolecular hydrogen bonding (Scheme 3). Polar solvents with higher HBA 
ability stabilize the reactants and destabilize the transition state leading to an increase 
in energy of activation and lower rate of the reaction.  Addition of surfactants 
(cationic, anionic and non-ionic) decreases the rate of reaction, which has been 
explained through the partition of oxidant and substrate in different 
microheterogeneous media. 
N
CH3
OH
O
O Cr
O
O O-CTA+
OCrO2O
-CTA+
N
CH3
OH
O
O
H
Cr
O
O O-CTA+
OCrO2O
-CTA+
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H
H
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     Intramolecular H-Bonding
in nonpolar/low polar  solvents
Intermolecular H-Bonding
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X: electronegative atom in HBA solvents  
(Scheme 3) 
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The oxidation of anti-tubercular drug isoniazid (10) using CTADC has been 
presented in chapter 4. Isoniazid on oxidation in nonpolar medium generates 
isonicotinic acid (11) both in the presence and in the absence of acetic acid. 
Occurrence of Michaelis-Menten type kinetics with respect to isoniazid confirms the 
binding of oxidant and substrate to form a complex before the rate-determining step 
(Scheme 4). Existence of inverse solvent kinetic isotope effect (k(H2O)/k(D2O) = 0.7) 
in the acid catalyzed reaction provides evidence for a multistep reaction mechanism. 
Decrease in rate constant with the increase in [CTADC] reveals the formation of 
reverse micelle type aggregates of CTADC in non-polar solvents. In the presence of 
different ionic and non-ionic surfactants (CTAB, SDS and TX-100), CTADC forms 
mixed aggregates and controls the reaction due to the charge on the interface and 
partitioning of oxidant and substrate into two different domains. High negative 
entropy of activation (S‡ = -145 and -159 J K-1 mol-1 in the absence and in the 
presence of acetic acid) obtained by calculating the thermodynamic parameters 
proposes a more ordered and highly solvated transition state than the reactants. 
Furthermore, solvent polarity-reactivity relationship reveals (i) the presence of less 
polar and less ionic transition state compared to the reactants during the oxidation, (ii) 
differential contribution from nonpolar and dipolar aprotic solvents toward the 
reaction process and (iii) existence of polarity/hydrophobic switch at logP = 0.73 (log 
P refers to logarithm of partition coefficient between octanol and water). Nonpolar 
solvents contribute more to the reverse micellization whereas polar solvents 
contribute to the stability of reactants and transition state. A suitable mechanism has 
been proposed on the basis of experimental results. These results may provide insight 
into the mechanism of isoniazid oxidation in hydrophobic environment and may assist 
in understanding the drug resistance in different location. 
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Chapter 5 deals with the oxidation of an established anticonvulsant and 
antiepileptic drug, carbamazepine (12) by cetyltrimethylammonium permanganate 
(CTAP) in non-polar medium. CTAP selectively converts carbamazepine to           
1H-dibenzo[b,f]azepine-4,5-dione (13). The kinetics of the reaction was studied in 
organic media spectrophotometrically by monitoring the depletion of Mn(VII) at 530 
nm.  The reaction has been found to be fractional order with respect to carbamazepine 
and first order with respect to CTAP. Based on the experimental findings, a suitable 
mechanism has been proposed consisting of a rate determining syn addition of 
permanganate to the C=C double bond of carbamazepine to form Mn(V)-ester 
intermediate through a nonpolar cyclic transition state (Scheme 5). Subsequently, the 
intermediate decomposes and hydrolyses to the dicarbonyl product. The proposed 
reaction mechanism gets supportive evidences by the effect of solvent polarity and 
temperature on the rate of the reaction. Addition of ionic surfactants increases the rate 
of reaction. The catalyzing effect is explained through the possible formation of 
mixed reverse micellar aggregates where carbamazepine is partitioned more to the 
interfacial region in the vicinity of permanganate anion. 
N
O NH2
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O
O O-CTA+
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O NH2
O
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O
O O-
N
O NH2
O
Mn
O
O O
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22'
33'
44'
N
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O O
13
 
(Scheme 5) 
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Chapter 6 describes the oxidative cleavage of an antibacterial drug 
norfloxacin (14) by CTAP in acetonitrile-water binary mixtures in the presence of 
acetic acid. The metabolized products have been identified as 7-amino-1-ethyl-6-
fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (15), formaldehyde, and 
ammonia (Scheme 6). The kinetics of the reaction was studied by monitoring the 
absorbance of Mn(VII) at 530 nm under pseudo-first-order condition. The reaction 
has been found to be first-order with respect to CTAP and fractional order with 
respect to norfloxacin and acetic acid (Equation 1). Michaelis-Menten type kinetics 
with respect to norfloxacin confirms the binding of oxidant and substrate to form a 
complex before the rate determining step. Based on the experimental findings, a 
suitable ionic mechanism has been proposed.  The proposed reaction mechanism has 
been supported by the effect of solvent polarity and effect of temperature on the 
reaction rate. High negative entropy of activation (S≠ = -259 to -158 J K-1 mol-1) 
proposes the existence of a forced, more ordered and extensively solvated transition 
state. Further, the study on solvent polarity-reactivity relationship reveals (i) the 
presence of less polar transition state compared to the reactants, (ii) differential 
contribution from dipolar aprotic (acetonitrile) and polar protic (water) solvents 
toward the reaction process through specific and nonspecific solute-solvent 
interaction and (iii) the presence of intramolecular hydrogen bonding in oxidant-
substrate complex in acetonitrile rich domain and intermolecular hydrogen bonding 
between oxidant-substrate complex and water in water rich domain (Scheme 7).  
Rate= 0.15 [CTAP]
 0.99
 [Norfloxacin]
 0.73
[Acetic acid]
 0.59
      (1) 
NN
HN
OH
O O
NH2N
OH
O O
F F
1
2
34
7
5
6
8
CTAP
14 15
+ CH2O + NH3 + MnO2
CH3CN/H2O
CH3COOH
 
(Scheme 6) 
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O
O
OH
H
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in water rich domain
Strong intramolecular hydrogen bonding 
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(Scheme 7) 
Summary and the future scope of the present research work have been 
presented in Chapter 7. The work presented in the thesis has been proved to be a 
successful attempt on establishing CTADC and CTAP as mild, chemoselective, 
lipopathic and biomimetic oxidants. The uniqueness in terms of reactivity, selectivity 
and difference with that of other classical and non-classical oxidants has been 
attributed to the presence of CTA
+ 
which tunes the reactivity of the anionic oxidizing 
counterpart through tight ion pair formation in nonpolar medium. These oxidants may 
serve as a non-enzymatic, chemical oxidation model primarily to synthesize the 
selective metabolites of drug candidates in the course of drug discovery and 
development. Elucidation of probable mechanistic pathway of drug oxidation using 
these oxidants in the presence of artificial organised assemblies may serve as a 
reasonable model to enlighten the complex biological reactions occurring at the lipid–
solution interface in the living system and give valuable information for finding more 
suitable drug candidate to fight with oxidative stress and to combat drug resistance.   
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1.1       INTRODUCTION 
Oxidation is one of the fundamental reactions in synthetic organic chemistry 
having importance in both academia and industry, and there is always a demand for 
selective and mild oxidation methods. Indeed, numerous research groups have 
directed their efforts towards the development of novel oxidation processes and the 
trend is continuing. Most of the oxidants are based on oxo derivatives of inorganic 
transition metals like Cr(VI), Mn(VII), Ce(IV), Fe(III), Ru(IV), V(V) etc. However, 
the poor solubility of these inorganic oxidants in nonaqueous medium restricts their 
uses for the oxidation of water insoluble organic substrates and, thus it leads to the 
engineering of many novel oxidants among which the phase transferring oxidants or 
lipopathic oxidants are gaining wide interest. The discovery of phase transfer catalysts 
(PTC) such as quaternary ammonium salts which can transport the active oxidant 
species into organic phase helped to extend their use in organic synthesis to a great 
extent.
1-5 
These active anionic oxidants are transferred to the organic phase in the 
form of soluble salt or an ion pair with PTC (Scheme 1.1). This possibility has 
attracted enormous interest from synthetic as well as mechanistic point of view.  In 
some experiments, the soluble salts are formed in phase-transfer processes in biphasic 
medium and are utilized in situ without isolation, while sometimes, the salts are first 
isolated in aqueous medium and are then dissolved in the desired nonaqueous 
solvents.
3-5
  
R4N
+X- +
(aq)
KMnO4
(aq)
R4N
+ MnO4
- + KX
(org) (aq)  
(Scheme 1.1) 
To convert the inorganic oxidants lipopathic, onium ions (generally refer to 
hypervalent ammonium, phosphonium, arsonium, tellurium, halonium ions etc,)
6
 
having alkyl groups are linked as counterions which help in carrying the oxidant from 
aqueous medium into organic medium.
7-9
 Utilization  of  onium  ions  as  phase 
transfer catalyst is  widely explored in literature.
 
Due to amphipathic characteristics of 
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these onium ions and resultant ion pair characteristics with the anionic oxidants in 
different solvents, the solubility, reactivity, and redox potentials of these oxidants 
vary significantly.
 10-28
 These reagents are found to be mild, chemoselective and 
regioselective.
7-28 
In different reaction conditions, sometimes these oxidants 
containing long chain alkyl onium ions show biomimetic characteristics, due to the 
counter ions, providing a micro-heterogeneous environment with different 
solubilization pockets for the substrates as in case of micelles, reverse micelles, 
microemulsions, vesicles for artificial systems, and proteins and lipid membranes in 
living systems.
10-17
  
With an objective to develop efficient oxidation protocol a great deal of efforts 
in research has been directed toward the development of new oxidants with these 
onium ions. In this regard, oxidizing system containing onium ions and transition 
metal oxo-species of Mn(VII) and Cr(VI) play a vital role since Mn(VII) and Cr(VI) 
are known for the versatility to carry out a wide spectrum of synthetically useful 
oxidative transformations.
29-32
 Herein, we have presented some important synthetic 
applications of these Mn(VII) and Cr(VI) based lipopathic  oxidants containing onium 
counterions giving special reference to their mildness, selectivity and mechanism.  
1.2       OXIDATION OF ORGANIC SUBSTRATES BY LIPOPATHIC Cr(VI) 
Before the discovery of onium chromate or dichromate, water-soluble 
potassium or sodium dichromates were in use with strong acids as oxidants and in 
most cases the products were nonspecific. To make the reagents mild, the first attempt 
might be due to from Sarett school of research, who used pyridine to form salt with 
CrO3, a Lewis acid, to oxidize some steroidal alcohols.
33
 This reagent was 
subsequently used by various workers without analyzing the structure of the 
oxidant.
34-35
 Corey, in his novel attempt for establishing pyridinium chlorochromate 
(PCC)
26
 as a versatile oxidant, revisited to the Sarett’s reagent and discovered it to be 
pyridinium dichromate (PDC).
27
 Later on many heterocyclic ammonium ion based 
Cr(VI) oxidants were synthesized and their oxidation potential towards various 
   
Chapter 1 
3 
 
substrates were investigated. Synthesis and applications of various lipopathic Cr(VI) 
oxidants containing heterocyclic onium ions have been reviewed by Patel and Mishra 
in recent past.
7
 Similarly a number of symmetric and asymmetric 
tetraalkylammonium ions with varying alkyl chain length have been synthesized in 
different research schools to serve as carriers of the oxidants and to deal with organic 
substrates in organic medium. Few applications of some of these lipopathic Cr(VI) 
oxidizing agents having heterocyclic and alkyl onium ions have been elaborated here 
to show their oxidizing ability, selectivity and mildness.  
1.2.1    Heterocyclic ammonium halochromates and dichromates 
Pyridinium chlorochromate (PCC) is one of the most important onium 
halochromates, well known for its versatility and selectivity in numerous oxidative 
transformations. It was first prepared by the addition of pyridine to an equimolar 
mixture of hydrochloric acid and chromium trioxide at 0
o
C (Scheme 1.2).
26
 It was 
extensively used for the selective oxidation of primary alcohol to aldehyde and 
secondary alcohol to ketone.  
+ CrO3 + HCl
N N
H
ClCrO3
-
PCC  
(Scheme 1.2) 
McMorris and Staake used PCC to oxidize the secondary hydroxy group of 5-
chloro-5-methyl-2-cyclopenten-1-ol to corresponding ketone (1) without affecting the 
stereochemistry of the adjacent carbon (Scheme 1.3).
37
 The presence of pyridinium 
ion makes PCC slightly acidic. The pH of 0.01M solution of PCC is 1.75.
38
 Due to 
which the oxidations of compounds with acid sensitive group like tetrahydropyranyl 
ethers, the reaction mixture has to be buffered with powdered sodium acetate (Scheme 
1.4).
26 
Similar buffering methodology was used by  Ordonez et al. for oxidizing (E)--
hydroxysulfoxide by PCC (Scheme 1.5).
39
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OH
Cl
Cl
Cl
Cl
OH
Cl
Cl
OH
O O
OH
PCC
CH
2 Cl
2
PCC
PCC
PCC
CH2C
l2
CH2C
l2
CH
2 Cl
2
(+)-1 (-)-1
 
(Scheme 1.3) 
CH2OTHP
H
HOH2C
H
PCC/CH2Cl2
CH3COONa
H
CH2OTHP
OHC
H
81%  
(Scheme 1.4) 
R S
p-Tot
OH
O
R S
p-Tot
O
O
PCC/CH2Cl2
CH3COONa, RT
R= n-Pr, i-Pr
84-85%  
(Scheme 1.5) 
PCC was utilized by Corey and Boger for the oxidative cationic ring fusion of 
some cyclic unsaturated alcohols and aldehydes.
40
 Efficient cyclization was observed 
only when the substrate is capable of affording a tertiary cation in the initial cyclic 
intermediate (Scheme 1.6). 
CHO
PCC
CH2Cl2
OH
+
O
OH
O
OH
OH
+
H+
O
 
(Scheme 1.6) 
The reactivity of PCC was found to be solvent dependent. As shown in 
Scheme 1.7, the oxidation of secondary hydroxy groups to the corresponding carbonyl 
in sugars by using PCC was found to be inefficient in dichloromethane (DCM) while 
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in benzene the reactivity was increased to a large extent and corresponding cyclic 
ketones were obtained in good yield.
41
   
H3COCOO
O
OH PCC
Benzene
PCC
CH2Cl2
Very slow
reaction O
H3COCOO
O
O
O
73%
 
     (Scheme 1.7) 
Generally, tertiary alcohols are inaccessible for oxidation by oxidizing agents. 
However, with appropriate substituents PCC can transpose tertiary –OH group and 
subsequently oxidize to corresponding carbonyl compounds (Scheme 1.8).
42 
The 
similarity in the reactivity of cyclopropyl ring system with the allyl moiety also led to 
a similar transpose mechanism during oxidation by PCC. Wada et al. used this 
protocol to convert the tertiary alcohol (2) with a cyclopropane ring to a ,-
unsaturated ketone (3) (Scheme 1.9).
43
   
R
OH R
PCC
CH2Cl2
O
OH
R
PCC
CH2Cl2
R
O
2 3  
(Scheme 1.8)                                                          (Scheme 1.9) 
Ren et al. reported a facile one-pot synthesis of 1,3-diketone (5) with 
stereogenic quaternary center at C-2 position on the basis of the oxidative 
rearrangement of a series of -hydroxy epoxides (4) in the presence of PCC and 
proposed a suitable mechanism for the conversion (Scheme 1.10).
44
   
Beihoffer et al. used PCC for the intramolecular oxidative cyclization of bis 
homoallylic tertiary alcohols to yield substituted tetrahydrofuran products via the 
tethered chromate ester (Scheme 1.11).
45
 The authors applied the method in several 
such tertiary alcohols which varied in the number and position of alkyl groups 
attached to the C=C. The relative reactivity of these substrates toward PCC was found 
to depend only on the number of R groups on the C=C, and not on the degree of 
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substitution on the most highly substituted alkene carbon. From this observation they 
suggested a symmetrical transition state in this intramolecular Cr(VI) alkene 
oxidation.  
O
R1 OH
R2
n
R3
PCC
CH2Cl2, RT
R3
O
R2
O
R1
n
R1,R2 = alkyl or aryl
R3 = Me, H   n = 0,1
O R2R1
H
HO
R3
R4
Cr
O O
O
OH
OPyH
R2
HR1
R3
R4
Cl
PCC H O
R4
R2
O
R1
R3
Cr
OHO
Cl
H+Py-O
O O
R4R1
R2
R3
+ CrHO
OH
Cl
O-PyH+
R1,R2 = cyclohexyl, cyclopentyl
R3, R4 = aryl, pentyl
4 5
4
5
 (Scheme 1.10) 
OH
PCC
O OH
 
(Scheme 1.11) 
The Cr(VI) oxidation on the double bond is limited to alkenes or their 
derivatives. In contrast, PCC can be applied for the conversion of more electron rich 
enol ethers to esters and cyclic enol ethers to lactones (Scheme 1.12).
46  
R1 H
H OR2
PCC
CH2Cl2
R1
H2
C COOR2
O
PCC
CH2Cl2 O O
O
OTBS
OPMB
PCC, Silica gel
450C, 75%
O
OTBS
OPMB
O
 
(Scheme 1.12) 
PCC in conjunction with silica gel was proved to be a better oxidant for 
organic substrates. In the synthesis of dienyl diesters (8) Phillips et al. used silica 
supported PCC for the oxidation of ,-unsaturated hydroxy esters (6) followed by 
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trapping of the intermediate aldehydes with Wittig reagent 7 (Ph3P=CR2CO2R3) in a 
sequential one-pot procedure (Scheme 1.13).
47 
OH
EtO2C R1
n
R1 = H,Me   n = 2, 3
PCC, imidazole
Ph3P=CR2CO2R3
EtO2C CO2R3n
R1 R2
R1 = H,Me   R2 = Me, Et
6
7
8
 
(Scheme 1.13) 
PCC adsorbed on silica was applied to react with an allylic tertiary hydroxy 
group in 3-cyclohexene-1,2-diols (9) to yield 1,4-dihydrobenzoquinone (10).
48
 Kim 
and Koo proposed a mechanism for the reaction wherein the secondary alcohol is 
initially oxidized to the corresponding ketone followed by subsequent transposition of 
tertiary allylic alcohol and its oxidation and enolization finally led to the product 
formation (Scheme 1.14).
48 
OHR
HO PCC, silica
CH2Cl2
R = alkyl
OHR
O
OR
O
Cr
O
O-
O
O
R
H
O
Cr
O
O-
O
O
O
R
HO
OH
R
9
10
 
(Scheme 1.14) 
By adsorbing PCC on various solid supports like alumina, silica gel and 
montmorillonite, Eynde et al.
49 
investigated the aromatization of 1,4-dihydropyridines 
(11) to the corresponding pyridine (12) (Scheme 1.15) and found it to be more 
advantageous than aromatization in solution.
 
 The solid matrix helps in the isolation of 
pure product from the gummy mass, which is mostly obtained in solution.  
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N
H R
CO2EtEtO2C
Me Me
H
PCC, silica support
CH2Cl2
N
CO2EtEtO2C
Me Me
R
R = H, Alkyl, Aryl11 12  
(Scheme 1.15) 
McNab et al.
50
 found PCC as an efficient oxidizing agent for the conversion of 
secondary alcohol 13 to the pyrrolizine-1,3-dione (14). Efficient agitation of the 
reaction mixture throughout the oxidation along with magnetic stirring and bubbling 
nitrogen through the solution significantly increased the yield of the product.  For the 
conversion of the 13 to 14 other oxidation methods met with little success. For 
example, Dess–Martin condition gave unidentified decomposition products. Swern 
oxidation converted the desired dione 14 to ylide 15 (Scheme 1.16). Pyridinium 
dichromate (PDC) and manganese dioxide (MnO2) mediated oxidation of 13 was 
successful but the yield was significantly lower. 
N
OH
O
N
O
O
N
O
O
SMe2
PCC
60%
Swern oxidation
Dess-Martin oxidation
Decomposed product
13
14
15
14
 
(Scheme 1.16) 
For the synthesis of various substituted enantiomerically enriched flavanones, 
and chromanones Zhao et al. utilized a two step strategy comprises of stereoselective 
hydrogenation followed by selective oxidation (Scheme 1.17).
51
 To preserve the 
integrity of the newly formed stereocenter at C2, PCC was found to be the best choice 
as mild and selective oxidizing agent.  
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O R
O
Flavone
Chromone
[Ru], NHC
H2
O
OH
R
PCC, CH2Cl2
RT, 10 min
O
O
R
Flavanone
Chromanone
NN
BF4
-
Chiral N-Heterocyclic cerbene (NHC) ligand
Flavanols
Chromanols
 
(Scheme 1.17) 
Reddy et al.
52
 reported a new synthetic route to -lactone, simplactone B (19) 
utilizing the highly stereoselective Prins cyclization and PCC mediated over oxidation 
from (R)-benzyl glycidyl ether 16 (Scheme 1.18).  Oxidation of the cyclized alcohol 
17 using excess of PCC in refluxing conditions in benzene resulted in the lactone 18 
in 83% yield (as the only isolable isomer from column chromatography). 
Deprotection of MOM group of 18 using trifluoroacetic acid (TFA) in DCM furnished 
the target product simplactone B 19 in 85% yield. The oxidation has been presumed 
to proceed as shown in Scheme 1.18.  Similar strategy for the synthesis of -lactone 
via PCC mediated oxidative cleavage of pyranyl methanols have been reported by 
Yadav  et al.
53-54 
O
OBn
O
OMOM
OH
Benzene
Reflux, 6h, 83%
O
OMOM
O
TFA, DCM
RT, 2h, 85% O
OH
O
O
OMOM
O
OMOM
O
OMOM
O
OMOM
OH
PCC
O
OH
O
Cr
O
O
O
CrO2 
   + 
HCHO
16
17 18 19
18
+
17  
(Scheme 1.18) 
 
   
Chapter 1 
10 
 
As chromium(VI) species are known to be carcinogenic and environmentally 
hazardous, Piccialli et al.
55
 have used a greener approach for the oxidation of  some 
mono- and poly-THF compounds using the catalytic system PCC (cat.)/H5IO6. PCC 
with periodic acid (H5IO6) generates the active oxidant chlorochromatoperiodate 
(CCP). Novel oxidative pathways leading to the modification/degradation of 
tetrahydrofuran (THF) ring, as well as of the poly-THF backbone, have been 
described. Attack of the oxidant at the angular C–H bond of the target THF ring with 
formation of a mixed chromium ester has been proposed to be the first event followed 
by two main routes. Oxidative carbon-carbon bond cleavage, to give dicarbonyl 
products (20), was reported for 2,2,5-trisubstituted THFs while for 2,5-disubstituted 
mono-THFs,  1,4-Diketones (21) were found to be the only product. The proposed 
catalytic cycles for these two processes have been presented in Scheme 1.19 and 
1.20.
55
 Hunsen described similar greener oxidation of alcohols, glycosides and 
sulfides using PCC as the catalyst together with periodic acid as co-oxidant.
56
   
O
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OBz
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O
Cr Cl
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HO
H
O
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OBz
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O
OBz
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O
O
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OH
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O
O
Cl
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O
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H
H
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(Scheme 1.19) 
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(Scheme 1.20) 
For the synthesis of Farnesoid X Receptor (FXR) agonist 6a-
ethylchenodeoxycholic acid (6ECDCA), PCC was used for the regioselective 
oxidation of one of the two hydroxyls of the l-chenodeoxycholic acid (CDCA). The 
regioselective oxidation of the axial 7-hydroxyl of CDCA with PCC in chloroform or 
DCM at room temperature afforded the desired 7-keto (22) in 82% yield (scheme 
1.21).
57
 The survival of the equatorial 3-hydroxyl can be explained through the higher 
ease of oxidation of axial hydroxyl groups by Cr(VI) oxidants than equatorial 
hydroxyls. During the removal of the chromate ester carbinol hydrogen, 1,3-diaxial 
strain (axial hydrogen from carbon 4, 9 and 14) gets relieved for an axial chromate 
ester (23), but not for an equatorial ester.  
Oxidation of 14-α-hydroxydihydroisopimarate (24) by PCC was not 
particularly selective and formed a mixture of compounds, the ratio of which 
depended on the amount of oxidant used (Scheme 1.22).
58
 Epoxy derivatives 27 and 
28 could be formed as a result of isomerization of chromic ester 29 into 7-
oxychromate 30 with subsequent formation of 8α, 14α-epoxychromate 31, hydrolysis 
of which gave epoxy alcohol 27 and oxidation gave 7-keto-derivative 28. 
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(Scheme 1.21) 
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(Scheme 1.22) 
Oxidation of sterically crowded γ, δ-unsaturated primary and secondary 
alcohols (32 a-g) with 2.5 equivalents of PCC and silica gel in DCM at room 
temperature furnished the corresponding bicyclic ketones (33 a-g) in moderate to 
good yield as well as the expected aldehydes (34 a-g) (Scheme 1.23).
59
 The bicyclic 
ketone (33a) was also found to form on oxidation of alcohol (32a) under various 
conditions, viz. PDC in DCM, PCC in the absence of silica gel and PCC and sodium 
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acetate. However, Jones reagent failed to generate the ketone 33a, and furnished only 
a mixture of aldehyde 34a and the corresponding acid which ruled out the role of the 
acidity of PCC in the formation of the bicyclic ketone.  Similar strategy of the 
oxidation of γ, δ-unsaturated alcohols by PCC to afford bicyclic ketone was also 
applied by Heinrich et al. to carry out the oxidation of the etheno-bridged 
[4.3.1]propelladienol (35) to oxa[5.6.5.6]fenestratetraene (36). The reduction of 36 
with diisobutylaluminum hydride (DIBAL-H) regenerated its precursor (Scheme 
1.24).
60 
OH
+
R
O
O
H
O
32 a-g 33 a-g 34 a-g
R
R
a: R= H, b: R= Me, c: R= Bu, d: R= Vinyl, e: R= Allyl,
              f: R= homoallyl, g: R= Benzyl
PCC/Silica
DCM, RT
 
(Scheme 1.23) 
OH OTf
OTf
PCC
DIBAL-H
O
35 36  
(Scheme 1.24) 
For the selective conversion of densely functionalized ally ether (7R, 6S, 5S, 
4R)-7-epi-Tri-acetoxy-3,6-dihydro-2H-pyran (37) to the corresponding (7R, 6S, 5S, 
4R)-7-epi-triacetoxy(-)goniotriol (38) Srikanth et al. used PCC in DCM medium. 
PCC oxidized 37 to 38 in good yield without affecting the stereochemistry at 
neighboring carbons (Scheme 1.25).
61
 Gowrishankar et al. have also reported similar 
chemo and regioselectivity in PCC mediated oxidation of the exo-methylene 
tetrahydrofuran derivatives (39, 41, 43, 45) to the corresponding β, β-disubstituted-α-
methylene-γ-butyrolactones (40, 42, 44, 46) (Scheme 1.26).62  
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         44 h
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46
 
(Scheme 1.26) 
Silica gel supported PCC was successfully applied as heterogeneous oxidizing 
agent for the oxidative cyclization of structurally diverse thiophenolic and phenolic 
schiffs bases (47), thereby providing an efficient and convenient method for the 
synthesis of a library of 2-arylbenzothiazoles and 2-arylbenzoxazoles (48) in good to 
excellent yields (Scheme 1.27).
63
  
N Ar PCC/silica
DCM, rt
Z = O, S
Z
N
Ar
47 48
ZH
 
(Scheme 1.27) 
A simple and efficient method for the oxidation of indoles (49) and 7-
azaindoles (51) to isatins (50) and 7-azaisatins (52) using PCC-silica gel with the aid 
of Lewis acid catalyst aluminium chloride (AlCl3) in dichloroethane was described by 
Sriram et al. (Scheme 1.28).
64
 Simplicity of the reaction conditions, easy workup 
procedure, and good yields are the key features of this protocol.  
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(Scheme 1.28) 
Similar to PCC, Pyridinium fluorochromate (PFC) was prepared from a 
solution of CrO3 in hydrofluoric acid (HF) and pyridine at an ice-cold temperature 
and was used for various oxidation processes.
38
 It was  used  in the selective oxidation 
of secondary alcohols in the presence of primary alcohols and in the conversion of 
polycyclic hydrocarbons to cyclic ketones, benzoin to benzil, PPh3 to Ph3P=O, 
methylphenyl sulfide to corresponding sulfoxide, cyclohexanone oxime to 
cyclohexanone, deprotection of dioxolanes and dithiolanes to aldehydes and  allylic 
Δ5-steroid to the corresponding α,β- unsaturated ketone.65 PFC was applied to a 
selective oxidation of secondary hydroxy groups in the presence of primary or 
secondary tert-butyldimethylsiloxy groups and the selectivity was found to be higher 
than that of the PCC.
66
 The higher selectivity was attributed to the lower acidity of 
PFC than PCC.   
N
N
OH
N
N
OH
N
N
N
N
O
O
CH2COOH
COOH
O
O
+ +
N
N
OH
O
O
N
N
O
O
OH
N
N
O
O
PFC
X
45%
+
PFC
53 54 55 56
57
 (Scheme 1.29) 
Versatility of PFC can easily be shown from the oxidation of vasicine (53). 53 
was selectively converted to vasicinone (54) as the major product along with the 
minor products 55, 56 and 57 (Scheme 1.29) when oxidized by PFC in acidic 
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medium.
67
 Similarly oxidation of 3-carnene (58) and -pinene (59) with PFC 
afforded some novel oxidation products in acidic medium (Scheme 1.30).
68
 
PFC
O
45%
O O
O
O
30%
17%
PFC
CHO5%35%
+
+ +
58
59
60 61 62
63 64  
(Scheme 1.30) 
Pyridinium bromochromate (PBC), another reagent of the onium 
halochromate family was used for the oxidation of several organic compounds such as 
benzhydrol, methionine, oxalic and formic acid, aliphatic aldehydes, benzyl alcohol, 
aliphatic alcohol, thioacids, organic sulfides, oximes and amino acids.
69
 PBC can also 
be used for the bromination of aromatic compounds.
69-71
 For the bromination of 
various poly-substituted 4-pyridones (65) to get the corresponding brominated 
product (66) via an oxidative nuclear bromination PBC was used as sole reagent 
(Scheme 1.31). In this case PBC performed the dual role of oxidant as well as source 
of bromonium ion.
71 
N
R2
N
H
O
OR2
R1 R
3 PBC
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N
R2
N
H
O
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R1 R3
Br
R1 = aryl; R2 = alkyl; R3 = aryl or alkyl
N+HCrBr
O
O
O
PBC
65
66
 
(Scheme 1.31) 
Quinolinium fluorochromate (QFC), can easily be prepared from quinoline, 
40% aqueous HF and chromium trioxide in a molar ratio of 1:1.5:1.
72,73 
QFC is acidic 
(pH of a 0.01 M solution: 2.65) but less pronounced than PCC (pH of a 0.01 M 
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solution: 1.75). Primary alcohols are found to be oxidized faster than secondary 
alcohol by this reagent.
74 
In a competitive deprotection reaction of thioamides, 
thioureas, thionoesters and thioketones by QFC; thioamides and thioureas were 
selectively converted to the corresponding carbonyl groups in presence of the other 
two functional groups (Scheme 1.32).
75
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(Scheme 1.32) 
3-Carboxypyridinium chlorochromate (CPCC) prepared as per Scheme 1.33
76
 
was used for the efficient conversion of primary and secondary trimethylsilyl and 
tetrahydropyranyl (THP) ethers to their carbonyl compounds under nonaqueous 
condition. Trimethylsilyl ethers were oxidized selectively in the presence of 
tetrahydropyranyl ethers.
77
 
N
COOH
+ CrO3 + HCl
N
COOH
H
+
ClCrO3
-
CPCC  
(Scheme 1.33) 
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CPCC in the presence of aluminium chloride can selectively oxidize sulfides 
to sulfoxide and sulfones without effecting different functional groups including 
carbon-carbon double bonds, ketones, oximes, aldehydes, ethers, and acetals.
78
 
Aromatization of a variety of 1,4-dihydropyridines was conducted  to get their 
corresponding pyridines in excellent yields by CPCC.
79
 Different types of thioamides, 
thioureas, thiono esters and thioketones were deprotected to their corresponding 
carbonyl compounds with this reagent in good to excellent yields. 
2,6- Dicarboxypyridinium chlorochromate (DCPCC) prepared by the reaction 
of pyridine-2,6-dicarboxylic acid with chromium trioxide in 6N hydrochloric acid was 
found to be less acidic than that of PCC.
80-82
 This reagent was able to selectively 
oxidize the hydroxy group in presence of other oxidizable functional groups and 
benzylic alcohols in presence of other primary or secondary hydroxy groups (Scheme 
1.34).
81
 Selective deprotection of acetals or 1,1-diacetates in the presence of 
thioacetals at room temperature was also undertaken with this reagent. 
H2
C
H2
C OHPh +
H2
C OHPh
DCPCC
MeCN, RT, 8min
H2
C
H2
C OHPh + CHOPh
unchanged
H2
C
H2
C OHPh +
H2
C OHC6H4o-Cl
DCPCC
MeCN, RT, 9min
H2
C
H2
C OHPh + CHOC6H4o-Cl
unchanged
97%
98%
 (Scheme 1.34) 
Another noteworthy advantage of the reagent is the exclusive oxidation of 
oximes irrespective of the presence of semicarbazones or phenyl hydrazones. 
Oxidation of semicarbazones or phenyl hydrazones require a higher molar ratio of 
oxidant, much longer reaction time, and reflux temperature in acetonitrile and give 
low yield of products.
81 
Heravi et al. found DCPCC as a  highly effective oxidizing 
agent for the very fast conversion of dihydropyridines to pyridines under simple and 
relatively mild conditions in excellent yields.
83
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Pyridinium dichromate (PDC), another well-known and effective lipopathic 
Cr(VI) reagents was synthesized by gradual addition of pyridine to a cooled solution 
of chromium trioxide in water maintaining the temperature under 30
0
C.
27
 After 
dilution with acetone and cooling to - 20
0
C, PDC was collected as orange crystals 
with a good yield. The high solubility in H2O, DMF, DMSO, and DMA contributes to 
the versatility of the reagents for organic substrates. The reagent has been mostly used 
in DMF and DCM. 
For oxidation of alcohols by PDC in DMF generally 1.25 equivalent of the 
oxidant is required to get corresponding carbonyl compounds with excellent yield 
without any side product, over oxidation or E to Z isomerization.
84-87 
However with 
3.5 equiv. of PDC in DMF, saturated primary alcohols are readily converted to 
carboxylic acids in good yields at room temperature through the intermediacy of 
isolable aldehydes.
88,89
 This direct conversion of primary alcohols to carboxylic acids 
by PDC is convenient and is also possible in alcohols containing acid and base 
sensitive functionality.
90-92 
 For example, oxidation of the primary alcohol 
functionality of 67 with PDC in DMF afforded the corresponding acid (68)  in 72% 
yield without effecting the protected hydroxyl group (Scheme 1.35).
93
  
OH
OPMB
PDC, DMF, 72%
OH
OPMB
O
67 68  
(Scheme 1.35) 
The mildness and selectivity of PDC is well documented from the oxidation of 
secondary hydroxyl group of 69 to yield the corresponding cyclic carbonyl compound 
70 in 95% yield at 0 
0
C in DMF (Scheme 1.36).  The sensitive thioacetal group was 
unaffected by this reagent.  For the oxidation of 69, PCC and Jones reagent were 
found to be nonspecific and the thioacetal unit was also affected by these reagents.
27 
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N
H 2
Cr2O7
2-
PDC
O
Br
OH
S S
DMF
00C, 6h, 95%
O
Br
O
S S
69 70  
(Scheme 1.36) 
The oxidation of citronellol (71) to the corresponding acid (72) is another 
example of the mildness of the reagent. Under acidic conditions, the intermediate 
aldehyde (73) of citronellol undergoes cationic cyclization to form pulegone (74) 
(Scheme 1.37).
40 
H CH3
OH
PDC
DMFCOOH
H CH3
Cr(VI)/Acid
CHO
H CH3 H CH3
OH
H CH3
O
7172 73 74
 (Scheme 1.37) 
Arnone et al. reported selective oxidation of secondary alcohol over primary 
alcohol by PDC.
94
 At room temperature when treated with PDC for 4 hrs 75 yielded 
76 (Scheme 1.38). 
O
HO
Cl
OH
OH
O
HO
Cl
OH
O
PDC, CH2Cl2
RT, 4h
90%
75 76  
  (Scheme 1.38) 
PDC in DMF oxidized derivative of homoallylic alcohol (77) to trans-
enediones (79) in good yields (Scheme 1.39) and proposed to be proceed through the 
intermediacy of the ketone (78).
95 
Hector et al. 
96
 also used PDC for the conversion of 
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various substituted steroidal homoallylic alcohol 5-3-alcohols (80) to the 
corresponding 4-3,6-diketones (81) in good yields  (Scheme 1.40). 
R1
H
C
H2
C
OH
C
H
C
H
R2 R1 C
H2
C
O
C
H
C
H
R2
PDC:DMF
R1 C C
H
O
C
H
C R2
O
PDC:DMF
77 78 79   
(Scheme 1.39) 
HO O
PDC:DMF
rt
66-95%
O80 81  
(Scheme 1.40) 
Oxidation of triol (82) with PDC gave diketone (83) as the sole product in 
93% yield instead of the expected ketone (84). Further, the stereochemistry of the 
secondary –OH group was not affected during the transformation. Even though the 
reaction time was increased to 19h using 10 equivalent of PDC, the corresponding 
triketone (85) was not formed (Scheme  1.41).
97
 In the oxidation of triol (86a)  by 
PDC with an aim to get the corresponding 16-oxo compound Morzycki et al. rather 
isolated  D-seco-aldehyde (87a) in 85% yield even in presence of excess of the 
reagent. The fragmentation of a cyclic chromate ester intermediate was proposed for 
the formation of this product (Scheme 1.42).
98
 
 
OH
OH
OH
PDC
CH2Cl2, rt
OH
O
O
OH
OH
O O
O
O
82 83 84 85
 
(Scheme 1.41) 
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86 a: R=H
     b: R= TES
87 a: R=H (85%)
     b: R= TES (65%)
(Scheme 1.42) 
When the diastereomeric triols 88 and 89 were subjected to oxidation with 
PDC, interestingly a single product 90 was formed (Scheme 1.43).
97
 A probable 
reaction mechanism was proposed in which the selective oxidative cleavage of vicinal 
tertiary diols is accompanied by remote asymmetric induction and the stereochemistry 
of the secondary hydroxyl group is controlled. Again, the triketone (91) might not be 
produced due to the stabilization of the sterically hindered hydroxyl group as shown 
in structure ‘C’.  
OH
OH
OH
PDC
CH2Cl2, 4h, rt
O
O OH
OH
OH
OH
PDC
CH2Cl2, 4h, rt
OH
OH
OH OH
OH
O O
oxidation
fast
O
Cr
O
O
O H
O H
O
O OH
single isomer
O
O
O
H
oxidationO
O O
X
88 90 89
90
88
91
A B
C
 
(Scheme 1.43) 
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Nyangulu et al. used PDC in benzene in presence of tert-butylhydroperoxide 
and celite to oxidize various alkyl-substituted aromatics at benzylic carbon hydrogen 
bond to furnish a ketone (Scheme 1.44).
99
  
OH
COOCH3
OH
COOCH3PDC/benzene
t-BuOOH
O
78%  
(Scheme 1.44) 
PDC in DCM selectively oxidized primary trimethylsilyl ether in presence of 
secondary trimethylsilyl ether.
100
 tert-Butyldimethyl and tert-butoxydiphenylsiloxy 
groups are found to be stable under these conditions. Thus, an alcohol can be 
selectively oxidized to the carbonyl compound in presence of tert-butyldimethylsiloxy 
groups. Similar selectivity has been observed in presence of triisopropyl-, tert-
butyldiphenylsiloxy,
 
and tributylsiloxy groups. Selective oxidation of the –OH group 
by PDC in presence of dimethoxytrityl (DMT) ether was undertaken to oxidize 2’-
hydroxy of thymidine (92) to the corresponding ketone (93) (Scheme 1.45).
101 
N
NH
R
O
O
ODMTO
OH
N
NH
R
O
O
ODMTO
O
PDC
R = H, CH3
92 93  
(Scheme 1.45) 
Coleman et al. for the synthesis of eupomatilone 6 (96 and 97) used PDC for 
the selective oxidation of 94 to corresponding aldehyde (85% yield). The aldehyde 
formed in the first step cyclized to lactol, 95 after fluoride-mediated deprotection of 
the silyl ether in THF. Compound 95 was produced as a mixture of diastereomers, 
presumably from epimerization of the intermediate aldehyde under basic reaction 
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conditions. Lactol to lactone oxidation in DCM afforded a 1:3 mixture of 96 and its 
epimer, 97 (Scheme 1.46).
102 
H3CO
H3CO
OCH3
OH
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O
O
H3CO
H3CO
OCH3
O
O
O
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O
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O
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H3CO
OCH3
O
O
O
O
+PDC
CH2Cl2
PDC
nBu4NF
Eupomatilone 694 95 96 97
 
(Scheme 1.46) 
PDC is also useful for oxidizing aldehydes in aprotic media, giving rise to the 
corresponding acids.
27
 However it requires a longer reaction time. During the 
synthesis of ()dihydronepetalactone, the precursor 99 was synthesized from the 
corresponding aldehydes (98) by treating with PDC in DMF at 20
0
C for 22 h (Scheme 
1.47).
103 
O
H
H
OHC
O
H
H
HOOC
PDC, DMF
200C, 22h
98 99
79%
 
 (Scheme 1.47) 
PDC in presence of acetic anhydride (Ac2O) as oxidizing system was used 
recently by  Mahadevegowda and Khan for bis oxidative cleavage reaction of THF 
alcohols (100) to afford lactones (101).
104
  A detailed plausible mechanism of the 
cleavage reaction was proposed (Scheme 1.48). The treatment of THFs with PDC in 
presence of acetic anhydride causes Cα-Cβ bond scission, driven by the generation of 
an oxonium intermediate A with expulsion of a formaldehyde. Intermediate A then 
reacts with another equivalent of dichromate in two possible path ways (a and b) to 
form intermediates B and D respectively. The reductive decomposition of cyclic 
chromate ester C through Cα-Cβ bond cleavage delivers c-lactones (101) with the 
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liberation of another equivalent of formaldehyde in both the pathways. This method 
was further extended for the oxidation of other THF diols (102) to afford lactones 
(103) in moderate yields (Scheme 1.49).
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(Scheme 1.48) 
O
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R2H
H
PDC, AC2O
DMF, rt, 1h
O
R1
R2H
H O
R1 = H, R2 = CH2OTBDPS
R1 = CH2OTBDPS, R
2 = H 54%
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(Scheme 1.49) 
PDC was utilized for the oxidative allylic rearrangement of cycloalkenol (104) 
to afford the keto derivative 105 easily, despite a high degree of functionalization and 
steric interactions. It was assumed that the hydroxyl group is fixed in a pseudo-axial 
orientation in the transition state during [3,3]-sigmatropic rearrangement, thus 
minimizing the steric hindrance (Scheme 1.50). Any other orientation would cause 
severe steric interaction with the 3-methyl group.
106 
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HO
CO2CH3 PDC, CH2Cl2
reflux, 91%
CO2CH3
O O
Cr
O O
O
CO2CH3
(+)-104
(+)-105  
(Scheme 1.50) 
Mal et al. synthesized furo[3,2-c]pyran-4-one upon PDC oxidation of chiral 
substituted furan without affecting the protecting groups and the stereochemistry of 
the adjacent carbon (Scheme 1.51). 
107 
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(Scheme 1.51) 
1.2.2  Alkylammonium halochromates and dichromates 
With an aim to develop mild, lipopathic and chemoselective oxidizing system 
many alkylammonium ions are also used as counterions as the carrier of anion 
oxidants.  Significant improvement has been achieved by the use of new oxidizing 
agents with tetralkylammonium ion like tetrahexylammonium, tetrabutylammonium 
tetrapropylammonium, tetraethylammonium, tetramethylammonium etc. as counter 
ions and chlorochromate, fluorochromate, bromochromate and dichromate as anionic 
oxidants.  
Tetrabutylammonium ion has been extensively used due to its balanced 
amphiphilic characteristics. Various oxidants developed with tetrabuylammonium ion 
include tetrabutylammonium chlorochromate (TBACC),
108 
fluorochromate 
(TBAFC),
109 
chromate (TBAC),
110
 bromochromate (TBABC).
111 
 TBAFC has been 
used for the effective and selective oxidation of alcohols, under mild conditions.
109
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TBABC and tetrapropylammonium bromochromate (TPABC)
111 
oxidize alcohols to 
corresponding  carbonyl compounds under mild conditions.  
Pourali et al.
110
 reported the conversion of oximes into the corresponding 
carbonyl compounds by using TBAC under homogeneous, aprotic and moderately 
acidic conditions. TBAC oxidizes hydroquinones to quinones in dichloromethane 
whereas in the presence of sodium nitrite it catalyzes the nitration process without 
affecting the phenolic hydroxyl group.
112
  Similar reactivity has been observed for 
tetrabutylammonium dichromate (TBAD) under neutral aprotic conditions in CH2Cl2 
(Scheme 1.52).         
OH
R
OH
H
NO2
TBAD or TBAC
NaNO2
CH2Cl2/ Reflux
OH
OH
O
O
CH2Cl2/ Reflux
TBAD or TBAC
 
(Scheme 1.52) 
Tetraethylammonium chlorochromate (TEACC)
113
 is one of the versatile 
reagents for efficient and selective oxidation of organic substrates like crotonaldehyde 
in acetic acid.
114  
TEACC was used by Tomar and Kumar for the oxidation of  
aldohexose like, D-mannose, D-fructose, D-glucose and D-galactose.
115 
Oxidation 
kinetics of some α-hydroxy acids like glycolic, lactic, malic, and a few substituted 
mandelic acids to the corresponding carbonyl compounds with TEACC was studied 
by Swami et al. in DMSO medium (Scheme 1.53).
116 
Similarly TEACC was also 
utilized for the selective oxidation of some lower oxyacids of phosphorus to the 
corresponding oxyacids with phosphorus in higher oxidation state in apolar medium 
(Scheme 1.53).
117 
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 (Scheme 1.53) 
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The conversion of diols and their monoethers to corresponding hydroxy 
carbonyl compounds,
118
 organic sulphides to the sulfoxides,
119 
 aliphatic primary 
alcohols to aldehydes,
120
  aliphatic aldehydes to carboxylic acids,
121
 and 
deoximination of aldo- and keto-oximes
122 
 by TEACC in DMSO medium 
demonstrated the mildness and selectivity of this oxidant.  
  Tetramethylammonium fluorochromate (TMAFC) and chlorochromate  
(TMACC) prepared by the reaction of the corresponding quaternary ammonium salts 
with CrO3 in a 1:1 molar ratio in acetonitrile medium constitute another class of 
lipopathic Cr(VI) oxidants.
123 
 TMACC was used by Hajipour et al. for oxidative 
deprotection of trimethylsilyl, tetrahydropyranyl ethers, ethylene acetals and ketals to 
the corresponding carbonyls 
124
 and  selective oxidation of thiols to corresponding 
disulfides.
125
 
A valuable addition to the prolific oxidant family is the trialkylammonium 
halochromates (R3NH [CrO3X]) (R= CH3, C2H5, C3H7 and C4H9, X= Cl, F).
126
 These 
reagents are of low cost, readily available and capable of oxidizing numerous organic 
substrates. Oxidative conversion of benzhydrols to the corresponding benzophenones 
by tributylammonium chlorochromate (TriBACC), alcohols to aldehydes or ketones, 
anthracene and phenanthrene to anthraquinone and  phenanthraquinone by 
tripropylammonium fluorochromate (TriPAFC), thiols to corresponding disulfides by 
tripropylammonium chlorochromate (TriPACC) and  TriPAFC are some note worthy 
applications of these reagents.
126
  
Chemisorbed on alumina and silica, dimethylammonium chlorochromate 
(DMACC) was found to be effective for oxidation of alcohols, benzoins
 
and 
regeneration of carbonyl compounds by oxidative cleavage of C=N under non-
aqueous condition.
127-129 
Similarly the effectiveness of N-methylbenzylammonium 
fluorochromate (MBAFC)
130 
and N-ethylbenzylammonium fluorochromate 
(EBAFC)
131
 was considerably increased upon its adsorption on silica gel. Many 
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functional groups are inert towards these oxidizing agents, including thiols, sulfides 
and phenols, enhancing the usefulness as chemoselective reagents for the synthesis of 
highly functionalized molecules. Regeneration of carbonyl compounds from their 
nitrogen containing derivatives (oximes, p-nitrophenylhydrazones, 4-
phenylsemicarbazones and semicarbazones) was achieved using methylammonium 
chlorochromate adsorbed on silica gel (MCC/SiO2) with good yields.
132 
Landini and Rolla synthesized bis-tetrabutylammonium dichromate (BTBAD) 
and used for the successful conversion of  substituted benzyl bromides to the 
corresponding carbonyl compounds.
133
 Under microwave conditions, deprotection of 
oximes by BTBAD was achieved by Murugan and Reddy.
134
 By employing BTBAD, 
1,4-diacylbenzenes was synthesized in good yield by Suhana and Srinivasan.
135
 
Tetramethylethylenediammonium dichromate (TMEDADC) obtained from CrO3 and 
TMEDA was utilized for selective oxidation of benzylic and allylic alcohols.
136 
Cetyltrimethylammonium dichromate (CTADC) was synthesized by Patel et 
al. by a simple ion exchange method from cetyltrimethylammonium bromide (CTAB) 
and potassium dichromate (Scheme 1.54).
137
 CTADC is insoluble in water and 
soluble in most of the organic solvents. It is found to be stable in these solvents at 
reflux temperature and for an appreciable time period (>24 h). On water surface, it 
forms condensed monolayer and assumes an area of 51 A°
2
/ molecule at a 
temperature of 298 K.
138 
2C16H33N
+
(CH3)3Br  +  K2Cr2O7  → [C16H33N
+
(CH3)3]2Cr2O7  +  2KBr 
(Scheme 1.54) 
CTADC has shown its effectiveness in the oxidation of various functional 
groups like alcohols, aldehydes, hydroxyquinones, cinnamic acid etc in chloroform or 
DCM under mild reaction conditions.
137
 The oxidized products of alcohols and 
hydroxyquinones are found to be the corresponding carbonyl compounds and 
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benzoquinones, respectively. CTADC converts cinnamic acid to benzoic acid and 
aromatic aldehydes to benzoic acids in nonpolar medium. The reagent oxidizes amino 
and mercapto groups to give the corresponding diazo and disulfides respectively 
through dehydrogenation process (Scheme 1.55).
139
 This strategy of selective 
oxidation of amino compounds by CTADC was successfully demonstrated in the 
oxidation of 2-aminobenzothiazole to the corresponding diazo product selectively 
instead of expected sulfur oxidized products (sulfoxide or sulfone) (Scheme 1.56).  
R SH R S S R
CTADC
NH2
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CHCl3CHCl3
N N
XX
X = H, o-OH, p-OH, p-OMe, p-Cl
R= Bu, Ph, o-MePh, p-MePh, Bn,
Benzothiazolyl
X
 
(Scheme 1.55) 
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(Scheme 1.56) 
Oxidation of cholesterol by CTADC in refluxing DCM afforded 7-
dehydrocholesterol as a result of the introduction of a double bond by 
dehydrogenation process.  The –OH group at C3 remain unaltered. The proposed 
remote functionalization mechanism suggests the initiation of the reaction through an 
association of the 3-OH group with the chromate ion of CTADC and a secondary 
overlap of π-orbitals of cholesterol at the C5-C6 position with that of Cr=O bond, 
which assist the system in achieving proper orientation. Subsequent reaction takes 
place at an equidistant site of the active centre of the reagent at the cholesterol nucleus 
(Scheme 1.57).
140
 In the presence of acetic acid however the expected 5-cholesten-3-
one was isolated as the major product. The difference in the reactivity in the presence 
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of acetic acid is proposed to be primarily due to the decrease in the contactness 
between CTA cation and dichromate anion.
138
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(Scheme 1.57) 
The difference in reactivity of CTADC in terms of product formation in the 
presence of acetic acid and in the absence of acetic acid was also observed in the 
oxidation of oximes (Scheme 1.58).
141-142
 Easy deprotection of oximes was achieved 
by CTADC in the presence of a trace amount of acetic acid in dichloromethane.  
However, when the above reaction was performed in the absence of acetic acid, the 
corresponding nitrile derivatives was obtained from aldoximes while ketoximes was 
found to be unreacted.  
O
R2
R1
NH2OH
CTADCH/H+
NOH
R2
R1
CTADC
R1 = H
R2 CN
R2 = aryl group
R1 = H, Me, C6H5CH(OH)
R1CR2 = cyclohexane  
(Scheme 1.58) 
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In order to explore the chemoselectivity of CTADC, a series of substituted 
phenylthioureas have been oxidized in organic medium.
143-144 
Oxidation of 
phenylthiourea by CTADC in acetonitrile without any acid afforded phenyl isonitrile, 
but in presence of acetic acid, the product was found to be phenylurea.
 
In case of 
substituted phenylthioureas, the products were corresponding ureas and isonitriles in 
neutral condition and corresponding ureas only in acidic condition (Scheme 1.59). 
The mildness and chemoselectivity of CTADC have also been observed in the 
oxidation of benzyl alcohol and simvastatin.
145-146 
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(Scheme 1.59) 
 
1.2.3  Phosphonium and tellurium chromates and dichromates 
Some chromates and dichromates with other than nitrogen oniums like 
phosphonium and telluronium were synthesized to deal with specific oxidation 
reactions (Table 1.1). 
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Table 1.1 Examples of some chromates and dichromates containing phosphonium 
and tellurium counterions.  
Sl. 
No. 
Reagent Investigation 
1 Benzyltriphenyl phosphonium 
chlorochromate (BTPPCC) 
Selective oxidation of benzyl alcohol in presence 
of phenyl ethanol, benzhydrol or methyl phenyl 
sulfide.
147
   
Oxidation of sulfides to corresponding 
sulfoxides.
148 
2 Butyltriphenyl phosphonium 
chlorochromate (BuTPPCC) 
Oxidation of alcohols to carbonyl compounds.
149 
3 Butyltriphenylphosponium 
dichromate (BTPPD) 
Oxidation of alcohols to carbonyl compounds, 
thiones to corresponding carbonyl compounds by 
microwave irradiation without any solvent, thiols 
to corresponding disulfides under microwave 
irradiation and sulfides to sulfoxides and sulfones 
in presence of aluminium chloride in solution and 
under microwave irradiation, aldehydes to 
carboxylic acid, amino acids to the corresponding 
aldimines, diols to hydroxyl carbonyls.
150-157 
4 Tetrabutylphosphonium 
dichromate (TBPDC) 
aromatization of 1,4-dihydropyridines to 
corresponding pyridine derivatives in acetonitrile 
and also under microwave irradiation.
158 
5 Triphenylmethylphosphonium 
dichromate (MTPPD) 
solid phase oxidation of benzylic alcohols to the 
corresponding aldehydes and ketones under 
solvent-free conditions with high 
chemoselectivity.
159 
6 Benzyldimethyltelluronium 
dichromate (BDMTDC) 
Selective oxidation of benzylic and allylic –OH 
group in presence of other primary or secondary –
OH group.
160 
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1.3       OXIDATION OF ORGANIC SUBSTRATES BY LIPOPATHIC Mn(VII) 
Permanganate has been widely used as a strong, easily handled, readily 
available and versatile oxidant that reacts with alcohols, alkenes, aldehydes, saturated 
C–H bonds, steroids and other functionalities. 161-166  The lack of selectivity of 
permanganate is due, at least in part, to its ability to react readily by either one- or two 
electron pathways, and its conversion into even stronger oxidants such as MnO3
+
. The 
reaction pathways are influenced by solvent, pH, solubility, substrate and other 
variables, thus complicating the mechanistic understanding. 
Before the discovery of lipopathic Mn(VII) oxidants, permanganate oxidations 
of organic substances were performed in aqueous media with organic co-solvents, in 
which potassium permanganate shows an appreciable solubility and inertness. The co-
solvents mostly used are t-butanol, acetone, pyridine, acetic acid, acetic anhydride, 
trifluoroacetic acid etc. The use of organic solvents allows the substrate and solvent to 
be in the same phase and avoids some of the complications of aqueous permanganate 
reactions, such as decomposition at high pH,
167
 autocatalysis at low pH,
168
 
involvement of water in the rate determining step
169
 and limited solubility of the 
organic substrates of interest.
170
  
Phase transfer catalysis (PTC) has been recognized as one of the versatile 
techniques for permanganate mediated oxidation of water insoluble organic 
substrates.  Gibson and Hosking were the first to report on the phase transfer catalytic 
permanganate oxidation of water insoluble substrates in organic media by 
triphenylmethylarsonium permanganate pairing the permanganate ion with a 
quaternary lipophilic cation.
171 
Purple benzene was prepared by using dicyclohexyl-
18-crown-6 as PTC from solid potassium permanganate by Sam and Simmons and 
subsequently used for many organic reactions.
172
 Herriott and Picker used different 
tetraalkyl ammonium salts to extract permanganate ion from aqueous solution for 
oxidation reactions.
173  
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For the use of Mn(VII) as the oxidant for organic substrates in organic 
solvents, crown ethers and onium ions as the carrier of oxidants have wide 
applications as phase transfer catalysts. An extensive review in this regard has been 
presented by Dash et al.
8  
In nonpolar solvents, due to the amphipathic nature of the 
tetraalkylammonium ions, quarternary ammonium permanganates are effective 
reagents for the oxidation of organic substrates.
174-176
 However, many organic 
solvents are highly sensitive to the oxidation potential of Mn(VII) and thus have 
limited use as solvents for oxidation reaction.
2, 177
 Further, decomposition of some 
quaternary salts, self oxidation and instability of most of these Mn(VII) oxidants in 
organic solvents limit their uses as lipopathic oxidants.
178-180
 Some significant 
applications of these oxidants have been presented here.  
Tetraalkylammonium permanganates are synthesized by simple ion exchange 
method by mixing tetraalkylammonium bromides and potassium permanganate in 
aqueous medium. These reagents are excellent phase-transfer oxidants for organic 
substrates in completely non-polar organic solvents, such as benzene, 
dichloromethane, chloroform, carbon tetrachloride, toluene, etc., and in completely 
anhydrous conditions. Quaternary ammonium salts in aqueous medium dissociate to 
constituting ions, while in organic solvents these salts exist in ion pairs.
175, 181-185
 The 
probability of salts existing as ion pairs is inversely proportional to the distance 
between the centres of the two ions and the dielectric constant of the solvents. The 
closeness between ion pairs was found to influence the rate of reaction. As an 
example, the rate constants for the oxidation of methyl cinnamate by methyltri-n-
octylammonium permanganate are greater than that for tetra-n-octylammonium 
permanganate, because the former allows a greater penetration of the anion into the 
structure of the cation due to lesser steric hindrance. When styrene derivatives were 
oxidized by quaternary ammonium or phosphonium permanganates in a polar organic 
solvent, such as acetone, the substituents and counterions have little or no effect on 
the rate of reaction.
182
 In less polar solvents, such as DCM or toluene, the rates of the 
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reaction are, however, dependent upon the nature of the quaternary ammonium or 
phosphonium ions. Thus it can be concluded that, quaternary ammonium 
permanganates exist as solvent-separated ion pairs in dipolar aprotic solvents like 
acetone, while they exist as tight ion pairs in apolar solvents like toluene and 
dichloromethane. 
Weber and Shepherd
186 
oxidized cyclohexene, cis-cyclooctene and trans-
cyclooctene to vicinal cis-diol stereospecifically by cold, dilute alkaline potassium 
permanganate in the presence of a catalytic quantity of benzyltriethylammonium 
chloride as PTC in water-dichloromethane mixture. Subsequently, Ogino and 
Mochizuki
187
 reported that KMnO4 solubilized in dichloromethane in the presence of 
an equimolar amount of benzyltriethylammonium chloride readily oxidizes alkenes to 
either 1,2-diols or aldehydes depending upon pH of the medium without any over-
oxidation.  
In an oxidation reaction of methyl (E)-cinnamate with quaternary ammonium 
permanganates in dichloromethane solutions, Lee and Brown
188 
proposed that the 
counter ion has a substantial effect on the rate of reaction.  The rate of reaction is 
fastest for those in which inter ionic distance in the quaternary ammonium ion pair is 
minimum. Hence, smaller cations have grater effects on the reactivity and promote a 
faster reaction.  
Lee and Perez-Benito
189
 have used methyltributylammonium permanganate 
(MTBAP) for the oxidation of 1-tetradecene in dichloromethane. Manganate(V) 
diesters was proposed to be the intermediate which on hydrolysis afforded cis-diol 
and colloidal manganese dioxide (MnO2) (Scheme 1.60). The colloidal MnO2 formed 
during the reaction was found to catalyze the reaction by providing a surface on which 
the catalyzed reaction takes place.  
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(Scheme 1.60) 
Tetrabutylammonium permanganate (TBAP) was used as a phase transferring 
oxidant for the oxidation of substituted methyl cinnamates.
189
 Positive ρ (reaction 
constant) values confirmed higher electron density in the transition state than the 
ground state. The numerical value of reaction constants (ρ) was found to be greater in 
acetone (ρ=1.43) than that of dichloromethane (ρ=0.95) which further supported the 
existence of tight ion pair in nonpolar solvents. Involvement of a rate limiting 
heterolytic cleavage of the carbon–manganese bond to give an enolate-like transition 
state was proposed (Scheme 1.61). The proximity of the quaternary ammonium ion 
through the formation of tight ion pair was proposed to increase the stability of the 
transition state in non-polar solvents. On the other hand, in dipolar aprotic solvents, 
quaternary ammonium ion contributes less towards the stability of the transition state 
due to the formation of solvent separated ion pairs. The hypomanganate (106) being a 
very reactive intermediate, rapidly converted to a manganese(IV) cyclic diester 107 
via a one-electron reduction, possibly by abstraction of a hydrogen atom from a 
molecule of solvent (Scheme 1.62). 107 subsequently decomposed to a diol anion 
(108) and MnO2.
189
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(Scheme 1.62) 
Oxidation of unsaturated carboxylic acids was carried out using MTBAP in 
non-aqueous solvents.
190
 The reaction was found to differ in several ways, both from 
the corresponding aqueous-phase oxidations
191
 and from the oxidation of unsaturated 
esters.
192
 A Mn(III) species was found to be the final product of the reduction of 
permanganate by unsaturated acids in dichloromethane. The catalytic activity was 
proposed to be due to the formation of a powerful oxidant HMnO4 (Scheme 1.63). 
QMnO4   +    RCOOH HMnO4   +   RCOO
-Q+
 
(Scheme 1.63) 
An important addition to the lipopathic Mn(VII) oxidant family is the 
cetyltrimethylammonium permanganate (CTAP) synthesized by adding aqueous 
solution of CTAB to the aqueous solution of potassium permanganate (KMnO4). It is 
sparingly soluble in aqueous medium but highly soluble in nonpolar solvents such as 
chloroform, dichloromethane etc.
193
   
In order to explore the chemoselectivity of lipopathic Mn(VII), Mishra et al. 
have used CTAP for the oxidation of some monochromophoric styrylpyridinium dyes 
in chloroform medium and compared the results with the oxidation of the same 
substrate using KMnO4 in acidic medium.
193
 Due to the formation of tight ion pair in 
non-polar medium and also due to the charge on the substrate, both hydrophobic 
interaction and electrostatic effect bring the reactant and the substrate into close 
proximity, thereby facilitating the reaction. A plausible mechanism for the cleavage of 
double bond to form carbonyl products was proposed based on experimental 
evidences (Scheme 1.64). A similar mechanistic pathway leading to oxidative 
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cleavage of trans-double bond was also proposed for the oxidation of some 
substituted alkyl cinnamates by CTAP in chloroform medium.
194
 The proposal of 
negatively charged transition state was supported by the rate retarding effect of 
electron-donating and rate accelerating effect of electron-withdrawing substituents.  
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(Scheme 1.64) 
During the oxidation of styrylpyridinium dyes and alkyl cinnamates, which 
contain trans-double bonds, bond breaking was observed, leading to the formation of 
carbonyl compounds selectively. In case of some compounds containing cis-double 
bonds, e.g., cyclohexene, maleic anhydride and cholesterol,
 
oxidation products were 
found to be corresponding diols (Schemes 1.65).
195
 The strategy of oxidation of cis-
double bond by CTAP was applied successfully for the cis-dihydroxylation of the 
spiro fused dihydropyran ring of 109 to afford an analog of antibiotic griseusin A( 
110) (Scheme 1.66).
196
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(Scheme 1.65) 
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Treatment of a tricyclic rigid diene (111) with one equivalent of 
benzyltriethylammonium permanganate (BTEAP) at low temperature (-50
o
C) 
followed by quenching with aqueous sodium hydroxide afforded the diol 112 (70% 
yield) together with the diol epoxide 113 (20%).
197 
With increase in the temperature, 
yield of diol decreases with the formation of dialdehyde. Formation of 112 and 113 
has been proposed as depicted in Scheme 1.67. The cyclic manganese (V) diester 114, 
formed by the attack of the permanganate on the most reactive double bond, 
decomposes into diol 112 or epoxy-diol 113 through two different reduction 
processes. One electron reduction by reaction with the solvent to give the Mn(IV) 
diester 116 through path ‘a’ resulted in the diol 112 while an intramolecular  oxygen 
transfer to the other double bond which lies in close proximity to the manganese 
centre through path ‘b’ yielded epoxy-diol 113.  
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(Scheme 1.67) 
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Oxidation of C-H bonds by permanganate is an important class of organic 
transformations. Alkylammonium permanganates have been found to oxidize C-H 
bonds in organic solvents.
174, 198-199 
Tetraethyl, tetrabutyl and 
benzyltriethylammonium permanganate and methyltriphenylphosphonium 
permanganate are found to be about equally effective as oxidants for the conversion 
of alkanes into alcohol and ketones. 
In the oxidation of aryl alkanes such as toluene, ethylbenzene, 
diphenylmethane, triphenylmethane, 9,10-dihydroanthracene, xanthenes and fluorene 
by TBAP, toluene is oxidized to benzoic acid and a small amount of benzaldehyde 
where as other substrates are converted to carbonyl compounds and/or 
dehydrogenated products.
200
 The reduced manganese product of all of these reactions 
is colloidal MnO2. Abstraction of a hydrogen atom by permanganate was proposed to 
be the first step of these reactions facilitated due to the formation of strong O-H bond 
(Scheme 1.68).
169,201
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(Scheme 1.68) 
Oxidation of 4-halo-2-nitrotoluene with TBAP in pyridine was found to be an 
efficient method to synthesize 4-halo-2-nitrobenzoic acid (Scheme 1.69).
202
 To 
control the vigorous exothermic reaction and to do the reaction in a multi-gram scale, 
control feeding of cold TBAP solution into the reaction mixture at 60
o
C was 
performed and thus the initiation process was managed.   
NO2 X NO2
OH
O
X
X= Br, I
TBAP
 
(Scheme 1.69) 
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2,4-Dimethylnitrobenzene (2,4-DMNB) was oxidized to 3-methyl-4-
nitrobenzoic acid with potassium permanganate under heterogeneous conditions in the 
presence of a phase transfer catalyst, tetrabutylammonium bromide (TBAB). The 
reaction was carried out at 95 °C for 1 h with the ratio of n(2,4-DMNB): n(KMnO4): 
n(TBAB) = 1 : 2.16 : 0.07 and 3-methyl-4-nitrobenzoic acid was obtained in 41% 
yield. In the absence of PTC 4-nitro-1,3-benzenedicarboxylic acid was obtained as the 
only product.  Thus it can be concluded that presence of TBAB as PTC brings 
mildness, regioselectivity and chemoselectivity in the oxidation reaction through in 
situ formation of TBAP.
203
  
Srinivasan and Ramadas
204
 synthesized trisubstituted guanidines in excellent 
yields from 1,3-diarylthioureas using quaternaryammonium permanganates in the 
presence of an amine in THF (Scheme 1.70). This proposed scheme was preferred 
since the sulfonyl group is reported to be displaced about 15 times faster than the 
corresponding S-alkylated species in the case of monosubstituted thioureas.
205 
From a 
comparative study using BTEAP, CTAP and TBAP on several thioureas and amines it 
was found that BTEAP is better than the other two because of its stability, shock-
resistant and decomposition above 100°C. CTAP furnished poor results and the 
product isolation was rendered difficult due to foaming during the follow-up action in 
aqueous medium.  
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 (Scheme 1.70) 
Jain et al. have successfully utilized BTEAP for the oxidation of the allylic 
methylene group of 119 in dichloromethane medium and isolated the desired lactone 
120 in 77% yield (Scheme 1.71).
206
 Jones reagent, MnO2, and RuO4 failed to produce 
the desired allylic oxidation product. Oxidation via selenium dioxide, PCC, and KO2 
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also proved unsuccessful. A protocol originally developed by Paquette et al.
207
 using a 
mixture of PCC (5 equiv), chromium trioxide (5 equiv), and 3,5-dimethylpyrazole (10 
equiv) was found to be successful and yielded 11,11-dimethylbisbenzopyran lactone 
120 in moderate yield (54%). This shows the selectivity and efficiency of BTEAP for 
allylic oxidation process. 
O
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Me
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Me
Me
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BTEAP
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77%
119 120  
(Scheme 1.71) 
Makosza et al.
208
 used TBAP in the oxidative nucleophilic substitution of 
hydrogen (ONSH) in nitroarenes with carbanion of isopropyl phenyl acetate. TBAP 
was found  to be more suitable and advantageous than other oxidizing systems such as 
KMnO4, 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), dimethyl dioxirane 
(DMD)etc (Scheme 1.72 and 1.73).  Secondary carbanions of isopropyl phenyl acetate 
(122) add to nitroarenes (121) at ortho and para to the nitro group. The produced 
anionic H adducts (123) were then oxidized to a variety of products depending on the 
oxidizing agent and medium of the reaction. Permanganate anions oxidize only H 
adducts para to the nitro group, the final outcome depends on the conditions. The 
reaction carried out in liquid ammonia and KMnO4 as oxidant gives iso-propyl-α-
hydroxy-α-nitroarylphenylacetates (125) formed via hydroxylation of the initial 
ONSH products (124). In some cases additionally dimeric (126), trimeric (127) and 
tetrameric products were also found.  On the other hand, in THF ONSH product (124) 
was found to be the only product through selective oxidation of H adducts para to the 
nitro group. No over oxidation or side reactions were observed in this case. DDQ 
oxidized both ortho and para H adducts giving rise to mixtures of isomeric ONSH 
products (124 and 128). Oxidation by DMD gave isomeric substituted phenols (129 
and 130).   
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(Scheme 1.73) 
Verbeeck et al.
209
 have studied the mechanism of oxidative alkylamination of 
electron-deficient (hetero) aromatic compounds, via the oxidative nucleophilic 
substitution of hydrogen (ONSH) using AgPy2MnO4, KMnO4, AgNO3/KMnO4, 
TBACl/KMnO4 or TBAP as oxidant. On the basis of competitive kinetic isotope 
effect (KIE) experiments, oxidation step of the intermediate σH-adduct was proved to 
be the rate-limiting step of oxidative alkylaminations (Scheme 1.74).  In those cases 
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where the reaction with KMnO4 gave a low conversion and yield due to solubility 
problem, TBAP was found to a better alternative for TBACl/KMnO4 and expensive 
AgPy2MnO4 as it involved cheaper and more environmentally friendly reagents.  
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(Scheme 1.74) 
1.4  SELF AGGREGATION OF LIPOPATHIC OXIDANTS CONTAINING 
LONG CHAIN ONIUM IONS 
Lipopathic oxidants derived from long chain cationic onium ion and anionic 
counterions are known to have surface active properties and form various structured 
aggregated species like micelles, vesicles, liquid crystals, monolayers, bilayers, etc., 
and have drawn the attention of scientists for their multiple application potentials.  
Mishra and coworkers have studied the surface active properties of lipopathic 
oxidants CTADC, CTAP and CTACN in different medium. All these three lipopathic 
oxidants form condensed monolayer at air-water interface.
138
 From the isotherms of 
surface pressure versus area of CTADC, CTAP and CTACN the anchoring area of 
each oxidant on air-water interface were determined to be 51, 22 and 45 Å
2
 
respectively when spreading as Langmuir monolayer. The area/molecule of these 
oxidants with a common amphiphilic cationic CTA counterion depends largely on the 
size of the anionic counterpart indicating the existence of contact ionpair between the 
respective ions.
138 
Further, during the investigation of oxidation kinetics of some 
organic substrates in nonaqueous medium, the formation of reverse micellar and 
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mixed reverse micellar type aggregates of CTADC and CTAP has been 
encountered.
10, 140,142,145,146, 193,194 
Mukherjee et al.
11
 have synthesized some amphiphilic oxidants of dichromate, 
tungstate and molybdate of the type [CnH2n+1(CH3)3N
+
]2 X
2-
  (n = 10, 12, 14, 16 and 
18 and X= Cr2O7
2−
, MoO4
2−
 and WO4
2−
) and investigated their  bulk and interfacial 
properties in aqueous medium and at air-water interfaces (Scheme 1.75). Formation of 
layered structures in solid state was supported by X-ray diffraction (XRD) 
measurements. The phase transitions of the compounds were studied by thermo 
gravimetric analysis (TGA) and differential scanning calorimetry (DSC) analysis. The 
dichromate amphiphiles were found to be poorly soluble in water whereas the 
tungstates and molybdates were found to be water soluble. The authors have studied 
the interfacial behavior of these dichromate amphiphiles at air-water interface.  The 
Langmuir monolayers were found to be compressible and the higher homologues 
collapsed at higher states of compression. Cconductometry, tensiometry and 
calorimetry distinctly supported the formation of micelles for tungstate and molybdate 
complexes. The size and the zeta potential of the micelles of synthesized tungstate and 
molybdate complexes were found to increase with the increase in length of the 
hydrophobic tail of the complexes.   
 
(Scheme 1.75) 
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A novel diammonium Gemini surfactant phase transfer catalyst, diethyl-ether-
,ω-bis-dimethyldodecylammonium molybdate (12-EO-12-Mo), containing C12 
alkyl chain was found to enable the dark singlet oxygenation  of organic substrates 
such as -terpinene, β-citronellol etc. by chemically generated 1O2.
17 
12-EO-12-Mo 
provides a simple reaction medium with only three components for the preparative 
peroxidation of hydrophobic substrates and catalyze the reaction through possible 
formation of aggregated structure in aqueous medium or in aqueous-organic biphasic 
medium as depicted in Scheme 1.76.  
 
(Scheme 1.76) 
Polyoxometalates (POMs), such as a quaternary ammonium polytungsto-
phosphate catalyst when assembled at the interface of the emulsion droplets, catalyze 
the oxidation of sulfur-containing compounds presented in fuel oils.
210-213 
The 
lipopathic catalyst [(C18H37)2N
+
(CH3)2]3[PW12O40] containing C18 carbon chain when 
assembled in emulsion in diesel, can selectively oxidize 4,6-
dimethyldibenzothiophene-like compounds to sulfones with stoichiometric amounts 
of H2O2 under mild conditions (Scheme 1.77).
15 
The sulfones can then be readily 
separated from the diesel by using extraction methods and the catalyst can be 
recycled. The sulfur level can be lowered from about 500 ppm to 0.1 ppm without 
changing the properties of the diesel. 
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(Scheme 1.77) 
An ultra-deep desulfurization process for diesel, based on similar catalytic 
oxidation with the catalyst [C18H37N(CH3)3]4[H2NaPW10O36]   assembled in emulsion 
droplets followed by extraction, was developed by Li and his coworkers.
14
 The 
catalyst assembled in emulsion droplets was found to have very high intrinsic 
catalytic activity and selectively oxidize all kinds of sulfur-containing compounds 
present in model and actual diesel using an approximately stoichiometric amount of 
H2O2 as an oxidant under mild conditions. The sulfones formed in the diesel can be 
removed by a polar extractant. A schematic diagram as described by Li and his 
coworkers of this process has been presented in scheme 1.78. 
 
(Scheme 1.78) 
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Zhang et al.
13
 developed a quarternary ammonium polytungstophosphate 
[C18H37N(CH3)3]5Na2[PW11O39] (PW11) with lacunary Keggin-structures as a 
selective catalyst for oxidative desulfurization. The amphiphilic catalyst PW11 was 
found to assemble at the interface of the emulsion droplets (Scheme 1.79) and exhibit 
high catalytic activity towards the oxidation of BT to corresponding sulfone under 
mild conditions with H2O2 as oxidant in emulsion system.  
 
 
(Scheme 1.79) 
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Recently, oxidation of SCN
- 
by O2 as the oxidant in a micellar system, where 
amphiphilic catalysts [CH3(CH2)15N(CH3)3]5[PW11(TiO2)O39] (131), 
[CH3(CH2)15N(CH3)3]7 [PW10(TiO2)2O38] (132), and [CH3(CH2)15N(CH3)3]9 
[PW9(TiO2)3O37] (133) act as the surfactant and the catalysts, leading to simple 
inorganic species SO4
2-
,  HCO 3
-
 and NO3
- 
under extremely mild conditions was 
reported by Wei et a.l (Scheme 1. 80). These catalysts exhibit high efficiency of 
oxidation, ease of separation, long lifetime, and regenerability. The number of 
peroxo-titanium influences the catalytic activity, which shows the active range: 
131<133<132. This result could provide information on designing catalyst in 
oxidation reactions.
12
 
 
 
(Scheme 1.80) 
Similarly, many polyoxometalates containing long chain quaternary 
ammonium ions are synthesized and used as catalyst along with H2O2 as stoichiometic 
oxidant for green and selective oxidation of many organic functional groups.
214-219
 
The catalytic activity is mostly due to their ability to aggregate on emulsion droplets 
or at aqueous-organic interfaces.    
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1.5       SCOPE OF THE WORK  
Literature studies, as mentioned above, envisage wide applications of anionic 
oxidants with quaternary ammonium as the counter ion in oxidation reactions of 
substrates in both aqueous and nonaqueous medium. The interactions of oxidants, 
quaternary ammonium ions and the solvents in a reaction system lead to a differently 
behaving reaction condition, wherein, a strong oxidant can be mild, and a weak 
oxidant can have enhanced oxidation potential. Till now numerous attempts have been 
made to convert the water soluble Cr(VI), Mn(VII), Ce(IV), Ru(VII), W(VI), Mo(VI) 
salts to lipopathic with the help of phase transferring quaternary ammonium salts. 
With appropriate alkyl groups in the quaternary ammonium groups, the salts assemble 
in both aqueous and nonaqueous media to form organized assemblies mimicking 
bioaggregates like protein, lipids, and nucleic acids.  
In this context, use of amphipathic cetyltrimethylammonium (CTA) ion as the 
counterion has opened up a new vista to the ongoing oxidizing system. It is well 
known for its characteristics of being solubilized in both aqueous and nonaqueous 
media. Unlike other quaternary ammonium ions (tetrabutyl or octyl ammonium ions), 
CTA has a relatively small head group with more exposed charge and a well-balanced 
hydrophobic group to carry the ion to both water and organic media and thus is a 
magic amphiphile. CTA with its counter ion forms tight ion pair in organic solvents, 
whereas in aqueous medium it dissociates. CTA ion has a balanced amphiphilic 
system, capable of forming various organized assemblies like micelle in aqueous 
medium,
 
reversed micelles in organic solvents, microemulsion in aquo-organic 
medium and even hemimicelles on solid matrix.
 
 Surfactant assemblies are of great 
interest to the organic chemists because of their unusual catalysis of organic reactions 
and to biochemists because of their similarities to biological membranes and globular 
proteins.  
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Besides, in the development of new pharmaceuticals, one crucial task is to 
elucidate the metabolic fate of the drug candidate in the human body and need to be 
studied at the earliest stages.  Cell-based metabolism studies of active compounds 
using enzymes liver microsomes, hepatocytes, or microfungi present several 
advantages but the difficulty of isolation from the biological medium and small 
quantities of the metabolites are severe drawbacks. Thus in order to perform a 
satisfactory simulation of enzymatic oxidative metabolism in vivo, several transition 
metal based non-enzymatic chemical models have been proposed as biomimetic 
alternative approach to the cell-based metabolism study of bioactive compounds.
220-222
  
Some advantages of using in vitro oxidizing system are 
 Available in adequate amount for the synthesis of certain metabolites in 
sufficient amounts with sufficient purity to permit isolation, characterization 
and further studies. 
 The candidate metabolites as available in large quantities can be used to 
identify the real in vivo metabolites and provide sample for pharmacological 
testing.  
 Useful for investigation of metabolic reactions of different substrates and 
study of their mechanism in different environments. 
 The mode of metabolism can be clarified and unstable metabolites can be 
isolated, detected or trapped under selected and controlled reaction conditions. 
 These methods are cheaper compared to the enzymatic model. 
With an objective  to develop new efficient, selective, mild and biomimetic 
oxidation protocol, the oxidizing ability of some lipopathic oxidants namely 
cetyltrimethylammonium dichromate (CTADC), cetyltrimethylammonium 
permanganate (CTAP) and cetyltrimethylammonium cericnitrate (CTACN)  has been 
explored by our research group using cetyltrimethylammonium (CTA) ion as the 
onium counterion for anionic dichromate, permanganate and cericnitrate. The 
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preliminary reports on oxidation of various mono- and bi-functional organic 
substrates by CTADC and CTAP show their mildness and chemoselectivity as 
described in the previous section.  These oxidants form reverse micellar aggregate in 
nonpolar medium and forms mixed aggregated structure in presence of various 
surfactants due to the presence of the cationic carrier CTA
+
. Akin to the biological 
oxidant (enzyme), it provides suitable active site for reaction and thus mimics 
biological system.  
Owing to the above aspects, the present research work aims at employing CTADC 
and CTAP to study the oxidative cleavage of the following drugs containing multiple 
reactive functional groups in surfactant generated biomimetic environment. Special 
attention has been given to the metabolites formed and mechanism of these 
conversions. 
(i) Acetaminophen, an analgesic and anti-inflammatory drug by CTADC 
(ii) Epinephrine, a hormone and neurotransmitter by CTADC 
(iii) Isoniazid, an anti-tubercular drug by CTADC 
(iv) Carbamazepine , an anti-convulsant and antiepileptic drug  by CTAP 
(v) Norfloxacin, an anti-bacterial drug by CTAP 
To achieve the above objectives, the oxidation product(s) were isolated and 
characterized. The reaction kinetics was studied using UV-Vis spectrophotometric 
method in different media with varied polarities and also in micro-heterogeneous 
systems generated due to presence of surfactants. Suitable mechanisms have been 
proposed and supplemented by proper evidences such as deuterium kinetic isotope 
effect, solvent kinetic isotope effect, effect of medium, effect of temperature etc. 
Details on oxidative cleavage of these drugs by CTADC or CTAP has been discussed 
and presented in the subsequent chapters.  
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2.1  INTRODUCTION 
Acetaminophen or paracetamol, is a well-known drug that finds extensive 
application for its potent analgesic and antipyretic action. It is generally regarded as a 
non-steroidal anti-inflammatory drug (NSAID), though it possesses little anti-
inflammatory activity and also lacks the other typical actions of NSAIDs, such as 
anti-platelet activity and gastrotoxicity.
1, 2
 In spite of acetaminophen’s wide use and 
popularity, its mechanism of action at a molecular level has not yet been completely 
elucidated. Andersson et al.
3
 found that the electrophilic metabolites N-acetyl-p-
benzoquinone imine (NAPQI) and p-benzoquinone, but not acetaminophen itself, 
activate mouse and human TRPA1, as a consequence, reduce voltage-gated calcium 
and sodium currents in primary sensory neurons responsible for decrease in pain and 
fever. 
Acetaminophen is metabolized predominantly in the liver into nontoxic 
products primarily through three metabolic pathways (Scheme 2.1).
4,5 
Glucuronidation and sulfation account for more than 80% of the metabolism of the 
drug to form  glucuronide and  sulphate conjugates respectively.
4,5
 A minor fraction 
(less than 15%) of the drug is oxidized by cytochrome P450
6
 to form N-acetyl-p-
benzoquinone imine (NAPQI)
7,8
 and 3-hydroxy-acetaminophen (3-OH-APAP).
9
 
These oxidized reactive metabolites are inactivated with reduced glutathione to form 
cysteine and mercapturic acid conjugates. Thus, all three metabolic pathways yield 
final products that are inactive and non-toxic and are eventually excreted by the 
kidneys. In the third pathway, however, the intermediate oxidized product NAPQI is 
toxic. Overdoses of acetaminophen cause liver and renal toxicity as a result of 
depletion of glutathione and of covalent binding of the excess reactive metabolite to 
vital cell constituents.
10 
Objectives: In the present section, an attempt have been made to investigate the 
mechanism of the oxidative metabolism of acetaminophen by CTADC in nonpolar 
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medium and biomimetic medium generated due to the presence of surfactants to test 
the following hypothesis. 
 Will CTADC act as a mild, chemoselective and biomimetic oxidant for 
acetaminophen to produce products like NAPQI? 
 What will be the mechanism of these conversions? Will it be similar to enzyme 
catalysed process? 
 What will be the effect of   different parameters such as reaction temperature, 
solvent polarity/hydrophobicity, presence of surfactants etc. on the overall rate and 
mechanism of the oxidative metabolism? 
To achieve the above objectives, the oxidation products were isolated and 
characterized. Kinetics was run in organic media with varied polarities and in 
microheterogeneous systems generated in presence of various surfactants. The 
resultant data were analyzed using an appropriate kinetic model. By varying 
[substrate], [acid], [CTADC] and from the effect of temperature on reaction rate, a 
suitable mechanism for the reaction was proposed. The solvent kinetic isotope effect 
and deuterium kinetic isotope effect were also determined to have better insight into 
the reaction mechanism. 
HN
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OH
GlucuronidationSulfation
HN
COCH3
O
HN
COCH3
O
N
COCH3
O
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O
OHO
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(Scheme 2.1)  
   
Chapter 2 
66 
 
Further, kinetic and spectrophotometric determinations of acetaminophen in 
pharmaceutical formulations has been the subject of interest to many investigators due 
to their sensitivity, selectivity, simplicity and accuracy.
11 
In these methods, the drug 
(acetaminophen) is oxidized using the metal ion oxidant, and thus, the amount of drug 
has been estimated. But in most of the methods high concentration of strong acid, 
high temperature and longer reaction time is required for the process.
12 
However, as 
discussed in Chapter 1, for oxidation of various organic substrates using CTADC does 
not require any acid in most of the cases, while in some cases it requires a very low 
concentration of acid (around 5-10% of acetic acid) as compared to conventional 
Cr(VI) oxidants. Owing to the selectivity, sensitivity, accuracy of kinetic methods and 
due to the mildness of the oxidant, the oxidation kinetics of acetaminophen by 
CTADC can be a better alternative to the available methods for the determination of 
acetaminophen in drug formulations. 
2.2  EXPERIMENTAL 
2.2.1  Materials 
Acetaminophen was purchased from Sigma Aldrich, India and used without 
further purification. The organic solvents were purified by standard methods.
13 
The 
surfactants cetyltrimethylammonium bromide (CTAB) and sodium dodecylsulphate 
(SDS) were purified by recrystallization from aqueous ethanol, and their purity was 
checked from physical constants. Triton X-100 (TX-100) was purchased from Merck, 
India and was used without further purification. Acetic acid (Merck) was used as 
source of hydrogen ions and was also used as such. The D2O (Sigma-Aldrich) used is 
of NMR grade with 99.8% D.  
2.2.2  Synthesis of cetyltrimethylammonium dichromate (CTADC) 
CTADC was prepared by following the reported procedure.
14
 Aqueous 
solution of potassium dichromate (2.94 g, 0.05 M) was added slowly to an aqueous 
solution of CTAB (7.38 g, 0.1 M) with continuous stirring using a teflon coated 
magnetic bar at room temperature. A yellow coloured compound appeared 
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immediately. Stirring was continued for 15 minutes more after completion of the 
addition of the dichromate solution. The resulting yellow product was then filtered off 
and washed with water several times till no bromide and dichromate were detected in 
the filtrate. It was vacuum dried and kept in desiccators in the dark. M.P. 212 
0
C 
(decomposed), Yield: 98%  
2.2.3  Synthesis of deuterated acetaminophen    
Acetaminophen (500 mg) was added to 2 ml of D2O. To this mixture, 
acetonitrile was added drop wise until a clear solution was obtained. It was stirred for 
1 hour and was kept at room temperature for 3-4 h. The white crystalline solid 
appeared was isolated by filtration. Comparing the 
1
H NMR spectrum of D2O treated 
acetaminophen (Figure 2.1) with the 
1
H NMR spectrum of acetaminophen (Figure 
2.2), about 70% conversion of N-H to N-D was confirmed. 
2.2.4 Kinetic measurements 
The oxidation kinetics of acetaminophen by CTADC in acetonitrile in the 
presence of acetic acid was investigated using UV-vis spectroscopic method by 
monitoring the decrease in the optical density (OD) of CTADC at an analytical 
wavelength of 350 nm in a Shimadzu UV-vis spectrophotometer (UV-1800) fitted 
with thermostatic cell holders. The temperature in the reaction cell was controlled by 
circulating water by using Lauda thermostat within a temperature fluctuation of 0.05 
o
C. The reactions were performed under pseudo-first-order conditions by keeping a 
large excess (10 times or more) of the acetaminophen with respect to CTADC, and 
the observed rate constant (kobs) were calculated from the linear  plot (r =0.99) of log 
[CTADC] versus time for up to 75% completion of the reaction.
15,16
  The effects of 
variation of [CTADC], [acetaminophen], [acid] and [surfactant] on the rate constant 
were investigated by varying the concentration of the desired constituent in the 
reaction mixture. All experiments were repeated at least three times, and the rates of 
reactions were obtained with an error of 4%. Some of the kinetics were run under 
nitrogen atmosphere, and the data were found to be similar (within an error of ± 2%) 
to those in normal atmospheric conditions. Hence, most of the reactions were carried 
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out without nitrogen environment. The solvent isotope effect was investigated using 
3:7 mixtures of H2O/acetic acid and D2O/acetic acid separately instead of acetonitrile-
acetic acid during kinetic studies. Acetic acid was equilibrated with water and D2O 
separately for 3 h before its use in the reaction process.  
2.2.5 Product analysis 
The reaction mixture containing acetaminophen and CTADC in 3:1 ratio in 
acetonitrile medium was stirred and refluxed for 3 h in the presence of acetic acid. 
The mixture turned to reddish-green indicating the formation of reduced Cr (III). The 
completion of the reaction was monitored using TLC. Then the product (M. Pt. =115 
0
C) was separated by preparative TLC, taking chloroform and methanol as the 
solvent, and characterized by IR, NMR spectral analysis. IR Spectrum was recorded 
on KBr pellets on Perkin Elmer Spectrophotometer.
1
H and 
13
C NMR spectra were 
recorded in a Bruker 400 MHz NMR spectrometer. IR (KBr, νmax/cm
−1
): An intense 
peak at 1642 cm
-1
 due to (C=O) stretching, 1317 (Ar C-H bending). 
1
H NMR (400 
MHz, CDCl3): δ/ppm 6.806 (4H, s). 
13
C NMR (100 MHz, CDCl3): δ/ppm 136.54 and 
187.18. IR and NMR spectral data characterized the product to be p-benzoquinone. 
The presence of acetamide in the product mixture was verified from spot test and also 
comparing with the standard sample.
 
2.2.6 Stoichiometry 
The stoichiometry of the reaction was determined by performing the 
experiment at 298 K under the condition [CTADC] ≈ [Acetaminophen] at varying 
acetaminophen concentrations. The disappearance of Cr(VI) was followed until the 
absorbance values became constant. The [CTADC] after 48 h was estimated. A 
stoichiometry ratio of [CTADC]/ [Acetaminophen] ≈ 0.35 was observed, which 
confirmed a 1:3 CTADC: acetaminophen relationship. 
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2.3  RESULTS AND DISCUSSION  
Oxidative metabolism of acetaminophen by different oxidizing system is a 
subject of interest for many investigators to determine the amount of drug in 
pharmaceutical formulations or for degradation of anthropogenic compounds for 
treatment of waste and drinking water. Hiremath et al.
17
 oxidized acetaminophen to 
quinineoxime by diperiodatoargentate(III) in alkaline medium.  Kissinger et al.
18,19
 
and Sanchez-Obrero et al.
20
 have investigated the electrochemical oxidation of 
acetaminophen using different electrodes and proved that the first reaction step is an 
electrochemical oxidation involving two electrons and two protons to generate N-
acetyl-p-benzoquinone imine, which further decomposes to stable products by 
subsequent nonelectrochemical steps. Tabassum et al.
21, 22
 have proposed free radical 
pathways for oxidative degradation of acetaminophen to benzoquinone by acidified 
dichromate and neutral permanganate.  
Oxidation of acetaminophen by CTADC in 3:1 molar ratio in acetonitrile-
acetic acid mixture afforded p-benzoquinone and acetamide along with other 
products. From the stoichiometric analysis, it has been found that 1 mol equivalent of 
CTADC reacts with 3 mol equiv of acetaminophen, and therefore the ratio of 
Cr(VI)/acetaminophen is found to be 1:1.5. Cr(VI) is reduced to Cr(IV) during the 
reaction process, which is further disproportionate to the final reduced state of 
chromium (i.e. Cr(III)). The existence of Cr(III) in the product mixture was 
established from the absorption maximum at 580 nm.
23
 The proposal of one electron 
oxidation giving rise to free radicals may be ruled out for the present reaction due the 
following two factors: (i) oxidation of acetaminophen, in an atmosphere of nitrogen, 
failed to induce polymerization of acrylonitrile
16
 and (ii) the addition of acrylonitrile 
did not affect the rate of oxidation reaction.
24
 
The observed rate constant (kobs) of the reaction was calculated by monitoring 
the depletion of chromium(VI) peak at 350 nm in acetonitrile in presence of acetic 
acid (Table 2.1). The rate constant was found to increase exponentially with increase 
in the [acetic acid] with almost no reaction in the absence of acid. The logarithmic 
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plot of kobs versus [acetic acid] shows a second-order dependency with respect to 
acetic acid. The exponential increase in oxidation rate with increase in [acetic acid] 
indicates the involvement of protonation of dichromate in the oxidation process. The 
protonation may be a result of exchange of CTA
+
 with H
+
 in the acetonitrile/acetic 
acid medium.  
With respect to [Acetaminophen], a Michaelis-Menten type curve was 
obtained with a fractional order dependency (Figure 2.3 A). Further the Lineweaver-
Burk double reciprocal plot was found to be a straight line with an intercept in the y-
axis (Figure 2.3 B). Accordingly, a mechanism is proposed, in which a complex forms 
between the oxidant and the substrate prior to the rate determining step, akin to 
enzyme substrate complex. In the rate determining step, the complex subsequently 
decomposes to afford the products (scheme 2.2). 
Acetaminophen + Oxidant Complex
k+1
k-1
Complex Product
k2
 
(Scheme 2.2) 
Applying steady state approximation to Scheme 2.2, the following rate 
expression (equations 1-3) can be written.
25 
 
𝑅𝑎𝑡𝑒 =  −
𝑑  𝑂𝑥𝑖𝑑𝑎𝑛𝑡 
𝑑𝑡
=  
𝐾𝑘2  𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛  𝑂𝑥𝑖𝑑𝑎𝑛𝑡 
1 + 𝐾 𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛 
                                 (1) 
−
𝑑  𝑂𝑥𝑖𝑑𝑎𝑛𝑡 
𝑑𝑡
 ×
1
 𝑂𝑥𝑖𝑑𝑎𝑛𝑡 
=  𝑘𝑜𝑏𝑠 =  
𝐾𝑘2  𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛 
1 + 𝐾 𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛 
                         (2) 
1
𝑘𝑜𝑏𝑠
=  
1
𝑘2𝐾  𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛 
+  
1
𝑘2
                                                                              (3) 
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Figure 2.3 (A) Plot of 10
4 
x kobs versus 10
2 
x [acetaminophen] and (B) Plot of 1/(10
4 
x
 
kobs) versus 1/(10
2 
x
 
[acetaminophen]) in the oxidation reaction of CTADC with 
acetaminophen at 298 K. 
From the plot of kobs against [acetaminophen] (Figure 2.3 A), the Michaelis-
Menten constant, Km= ((k-1+ k2)/k+1) is found to be 0.5 x 10
-2
 M. While investigating 
the oxidation of acetaminophen by human cytochrome P450 2E1 and 2A6, Chen et al. 
obtained Km values in the range of 0.13 x 10
-2
 to 0.46 x 10
-2
 M.
26
 By using the 
Lineweaver-Burk type double reciprocal equation (equation 3) the equillibrium 
constant K = k+1/k-1 and k2 are found to be 232 L mol
-1
 and 3.67 x 10
-4
s
-1
 respectively. 
From K, Km and k2 values, the k+1 and k-1 were calculated to be 0.13 and 5.56 x 10
-4 
s
-1 
respectively. The closeness in the k2 and kobs values also suggests that the 
decomposition of the complex is the rate-limiting process. The linear plot (R
2
 = 0.98) 
of observed versus predicted rate constant (Figure 2.4) by using k2 and K values with 
varying [acetaminophen] supports the kinetic model. 
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Table 2.1 Effect of [Acetaminophen], [CTADC], and [Acetic acid] on the Oxidation 
of Acetaminophen by CTADC at 298 K 
[CTADC] x 10
4 
M [Acetaminophen] x 10
2
 M [Acetic acid] M kobs x 10
4 
s
-1
 
8.70 0.90 3.18 1.42 (0.06) 
6.54 0.90 3.18 1.50 (0.06) 
4.36 0.90 3.18 1.73 ( 0.07) 
2.18 0.90 3.18 2.42(0.09) 
1.30 0.90 3.18 3.22 (0.14) 
0.43 0.90 3.18 3.65 (0.16) 
2.18 3.60 3.18 3.84 ( 0.17) 
2.18 2.70 3.18 3.84 (0.17) 
2.18 1.80 3.18 3.45 (0.15) 
2.18 0.54 3.18 2.16 ( 0.08) 
2.18 0.18 3.18 1.38 ( 0.06) 
2.18 0.09 3.18 0.77(0.03) 
2.18 0.04 3.18 0.38 (0.02) 
2.18 0.90 1.27 0.27 ( 0.01) 
2.18 0.90 1.90 0.58 ( 0.03) 
2.18 0.90 2.54 1.00 ( 0.04) 
2.18 0.90 3.81 3.19 ( 0.14) 
2.18 0.90 4.44 3.76 ( 0.15) 
2.18 0.90 5.08 4.95 (0.22) 
2.18 0.90 5.71 5.80( 0.26) 
2.18 0.90 6.35 6.83( 0.29) 
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Figure 2.4 Plot of 10
4 
x
 
kpred versus 10
4 
x kobs in the oxidation of acetaminophen by 
CTADC in acetonitrile in presence of acetic acid. 
With an increase in [CTADC], the rate constant was found to decrease with a 
fractional order dependency (Figure 2.5). The decrease in the rate constant with 
increase in [CTADC] is well established in the oxidation of organic substrates by 
CTADC in organic medium.
27-31
 In aqueous media a linear decrease in rate constant 
with increase in the concentration of Cr(VI) was observed by Menakshisundaram and 
Vinothini.
32
 They explained the fact through the less formation of acid chromate, 
which is the reactive species in the reaction medium. Similar decreasing trend with 
increase in [oxidant] has been also observed by other authors.
33 
The decrease in rate 
constant in the present study is attributed to the aggregation of CTADC in organic 
solvents. Due to the reverse micellar type aggregation of CTADC in organic solvents, 
the dichromate ion is enveloped by the CTA
+
 and the acetaminophen is partitioned 
into different phases: (i) inner polar core, (ii) cationic reverse micellar interface, and 
(iii) nonpolar bulk solvent. Therefore, the effective concentration of the substrate in 
the proximity of the dichromate decreases which leads to a decrease in the rate 
constant. Further [AcOH] versus the rate constant profile predicts an acid catalyzed 
reaction.  But in the cationic interface of CTADC reversed micelle, a proton may not 
be available for the dichromate, and therefore a rate decrease is expected. With 
increasing [CTADC], there may be an increase in aggregation, and thus a negative 
trend is inevitable. 
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Figure 2.5 Plot of 10
4 
x kobs versus 10
4 
x [CTADC] in the oxidation reaction of 
acetaminophen by CTADC in acetonitrile at 298 K.  
 
Figure 2.6 Effect of [surfactant] on observed rate constants in the oxidation reaction 
of acetaminophen by CTADC in acetonitrile in presence of acetic acid at 298 K. 
2.3.1  Effect of surfactant 
To supplement the above proposition of reverse micellization at higher 
[CTADC], effect of various surfactants namely CTAB (cationic surfactant), TX-100 
(nonionic surfactant), and SDS (anionic surfactant) on the rate of reaction were 
analyzed. All these surfactants can form reverse micelles in organic solvents,
34-37
 
mixed aggregated structures (micelles, reverse micelles, microemulsions etc.) with 
various ionic and nonionicsurfactants,
38-42
 and also with CTADC.
30-31
 When CTAB 
was added to the reaction mixture, the rate constant was found to decrease sharply 
with increasing [CTAB] (Figure 2.6). Above a concentration of 7.2 x 10
-3 
M of 
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CTAB, the rate constant almost levels up around 0.5 x 10
-4
 s
-1
. This observation also 
corroborates the earlier argument of reverse micellar type aggregation and partition of 
the oxidant and substrate in different subphases. Assuming the rate decrease is only 
due to the partition effect, for complete entrapment of a dichromate (2.18 x 10
-4
 M) by 
CTA
+
 (7.2 x 10
-3
 M) it requires a composition of 1:33 of CTADC:CTAB. Though to a 
less extent, addition of nonionic surfactant TX-100 shows similar type of decreasing 
trend and requires 20 molecules of TX-100 for complete entrapment of 1 molecule of 
CTADC. If the rate decrease is only due to the partition effect, a substantial decrease 
in the rate constant with increase in [SDS] is also expected. On the other hand, if the 
rate change is only due to availability of proton on the reverse micellar interface, 
micellar catalysis by anionic interface is expected. However, addition of SDS has no 
remarkable effect on the rate of the reaction. This may be attributed to the 
neutralization of positive charges of the reverse micellar interface in presence of 
dodecylsulfate anion of SDS and provide a suitable residing site for H
+
, dichromate 
ion and acetaminophen. Thus the decrease in rate constant due to partitioning of 
oxidant and substrate may be counter-balanced by the increase in rate due to 
formation of a suitable environment for possible interaction of oxidant, substrate and 
acetic acid.  These two propositions are described schematically in Figure 2.7. Figure 
2.7 A and B represent the repulsion of H
+
 from the reverse micellar cationic interface 
of CTA
+
. The extent of repulsion is less in TX-100 reverse micelle, where the positive 
charge on the interface is only due to CTA
+ 
from CTADC. Figure 2.7 C shows the 
interaction between cationic CTA
+
 and anionic DS (dodecylsulfate), resulting in 
charge neutralization on the interface.  
From all the above observations, a mechanism is proposed (Scheme 2.3), 
where CTADC first equilibrates with acetic acid to form a protonated dichromate, 
which then forms a chromate ester complex with acetaminophen. The complex then 
decomposes to the products, namely benzoquinone and acetamide.  
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Figure 2.7 Schematic representation of surfactant effect on the oxidation reaction of 
acetaminophen by CTADC in acetonitrile presence of acetic acid A: Effect of CTAB, 
B: Effect of TX-100, C: Effect of SDS. 
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2.3.2  Effect of solvent polarity 
Investigation of effects of solvent polarity on reactivity always plays a crucial 
role in determining the nature of the transition state and the mechanism of the 
reaction. The change in the reaction rates due to change in solvent properties is 
mainly due to differential solvation of the starting material and transition state by the 
solvents. When the reactant molecules proceed to the transition state, the solvent 
molecules orient themselves to stabilize the transition state. If the transition state is 
stabilized to a greater extent than the starting material, the reaction proceeds faster. If 
the starting material is stabilized to a greater extent than the transition state, the 
reaction proceeds slower.  
In the present investigation, to observe the effect of environment, the rate of 
the reaction was measured with change in solvent polarity. The oxidation of 
acetaminophen by CTADC was studied in solutions containing varying proportions of 
acetonitrile-acetone and acetonitrile- ethyl acetate in presence of acetic acid.  The 
observed rate constants (Table 2.2 and 2.3) are correlated with different solvent 
parameters such as π∗ (solvent polarity),43-44 β (hydrogen bond acceptor basicity),43-44 
A (anion solvating power of the solvent),
45 
B (cation solvating power of the solvent),
45
  
A+ B (solvent polarity),
45 
log P (logarithm of partition coefficient between octanol and 
water; referred as solvent hydrophobicity)
46
  dielectric constant (ε), dipole moment(μ), 
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viscosity (η), density (ρ) and surface tension (γ). The polarity parameters for the 
solvent mixtures have been estimated approximately from the polarity parameters of 
the pure solvents.  
Table 2.2 Observed rate constants in the oxidation of acetaminophen by CTADC at 
298 K in acetonitrile-ethylacetate solvent mixture in the presence of acetic acid 
Mole 
fraction 
(CH3CN) 
Mole fraction 
(Ethyl- 
acetate) 
π∗ A B β Log P ε 104kobs(S
-1
) 
0.83 0.00 0.70 0.31 0.71 0.31 -0.28 30.99 2.42(±0.09) 
0.82 0.01 0.70 0.31 0.71 0.31 -0.27 30.81 2.42(±0.09) 
0.80 0.03 0.69 0.30 0.70 0.31 -0.25 30.05 2.40(±0.09) 
0.77 0.05 0.68 0.30 0.69 0.31 -0.23 29.27 2.38(±0.09) 
0.71 0.11 0.66 0.28 0.67 0.31 -0.16 27.19 2.29(±0.09) 
0.64 0.17 0.63 0.27 0.65 0.31 -0.09 24.90 2.00(±0.08) 
0.56 0.24 0.61 0.26 0.62 0.31 -0.02 22.37 1.57(±0.06) 
0.47 0.31 0.57 0.24 0.59 0.32 0.07 19.56 1.31(±0.05) 
0.37 0.40 0.54 0.22 0.56 0.32 0.16 16.43 0.92(±0.03) 
0.26 0.49 0.50 0.20 0.52 0.32 0.27 12.90 0.40(±0.01) 
An increase in the polarity and decrease in the hydrophobicity of the medium 
increased the rate of the reaction. This fact illustrates the formation of a more polar 
transition state than the reactants in the rate-determining step. Further, the increase in 
rate constant with an increase in ion solvating power (A + B) of the solvent depicts an 
ionic transition state for the oxidation reaction. However, similar increasing trend 
with the increase in both A and B proposes the involvement of both cation and anion 
in the transition state. On the basis of these observations, it may be proposed that in 
the rate-determining step, the complex (C) decomposes to the products through an 
ionic transition state as represented in Scheme 2.4. The non-ideal decrease in the rate 
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with decrease in solvent polarity (Figure 2.8-2.9) is ascribed to the preferential 
solvation of the transition state and the positively charged intermediate by 
acetonitrile.
47
 Due to the presence of nonbonding electrons, acetonitrile acts as a good 
cation solvator.
48
 The positive charge in the zwitterionic transition state is localized 
on the NH
+ 
moiety, whereas the negative charge is delocalized through the benzene 
ring and chromate moiety. Accordingly, the transition state (1) might behave more as 
a cation than anion and could be strongly solvated in acetonitrile through ion-dipole 
interactions, leading to stabilization of the transition state.
49  
Table 2.3 Observed rate constants in the oxidation of acetaminophen by CTADC at 
298 K in acetonitrile: acetone solvent mixture  
Mole 
fraction 
(CH3CN) 
Mole 
fraction 
(acetone) 
π∗ A B β log P ε 104 x kobs(S
-1
) 
0.82 0.01 0.71 0.31 0.71 0.31 -0.28 31.05 2.42(±0.09) 
0.82 0.01 0.70 0.31 0.71 0.31 -0.28 30.92 2.42(±0.09) 
0.79 0.04 0.70 0.30 0.71 0.31 -0.28 30.40 2.42(±0.09) 
0.76 0.07 0.69 0.30 0.71 0.31 -0.27 29.87 2.42(±0.09) 
0.68 0.14 0.68 0.29 0.70 0.32 -0.27 28.49 2.42(±0.09) 
0.60 0.21 0.66 0.28 0.69 0.33 -0.26 27.02 2.05(±0.08) 
0.52 0.29 0.65 0.26 0.68 0.33 -0.25 25.48 1.42(±0.06) 
0.43 0.38 0.63 0.25 0.67 0.34 -0.24 23.83 0.96(±0.03) 
0.33 0.47 0.61 0.24 0.66 0.35 -0.22 22.08 0.65(±0.02) 
An analysis of the rate constant values with respect to polarity parameters 
exhibits some interesting results. From the bilinear plots of kobs against polarity 
parameters (Figure 2.8-2.9), an ordination between two classes of solvent 
compositions was experienced. The dissimilar trends in these two groups of solvent 
   
Chapter 2 
82 
 
compositions suggest a complex mechanism with varied contribution of these solvents 
toward the reaction mechanism. The variation of rate constant with change in 
different parameters (such as concentration of reactants involved, the addition of 
surfactants and a change in polarity of the medium) shows the importance of two 
factors toward the mechanism: 
(i) Stability of transition state 
(ii) Partition of CTADC, acetaminophen and acetic acid in different 
microheterogeneous phases due to the formation of reverse micelles. 
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Figure 2.8 Plots of 10
4 
x
 
kobs versus dielectric constant of the medium (ε) in the 
oxidation of acetaminophen in A; acetonitrile-ethyl acetate and B; acetonitrile-acetone 
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In the acetonitrile-ethyl acetate mixture (Figure 2.8 A), with the decrease in 
dielectric constant of the medium from 31 to 27, a slow decrease in the rate constant 
is observed (slope = 0.02). In the lower side of the plot from dielectric constant values 
25 to 10, a sharp decrease is experienced, with slope of 0.13. Thus the decrease in rate 
constant with decrease in dielectric constant is six times faster in the lower side 
compared to that of the higher side. If the change in rate constant with change in 
solvent composition is only due to stability of polar transition state, linear plots of kobs 
versus polarity parameters are expected.  
 
 
Figure 2.9 Plots of 10
4 
x
 
kobs versus log P (solvent hydrophobicity) in the oxidation of 
acetaminophen in A; acetonitrile-ethyl acetate and B; acetonitrile- acetone binary 
mixture of solvents. (Dotted lines are drawn manually to show variations) 
In the mixture of acetonitrile and acetone, similar decrease in rate constant is 
observed in lower dielectric constant (from 28 to 22) region with slope of 0.29. 
However, in the higher side, the rate constant remains constant (Figure 2.8 B).  The 
sharp decrease in rate constant in the low polar region is explained through the 
combining effect of the lesser stability of transition state and the higher ease of 
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formation of reverse micellar aggregation of CTADC in nonpolar solvents. 
Quaternary ammonium and phosphonium salts exist as ion pairs or an aggregation of 
ion pairs in non-aqueous medium.
50
 The degree of aggregation of these salts in a 
nonpolar solvent is inversely proportional to the polarity of the medium.
51
 With an 
increase in nonpolarity of the solvents, reverse micellization increases, which results 
in a higher partition of oxidant and substrate into two different phases, imparting a 
rate decrease.   
To get further support for the proposed mechanism and transition state, the 
kinetic isotope effect (kH/kD), the solvent kinetic isotope effect k(H2O)/k(D2O), and 
the effect of temperature have been investigated.  
2.3.3  Determination of deuterium kinetic isotope effect 
Kinetic isotope effect (KIE) has frequently been used to study organic reaction 
mechanisms and to get information on the structure of the transition state.
52 
To study 
the deuterium kinetic isotope effect, acetaminophen was treated with D2O to obtain 
deuterated acetaminophen. By comparing the 
1
H NMR spectrum of the D2O treated 
acetaminophen (Figure 2.1) with the 
1
H NMR spectrum of acetaminophen (Figure 
2.2) and also with the literature report,
 53
 approximately 70% exchange of N-H proton 
to form deutero acetaminophen (3) was suggested. Using 3 as the substrate and 
keeping all other parameters constant, rate constant for the oxidation of deuterated 
substrate i.e. kD was measured. No significant primary kinetic isotope effect (kH / kD ) 
was observed. If the rate determining step involves the breaking of a N-H bond, a 
large deuterium isotope effect is to be expected. Because no isotope effect is found in 
the present reaction, it is concluded that the rate determining step does not involve the 
breaking of an N-H bond. Therefore, it may be assumed that the complex(C) 
decomposes to the N-acetyl-p-benzoquinone iminium ion in the rate-determining step, 
which on deprotonation furnished NAPQI in a fast process. NAPQI is further 
hydrolyzed to form benzoquinone and acetamide in the acidic medium (Scheme 2.5). 
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2.3.4  Determination of solvent kinetic isotope effect 
Isotopic labelling on solvents may influence the rate of the reaction and 
sometimes gives useful information for the elucidation of reaction mechanism. To 
obtain the solvent kinetic isotope effect (k(H2O)/k(D2O)), the reaction was carried out 
in 3:7 mixture of H2O-acetic acid and D2O-acetic acid separately. The solvent kinetic 
isotope effect, k(H2O) / k(D2O), was found to be ((1.57 x 10
-3
)/ (1.29 x 10
-3
) = 1.22).  
The magnitude of the isotope effect in this case is similar to that of a secondary 
isotope effect and it may be explained through the differential solute-solvent 
interaction due to isotopic substitution.
54
 On isotopic substitution, the physical 
characteristics of the solvents change; consequently, the strength of hydrogen bonds 
also change. The hydrogen bond strength is higher in D2O compared to water.
55 
The 
hydrogen bonding energy in D2O is 929 J mol
–1
 more negative than in H2O at 
298.15K.
56,57  
Both the reactant and the transition state formed stronger hydrogen 
bonds with D2O than water and thus stabilized more, leading to higher drop in free 
energy in D2O. However, as proposed in Scheme 2.4 and 2.5, there is charge 
induction in the transition state; thus, the difference in free energy of the transition 
states in D2O and in water is predicted to be less compared to the free energy 
difference of the reactants in both the solvents (Figure 2.10). Calculating the 
thermodynamic parameters in both the cases (Table 2.4), this difference is found to be 
0.4 (± 0.03) kJ mol
-1
. Consequently, the solvent kinetic isotope effect is greater than 
one, though considerably smaller. 
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2.3.5  Effect of temperature 
With increase in temperature, the rate constant was found to increase linearly 
(Table 2.4). The thermodynamic parameters like activation energy (Ea), enthalpy of 
activation (H‡), entropy of activation (S‡) and free energy of activation (G‡) were 
calculated using Arrhenius and Eyring equation and found to be 48.7 kJ mol
-1
, 46.2 kJ 
mol
-1
, -160 J mol
-1
 K
-1
 and 93.7 kJ mol
-1 
respectively in acetonitrile.                                                             
The proposed mechanism is also supported by the values of thermodynamic 
parameters. The lower energy of activation and high free energy of activation support 
the formation of highly solvated transition state. The high negative entropy of 
activation is also indicative of an extensively solvated activated complex than the 
reactants.
58 
The formation of ions from neutral molecules passes through a polar 
transition state, implying a drop in entropy due to extensive solvation and ΔS≠ 
assumes a larger negative value. Further, with a decrease in the solvent polarity, the 
value of ΔS≠ became higher negative showing an appreciable increase in ordering in 
less polar solvents (Table 2.4). All these experiments support the formation of an 
ionic polar transition state.  
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Figure 2.10 Free energy diagram (Solid line: D2O solvated reactant and TS; dotted 
line: H2O solvated reactant and TS) depicts drop in free energy of reactant and 
transition state due to solvation in D2O. The difference in free energy of reactants G 
(RD2O-RH2O) is greater than the difference in free energy of transition states G 
(TSD2O-TSH2O) due to difference in the strength of hydrogen bonds. 
Table 2.4 Activation parameters determined in different solvents for the oxidation of 
acetaminophen by CTADC. 
Solvent 
10
4
 kobs ( s
-1
) 
ΔH≠ 
kJ/mol 
ΔG≠ 
kJ/mol 
ΔS≠ 
J mol
-1
 K
-1
 293K 298K 303K 308K 313K 
Acetonitrile 
1.59   
±0.06 
2.42    
±0.09 
3.44   
±0.12 
4.45   
±0.14 
5.77 
±0.24 
46.22 93.74 -159.47 
Ethylacetate 
1.08   
±0.04 
1.46   
±0.05 
2.03   
±0.08 
2.65   
±0.11 
- 42.87 94.89 -174.44 
Dioxane 
0.47   
±0.02 
0.64   
±0.02 
0.84   
±0.04 
1.11   
±0.04 
- 40.35 96.97 -189.90 
H2O-Acetic 
acid(3:7) 
10.40  
±0.34 
15.74   
±0.53 
19.65  
±0.63 
27.11  
±1.06 
- 44.01 89.14 -151.41 
D2O-Acetic 
acid(3:7) 
9.40 
±0.29 
12.86  
±0.38 
17.96 
±0.58 
23.41 
±0.84 
- 43.61 89.49 -153.90 
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2.4  CONCLUSION 
In conclusion, the oxidant (CTADC) oxidizes acetaminophen to p-
benzoquinone following Michaelis-Menten kinetics. The first step involves a very fast 
formation of an association complex between acetaminophen and CTADC and is 
followed by a second rate determining dissociation of the complex proceeding via a 
polar transition state to form N-acetyl-p-benzoquinone iminium ion intermediate, 
which on subsequent deprotonation and hydrolysis forms the product. CTADC 
assembles to form reverse micelles in nonpolar solvents and mixed reverse micelles 
with other surfactants and provides different residing sides for reactants. The substrate 
and oxidant are thus partitioned into two different types of environments; accordingly, 
the reaction is controlled. The outcome from solvent effect illustrates the contribution 
of reverse micellization and the stability of transition state toward the rate of the 
reaction. The proposed mechanism also gets support from the solvent isotope effect, 
the deuterium kinetic isotope effect and the effect of temperature on the reaction rate.  
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3.1  INTRODUCTION 
Epinephrine, commonly known as adrenaline, is a hormone and 
neurotransmitter belonging to the catecholamine family.
1
 It liberates glucose into the 
blood stream through a variety of enzymatic reaction and finally stimulates the body 
to make a spontaneous decision to fight or flight.
2-4
 The role of epinephrine as a 
neurotransmitter highly depends upon its oxidation mechanism. Inside the body 
adrenaline is oxidized by an enzyme known as amine oxidase, and in that case 
adrenaline molecule is oxidized in the side chain.
5
 At an intermediate pH (6-8), 
epinephrine in aqueous buffer is oxidized to red coloured substance known as 
adrenochrome.
6
 Auto-oxidation of epinephrine produces hematin, methemoglobin
 
and 
adrenochrome.
7-10
   
Literature reports a good deal of examples for the oxidation of epinephrine to 
various coloured organic products and intermediates by different homogeneous and 
heterogeneous oxidizing systems.
11-23
 It is proposed that organic radicals are involved 
in these oxidations of epinephrine. Fenton’s reagent at pH 4.5 oxidizes adrenaline to 
adrenochrome by a free-radical mechanism.
11 
 In the catalytic oxidation of 
epinephrine to adrenochrome  by mesoporous silica nanoparticles (MSN) as 
heterogeneous catalyst, it is reported that large surface area, characteristic 
mesoporosity and surface structures  facilitate the deposit of reactants inside MSN 
particles, and catalyze the oxidation process.
18 
Szigyarto et al.
19
 have studied the 
Mn(II) complex catalyzed oxidation of epinephrine to adrenochrome at room 
temperature. They proposed that the catalytic effect is mainly due to the binding of 
the catalyst to dioxygen and the substrate and formation of a ternary complex between 
catalyst-dioxygen-substrate as active intermediate. Lupano et al.
20,21
 have used 
hydrogel based Co(II) catalyst complex for H2O2 activation for the oxidation of 
epinephrine to adrenochrome. With the use of a Co(II)-poly(EGDE-DA) complex, 
about 77% of conversion was achieved in 30 min, while with the use of             
Co(II)-Poly(EGDE-MAA-2MI) about 80% conversion of epinephrine to 
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adrenochrome was achieved in less than 6 min, following a pseudo-first-order kinetic 
model.   
Objectives: Owing to the selectivity, mildness and biomimetic characteristics of 
CTADC the main objective aims to investigate the oxidative metabolism of 
epinephrine by CTADC. The specific objectives of the present section are to analyze 
the following hypothesis. 
 Can CTADC act as a mild, chemoselective and biomimetic oxidant for 
epinephrine? What will be the product of the oxidative degradation? 
 What will be the mechanism of the conversion? Will it be a free radical process or 
ionic process? 
 What will be the effect of   different parameters such as reaction temperature, 
solvent polarity/hydrophobicity, acidity and presence of surfactants etc. on the 
overall rate and mechanism of the oxidative metabolism? 
To get a clear picture of the oxidative metabolism, mechanism of the oxidative 
conversion has been investigated through kinetic study in surfactant generated 
biomimetic medium.  
3.2  EXPERIMENTAL  
3.2.1  Materials 
CTADC was synthesized as per the procedure discussed in Chapter 2. 
Epinephrine was purchased from Sigma Aldrich, India and used without further 
purification. Glacial acetic acid (Merck, India) was used without further purification. 
The surfactants CTAB and SDS were purified by recrystallization from aqueous 
ethanol, and their purity was checked from physical constants. TX-100 was purchased 
from Merck, India and was used without further purification. Acetonitrile was 
purified by standard method. 
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3.2.2  Kinetic measurements 
The oxidation kinetics of epinephrine by CTADC in acetonitrile in the 
presence of acetic acid was investigated by monitoring the appearance of the product 
adrenochrome at an analytical wavelength of 455 nm in a Shimadzu UV-vis 
spectrophotometer (UV-1800) fitted with thermostatic cell holders. The temperature 
in the reaction cell was controlled by circulating water by using a Lauda thermostat 
within a temperature fluctuation of 0.05
o
C. All reactions were carried out under 
pseudo-first-order conditions, keeping excess of [CTADC] with respect to 
[epinephrine]. Pseudo-first-order rate constants (kobs) were calculated from the linear 
plots of ln (A∞ − At) vs. t. The effect of variation of [CTADC], [epinephrine], [acid] 
and [surfactant] on the rate constant was investigated by varying the concentration of 
the desired constituent in the reaction mixture. All experiments were repeated at least 
three-times and the rates of reactions were obtained within an error of 6%.  
3.2.3  Calculation of isokinetic temperature 
The isokinetic temperature was calculated following Exner’s method.24 In this 
method, two rate constants (k1 and k2) at two different temperatures (T1 and T2) are 
determined for a series of reaction. A linear plot of log k1 vs. log k2 confirms the 
validity of isokinetic relationship and the isokinetic temperature , is calculated using 
the following two equations (equation 1 and 2). Taking T1 = 308 K and T2 = 303 K, 
for the present reaction the isokinetic temperature was calculated to be 366K. 
log k2 = b log k1 + a        (1) 
 = T1T2 (1-b)/ (T1-T2b)       (2) 
3.2.4  Stoichiometry 
Limiting logarithmic method was used to determine the Stoichiometry of the 
oxidation reaction.
25-26
 For this, two different sets of experiments were done. In the 
first set of experiment, the epinephrine concentration was varied (0.6 x 10
-5
 to 0.9 x 
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10
-4
 M) at a fixed CTADC concentration (5.8 x 10
-4
 M) and in the second set of 
experiment the CTADC concentration was varied (4.6 x 10
-4
  to 1.4 x 10
-3 
M) at a 
fixed epinephrine concentration (0.6 x 10
-4
M). The absorbances of the product were 
recorded after a fixed time interval (20 minutes) after the mixing of reactants. The 
logarithms of the obtained absorbances were plotted against log [epinephrine] and log 
[CTADC] in the first and the second set of experiments respectively. The ratio of the 
slopes of the fitting lines represents the stoichiometry of the reaction and found to be 
3:2 epinephrine to CTADC, respectively.  
3.3  RESULTS AND DISCUSSION  
Under reflux conditions, the solution of CTADC and epinephrine in 
acetonitrile yielded a red colored product, which was identified as adrenochrome from 
the occurrence of a broad absorption peak at 455 nm in the UV-vis absorption 
spectrum of the reaction mixture (Figure 3.1).
18,19,23,27,28
 Extraction of a dirty green 
residue from the reaction mixture illustrates the reduction of Cr(VI) to Cr(III) in the 
reaction process. Using limiting logarithmic method stoichiometry of the reaction was 
calculated to be 3:2 epinephrine to CTADC respectively.
25,26
  
 
Figure 3.1 UV-vis spectra of reaction mixture for the reaction of CTADC and 
epinephrine in thepresence of acetic acid in acetonitrile showing the product 
formation at different time interval.  
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Reaction kinetics of epinephrine with CTADC in the presence of acetic acid 
was followed spectrophotometrically by monitoring the appearance of the product 
adrenochrome at an analytical wavelength of 455 nm (Figure 3.1). Though the 
reaction is also possible in the absence of acetic acid, epinephrine is sparingly soluble 
in acetonitrile in the absence of acetic acid. Hence kinetics was studied in presence of 
a fixed amount of acetic acid in the medium. The rate constants were measured under 
pseudo-first-order conditions with the concentration of CTADC maintained in more 
than 10-fold excess relative to the substrate concentration. All reactions obeyed first-
order kinetics. Pseudo-first-order rate constants (kobs) were calculated from the linear 
plots of ln (A∞ − At) vs. t. From the kobs values corresponding rates were calculated by 
multiplication of the kobs values with the [substrate]. The kobs and rate values at 
different reaction conditions are summarized in Table-3.1. 
3.3.1 Effect of reactant concentration 
From the linear logarithm plot of rate versus [substrate], the order of reaction 
with respect to epinephrine was found to be 1.35. Using multiple regression analysis, 
log (rate) values obtained at different conditions were correlated with the parameters 
of the reaction condition, that is, [substrate] and [oxidant], to obtain a relationship 
between the rates of reaction with the parameters of the reaction condition. The 
regression model, thus obtained, has been presented in equation 3. Accordingly the 
rate expression can be written as in equation 4. The constant term (i.e. -1.337) in the 
regression model demonstrates that when the reactant concentration tends to 1 the rate 
constant and hence the rate tends to 4.6 x 10
-2 
s
-1
.
  
Log (rate) = -1.337(±0.186) - 0.138(±0.059) log [CTADC] +1.349(±0.03) log 
[Epinephrine]            (3)                                                                        
R
2
 = 0.996, F = 1071   n = 12      
Rate= 0.046 [CTADC]
-0.14
 [Epinephrine]
1.35
                                        (4)                                                       
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Table 3.1 Effect of [Epinephrine] and [CTADC] on the Oxidation of epinephrine by 
CTADC in acetonitrile at 298 K 
 
a
Calculated using Eq (1) 
Using the regression model, the log (rate) values were predicted and plotted 
against the observed values (Figure 3.2). A linear plot without any outlier supports the 
regression model. 
 
Figure 3.2 Plot of predicted versus observed log (rate) for the oxidation reaction of 
epinephrine with CTADC in acetonitrile at 298 K. 
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x10
4
 (M) 
[Epinephrine]x 
10
4
 M) 
kobs ×10
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−1
) 
Rate x 10
8
 (M s
-1
) 
Observed Calculated
a
 
5.8 0.06 17.2 ± 0.9 1.03 1.17 
5.8 0.12 25.0 ± 1.2 3.00 2.97 
5.8 0.18 31.8 ± 1.6 5.72 5.12 
5.8 0.3 37.9 ± 1.9 11.37 10.20 
5.8 0.5 42.2 ± 1.9 21.10 20.32 
5.8 0.6 43.1 ± 2.1
 
25.86
 
25.98 
5.8 0.9 44.5 ± 2.2 40.05 44.88 
4.65 0.6 44.5 ± 2.1 26.70 26.78 
9.31 0.6 39.8 ± 1.9 23.88 24.35 
11.64 0.6 38.5 ± 1.9 23.10 23.61 
13.96 0.6 38.2 ± 1.8 22.92 23.03 
 Chapter 3 
97 
 
Oxidation of hydroxylic and phenolic substrates by CTADC goes through a 
multistep reaction process, where the first step is the formation of a 1:1 association 
complex between the oxidant and the substrate.
29-33
 The complex subsequently 
decomposes to the products through rate-determining hydrogen abstraction by the 
chromate oxygen. In the present study the fractional orders with respect to the oxidant 
and the substrate (equation 4) indicate the occurrence of a complex reaction 
mechanism, which may be proposed as in Scheme 3.1. Epinephrine first forms a 
complex C1 with CTADC which then decomposes to form epinephrine quinone (P1). 
Intramolecular cyclization through a nucleophilic attack by the nitrogen on the 
quinone ring of P1 followed by aromatization through proton transfer afforded 
leucochrome (P2). As reported earlier, the half-life of the primary oxidation product 
(P1) was only 0.06 sec; that is, this open chain quinone exists only as a very transient 
intermediate between epinephrine and adrenochrome.
34
 In presence of Cr(VI), 
leucochrome further oxidizes to the product adrenochrome (P3) through the rate 
determining decomposition of complex C2.   
The proposed mechanism gets support from the rate retarding effect of acetic 
acid. With an increase in the concentration of acetic acid, the rate of the reaction was 
found to decrease linearly (equation 5 and Figure 3.3). As per equation 5, in the 
absence of acetic acid, the rate of the reaction will be 32.67 x 10
-8
 M s
-1
. In acidic 
medium epinephrine exists in the cationic form (1) and is oxidized to the cationic 
quinone (2).
34
 The protonation at nitrogen prevents the nucleophilic attack for 
possible intramolecular cyclization to form the P2. With a decrease in acidity the 
increase in formation of free base leads to cyclization, and as a result, the rate of the 
reaction increases. If, step 2 would have been the rate-determining step, there would 
not be any rate retardation with increase in [acetic acid], rather a rate increase would 
have been observed because of an increase in formation of protonated dichromate and 
fast formation of Complexs C1 and C2. Thus, step-5 may be proposed to be the rate 
determining step. With an increase in acidity, [P2] decreases, affecting the [C2] and 
thus affecting the rate of the reaction.  
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(Scheme 3.1) 
 
Figure 3.3 Plot of rate of the reaction versus [acetic acid] for the oxidation of 
epinephrine with CTADC in acetonitrile at 298 K. 
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Rate = -2.1458 [Acetic acid] + 32.67       R
2
 = 0.997                      (5) 
NH2
CH3
OH
OH
OH
NH2
CH3
OH
O
O
1 2
++
 
After the removal of the organic products, the presence of green coloured 
residue in the reaction mixture supports the reduction of Cr(VI) to Cr(III).
35
 Free 
radical mechanism through one electron transfer may not be possible because of the 
following: (i) no precipitate was observed by addition of acrylonitrile to the reaction 
mixture.
36-38 
(ii) there is no signal in the EPR spectrum; (iii) the addition of 
acrylonitrile does not have any effect on the rate of reaction. Thus, during the 
oxidation process, Cr(VI) was reduced to Cr(IV). The reduced Cr(IV) by a 
disproportionation reaction in a sequential manner further changed to Cr(III)  
(Scheme 3.2). The existence of Cr(IV) as the reduced state in oxidation of various 
organic substrates by different chromium oxidants including onium chromates and 
dichromates is well established.
39,40 
Cr(VI) + Epinephrine    Cr(IV) + Adrenochrome 
Cr(IV) + Cr(VI)  2 Cr(V) 
Cr(V) + Cr(IV)  Cr(III) + Cr(VI) 
(Scheme 3.2) 
Similar to the oxidation of acetaminophen by CTADC (Chapter 2), a nonlinear 
decrease in rate with increase in [CTADC] is observed (Table 3.1) and can be 
explained through the possible formation of reverse micellar type aggregates. The 
dichromate ions thus remain enveloped by the CTA
+
 leading to decrease in the 
effective concentration of the substrate in the proximity of the dichromate.   
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3.3.2  Effect of surfactant 
To supplement the above proposition, the effect of surfactants such as CTAB, 
TX-100 and on the rate of the reaction was analyzed.  Asymptotic decreasing profiles 
in the rates are observed with increase in surfactant concentrations (Figure 3.4). The 
break points in these plots may provide evidence for the formation of mixed reverse 
micellar aggregate of CTADC with the added surfactant and partition of reactants in 
different subphases. In presence of SDS, a significantly higher decrease is observed as 
compared to the CTAB and TX-100. SDS forms a reverse micelle with negative 
charge at the interface and thus provides a favorable residing site for H
+
. Previous 
reports on acetic acid catalyzed oxidation of various organic substrates by CTADC, 
opposite trend has been observed with respect to [SDS].
29-32
 The results were 
explained through the stabilization of protonated dichromate in the anionic interface 
of SDS reverse micelle. In the present study, the protonated dichromate is also 
stabilized in the SDS reverse micellar interface (Scheme 3.3), which may increase the 
concentration of C1 leading to an enhancement in the formation of P1. On the other 
hand, it may decrease the concentration of P2 (which is supposed to be the reactant 
for the second oxidative process), due to stabilization of protonated epinephrine 
quinone (2) resulting in a decrease in the rate.  
 
Figure 3.4 Effect of [surfactant] on the rates of the reaction in the oxidation of 
epinephrine by CTADC at 298 K. 
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3.3.3  Effect of temperature 
The thermodynamic parameters such as Ea, H
‡
, G‡, and S‡ were calculated 
using the Arrhenius and Eyring equation, and the results are presented in Table 3.2.  
The high-negative values of S‡ support the involvement of a highly ordered 
transition state than the reactants as discussed in Chapter 2. Thus, formation of a 
cyclic or a forced transition state may be proposed for the abstraction of o-hydroxyl 
proton of complex C2 to form adrenochrome in the rate-determining step.
41
 
 
(Scheme 3.3) 
3.3.4  Effect of solvent polarity 
The proposed mechanism especially formation of forced nonpolar transition 
state is further supported by the effect of solvent polarity on the reaction rate. The 
oxidation reaction was carried out in solutions containing varying proportions of 
acetonitrile-DMSO in presence of acetic acid. The observed rate constants (Table 3.3) 
were correlated with different solvent parameters such as dielectric constant (ε), π∗ 
(solvent polarity),  β (hydrogen bond acceptor basicity),  A (anion solvating power of 
the solvent), 
 
B (cation solvating power of the solvent) and log P (logarithm of 
partition coefficient between octanol and water referred as solvent hydrophobicity). 
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The polarity parameters for the solvent mixtures have been estimated approximately 
from the polarity parameters of the pure solvents.  
Table 3.2 Observed rate constants at different temperatures and activation parameters 
for the oxidation of epinephrine by CTADC in presence of acetic acid.  
Solvent 
10
4
 kobs ( s
-1
) 
288K 293K 298K 303K 308K 313K 318K 323K 
CH3CN 
23.5 
±1.1 
32.8 
±1.5 
43.1  
±2.2 
56.4  
±2.8 
67.0  
±3.4 
- - - 
CH3CN: 
DMSO (1:1) 
- 
4.8  
±0.2 
6.3  
±0.3 
8.6  
±0.4 
12.9  
±0.5 
20.0  
±0.5 
25.6  
±1.1 
- 
DMSO - - 
0.4  
±0.02 
0.6  
±0.04 
1.1  
±0.07 
1.8  
±0.1 
3.0  
±0.2 
5.1  
±0.3 
Solvent 
Ea                     
kJ mol
-1
 
ΔH≠                 
kJ mol
-1
 
ΔG≠            
kJ mol
-1
 
ΔS≠                
J mol
-1
 K
-1
 
CH3CN 39.0 36.5 82.6 -168 
CH3CN: 
DMSO (1:1) 
54.0 51.5 90.6 -133 
DMSO 82.5 79.9 98.1 -62 
 
With an increase in polarity of the medium the rate constant is found to 
decrease, delineating less polar transition state than the reactants (Table 3.3). Figure 
3.5 and 3.6 show the change in kobs with change in the composition of DMSO and 
change in hydrogen bond acceptor (HBA) basicity β of the solvent in acetonitrile-
DMSO mixture, respectively. On increasing the mole fraction of DMSO from 0 to 0.2 
in acetonitrile/DMSO mixture, a sharp decrease in rate constant is observed (from 43 
x 10
-4 
to 9 x 10
-4
 s
-1
). On the other hand, at higher mole fraction of DMSO (> 0.2), the 
rate constant is virtually independent of the composition. This observation 
demonstrates preferential solvation of reactants and/or transition state in DMSO. The 
validity of isokinetic relationship with an isokinetic temperature of 366K confirms 
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that the bilinear decreasing trend is not due to a change in mechanism.
42,43 
Further, as 
DMSO contains nucleophilic oxygen, the decrease in rate may also be attributed to 
nucleophilic role of oxygen of DMSO instead of nitrogen in step 3 of the proposed 
mechanism (Scheme 3.1). To investigate the matter, the effect of composition of 
nonpolar solvent like chloroform on the rate constant was also investigated. Similar 
type of increase in rate constant with decrease in polarity was observed when the 
reaction was carried out in acetonitrile-chloroform mixture (Table 3.4, Figure 3.7). 
Thus, it may be proposed that, the change in rate constant with change in solvent 
polarity is primarily due to the preferential solvation of reactants in polar solvents.  
Table 3.3 Observed rate constants in the oxidation of epinephrine by CTADC at 
298K in acetonitrile: DMSO solvent mixture.  
 
Mole fraction 
(CH3CN) 
Mole fraction 
(DMSO) 
π∗ β logp ε 104 kobs(S
-1
) 
0.83 0 0.707 0.308 -0.283 31.174 43.1 ± 2.4 
0.82 0.01 0.708 0.313 -0.296 31.265 30.2 ± 1.7 
0.76 0.07 0.713 0.333 -0.352 31.638 15.2 ± 0.8 
0.71 0.11 0.718 0.349 -0.395 31.928 12.2 ± 0.6 
0.68 0.14 0.721 0.360 -0.424 32.127 10.2 ± 0.6 
0.60 0.22 0.728 0.388 -0.500 32.641 8.8 ± 0.5 
0.51 0.30 0.736 0.418 -0.581 33.183 7.7 ± 0.4 
0.42 0.39 0.745 0.450 -0.665 33.750 6.3 ± 0.4 
0.18 0.61 0.767 0.533 -0.89 35.27 2.4 ± 0.2 
0.00 0.78 0.784 0.595 -1.06 36.40 0.4 ± 0.02 
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Figure 3.5 Change in kobs with change in the composition of DMSO in acetonitrile- 
DMSO mixture in the oxidation of epinephrine by CTADC at 298 K. 
 
Figure 3.6 Change in kobs with change in β of the acetonitrile-DMSO solvent mixture 
in the oxidation of epinephrine by CTADC at 298 K. 
 
Figure 3.7 Change in kobs with change in the composition of chloroform in 
acetonitrile: chloroform mixture in the oxidation of epinephrine by CTADC at 298 K. 
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Table 3.4 Observed rate constants for the oxidation of epinephrine by CTADC at 
298K in acetonitrile- chloroform solvent mixture. 
Mole fraction 
(Chloroform) 
10
4
 kobs(S
-1
) 
0 43.1 ± 2.5 
0.148 44.4 ± 2.5 
0.74 46.0 ± 2.6 
1.184 47.4 ± 2.8 
1.48 51.2 ± 3.1 
2.22 57.4 ± 3.5 
2.96 83.7 ± 4.8 
  The decrease in rate constant with an increase in DMSO composition may be 
attributed to the following reasons. If the reactants are solvated more efficiently in 
DMSO than acetonitrile with respect to the activated complex, then Ea will increase. 
Consequently, kobs will decrease and reaction will be slower. Further, if the activated 
complex is solvated less efficiently in DMSO than acetonitrile compared to the 
reactants, then Ea will also increase in value leading to slower rate of the reaction. 
Though both DMSO and acetonitrile are dipolar aprotic solvents with minor 
difference in the polarity ( of DMSO= 46.45;  of acetonitrile= 37.5), there is a large 
difference in the HBA basicity ( of DMSO =0.76;  of acetonitrile =0.31). Thus, the 
preferential solvation of the reactants (the oxidant-substrate complex C2 in the rate-
determining step) is supposed to be due to specific solute-solvent interaction, that is, 
hydrogen bonding. This proposal also gets support from similar decrease of rate 
constant with respect to  (Figure 3.6).  In the oxidant-substrate complex C2, two 
types of hydrogen bonding leading to difference in rate are expected (i) intramolecular 
H-bonding in low polar and low HBA solvents, (ii) intermolecular H-Bonding with 
higher HBA solvents (Scheme 3.4).  From Scheme 3.4 it is obvious that, stronger 
intramolecular H-bonding leads to higher rate of hydrogen abstraction from the o-
hydroxy group, and thus the rate of the reaction is higher. High polar solvents having 
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higher β values preferentially solvate the complex and also stabilize the complex 
through intermolecular H-bonding, leading to lesser rate of decomposition of the 
complex. The higher energy of activation and slower rate of formation of 
adrenochrome with an increase in DMSO composition (Table 3.2) is thus attributed to 
the stronger intermolecular hydrogen bonding providing additional stabilization to 
oxidant-substrate complex. The high polar nature of DMSO may also destabilize the 
nonpolar transition state compared to acetonitrile. This phenomenon is presented 
graphically in Scheme 3.5. The lower the temperature is, the stronger is the 
preferential solvation of the probe molecules by the molecules of solvent.
44
  An 
increase in temperature results in increased kinetic energy of molecules, and thereby 
the interaction between molecules connected with preferential solvation becomes 
weaker. The hydrogen bonding between the reactants and solvents also weakens, 
resulting in an increase in the rate of reaction. 
N
CH3
OH
O
O Cr
O
O O-CTA+
OCrO2O
-CTA+
N
CH3
OH
O
O
H
Cr
O
O O-CTA+
OCrO2O
-CTA+
HBA
Solvents
+
H
H
H X HBA Solvent
X HBA Solvent
     Intramolecular H-Bonding
in nonpolar/low polar  solvents
Intermolecular H-Bonding
 with high HBA  solvents
X: electronegative atom in HBA solvents  
(Scheme 3.4) 
The proposition of the formation of a nonpolar transition state compared to 
that of the reactant is also supported from the numerical values of entropy of 
activation. The entropy of activation (ΔS≠) in acetonitrile is -168 J mol-1 K-1 while in 
DMSO it is found to be – 62 J mol-1 K-1.  The values of ΔS≠ are generally influenced 
by the degree of solvation and solvent polarity. If the transition state is more 
extensively solvated than the reactants, ΔS≠ assumes a larger negative value due to 
appreciable increase in ordering in the solvation shell.
43
 Thus, the higher negative 
value of ΔS≠ in acetonitrile as compared to DMSO may be attributed to the greater 
solvation of the nonpolar transition state in the less polar solvent. 
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Acetonitrile
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Ea = 39.0 kJ/mol Ea = 82.5 kJ/mol
TS
Reactants
     in
Reactants
     in
TS
 
(Scheme 3.5) 
3.4  CONCLUSION 
The oxidant (CTADC) oxidizes epinephrine to adrenochrome selectively 
without affecting the secondary hydroxyl group present in the side chain of the 
epinephrine. The reaction proceeds through a multi-step ionic mechanism. From the 
experimental data a mechanism was proposed where epinephrine is first converted to 
epinephrine quinone. Intramolecular cyclization followed by aromatization through 
proton transfer affords leucochrome which further oxidizes to the product 
adrenochrome through the rate-determining decomposition of complex C2 via a less 
polar transition state. The proposed mechanism gets support from the rate- retarding 
effect in presence of acetic acid and surfactant. CTADC assembles to form reverse 
micelles in nonpolar solvents with cations at the interface providing different residing 
sides for the reactants thus mimicking enzyme activity. The substrate and oxidant are 
partitioned into two different types of environments, and accordingly the reaction is 
controlled. The outcome from solvent effect illustrates that, in the rate- determining 
step the oxidant-substrate complex decomposes via a cyclic nonpolar transition state. 
Polar solvents with higher HBA ability stabilize the reactants and destabilize the 
transition state leading to an increase in energy of activation and lesser rate of 
reaction.  
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4.1       INTRODUCTION 
Tuberculosis (TB) is one of the deadly infectious diseases caused by 
Mycobacterium tuberculosis (Mtb) and is responsible for over two million deaths 
annually.
1 
TB is more widespread in the world today than never before due to the 
emergence of multiple drug resistant tuberculosis (MDR-TB), extensively-drug-
resistant TB (XDR-TB) and HIV associated TB.
2-4 
The treatment of this disease is one 
of the biggest challenges to the scientific community.   
Isoniazid (INH) is selected as one of the most effective inhibitors of bacteria 
Mycobacterium smegmatis and Mtb, and widely used as a first line drug along with 
rifampicin and streptomycin for the chemotherapy of tuberculosis since 1952.
5,6 
Soon 
after the reemergence of  tuberculosis in the mid-1980s coupled with increasing 
numbers of INH-resistant bacterial strains
7-9 
several research groups throughout the 
world are engaged in developing  novel, highly effective, fast acting anti-TB drugs 
with low toxicity profiles and performing activity against both drug-sensitive and 
drug resistant Mtb. Though several probable TB drug candidates are synthesized and 
screened for their antimycobacterial properties, none of these antimycobacterials are 
suitable and approved for tuberculosis treatment till today.
10-15 
Therefore, it becomes 
desirable to investigate the chemistry and the mode of action of this drug in diverse 
environment, which will help to understand drug resistance. 
INH (1)  is a pro-drug
16-19 
activated by the enzyme catalase-peroxidase KatG
20-
26 
to generate the active isonicotinoyl radical (2)
27-29 
which is responsible for the lethal 
effect on bacterial cells.
30-33 
2 forms covalent linkage with the nicotinamide moiety of 
NAD and NADP coenzymes of the reductases InhA
31-32
 and MabA
33 
respectively to 
form the true drug 3 (Scheme 4.1), and inhibit the biosynthesis of mycolic acids 
which is known to be the essential and specific constituents of the mycobacteria cell 
envelope.
34-36
 The formation of the reactive isonicotinoyl radical is found to proceed 
via an acyl diazene intermediate (4) through two electron dehydrogenative oxidation 
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process. One electron oxidation of 4 followed by loss of proton and liberation of 
dinitrogen generates the acyl radical (Scheme 4.2).
28, 37
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(Scheme 4.2) 
In the mechanistic studies of enzymic oxidation of isoniazid by the catalase-
peroxidase of Mycobacterium tuberculosis, Johnsson and Schultz reported the 
involvement of an electrophilic pathway, where the acyldiazene intermediate is 
further oxidized to acyldiazoniumion (5) which then reacts with water or amine to 
form isonicotinic acid or isonicotinamide respectively (Scheme 4.2).
18
 These results 
suggested that isoniazid is oxidized by the catalase-peroxidase in vivo into highly 
reactive radical and electrophilic species and target the essential enzyme of 
Mycobacterium tuberculosis through covalent irreversible modification of the protein. 
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The activation/oxidation of isoniazid by various oxidizing agents such as 
hydrogen peroxide, bromate, Mn
2+
, potassium permanganate, potassium ferricyanide, 
N-haloarenesulfonamidates, diperiodatocuprate(III), quinolinium dichromate, etc. 
have been undertaken mostly in the aqueous medium in the absence or in the presence 
of enzyme catalase-peroxidase to observe the effect of these oxidizing species 
towards the bio-activation of isoniazid.
38-45
 However, to the best of our knowledge the 
oxidation of isoniazid by Cr(VI) in a hydrophobic biomimetic environment has never 
been elucidated. Many biological processes occur at membrane surfaces or within 
their hydrophobic moiety. Owing to the presence of ionic head groups and 
hydrophobic tail of the lipids, biological membrane shows different binding properties 
of charged and uncharged forms of molecules such as drugs. Among the membrane 
models utilized, surfactant systems can be considered as an interesting alternative to 
study various biological processes  because of their amphiphilic properties like lipids 
and of the relative simplicity of these systems, and therefore have been used with this 
purpose.
46 
Objectives: In this context, we have made an attempt to investigate the kinetics and 
mechanism of oxidative metabolism of antitubercular drug isoniazid by CTADC 
using UV-vis spectroscopic method. CTADC was used for the purpose due to its 
surface active properties to form various organized assemblies.
47-51
 Specific objectives 
of the present section are outlined below. 
 To identify the products of oxidative metabolism of isoniazid by CTADC to 
observe the chemoselectivity and mildness of the reaction process. 
  To establish the mechanism of the oxidative degradation and to compare it 
with that of biological and biomimetic systems. 
 To establish a correlation between reaction parameters to that of the rate and 
mechanism of the reaction. 
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4.2       EXPERIMENTAL  
4.2.1    Materials  
Cetyltrimethylammonium dichromate (CTADC) was prepared by the method 
reported earlier
49
 as elaborated in chapter 2 and its purity was checked by estimating     
Cr (VI) iodometrically.
52
 Isoniazid (Merck, India) was purified by recrystallization 
from ethanol. Glacial acetic acid (Merck, India) was used without further purification. 
The organic solvents were purified by the standard methods.
53
 CTAB and SDS were 
purified by recrystallization from aqueous ethanol. TX-100 (Merck, India) was used 
without further purification. 
4.2.2 Product analysis 
The reaction mixture containing CTADC (1.72gm, 2M) and isoniazid 
(0.15gm, 1M) in chloroform in presence of 10% acetic acid was stirred and refluxed 
at 50
°
C for 3 hours. The mixture turned green indicating the formation of Cr(III). The 
completion of the reaction was monitored by TLC. The solvent was evaporated and 
the reaction mixture was subjected to column chromatography. The column 
chromatographic separation was done in a classical glass column using silica gel 
(100-200 Mesh) as adsorbent and chloroform-methanol (9:1) mixture as eluent. A 
white solid product thus obtained (86 mg, yield 64%, Melting Point 305 
o
C 
(sublimes)) was characterized from IR, NMR and CHNS analysis. IR (KBr, 
νmax/cm−1): 2924 (C-H str ), 2407 (O-H str), 1712 (C=O str) 1415 (C=N str) (Figure 
4.1). 
1
H NMR (400 MHz, DMSO-d6): δ/ppm 3.47 (bs), 8.76 (2H, d, J = 3.6 Hz), 7.8 
(2H, d, J = 3.6 Hz) (Figure 4.2). 
13
C NMR (100 MHz, DMSO-d6): δ/ppm 166.96, 
150.18, 140.1, 129.3 (Figure 4.3). Anal. Calcd. for C6H5N1O2: C, 58.54; H, 4.06; N, 
11.38. Found: C, 58.12; H, 4.04; N, 11.34. The IR, NMR and CHNS data analysis of 
the product agreed well with that of isonicotinic acid. In absence of acetic acid the 
oxidation reaction was completed after about six hours. The product in this case was 
also found to be isonicotinic acid. 
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Figure 4.1 IR Spectrum of isonicotinic acid 
 
4.2.3  Kinetic measurements 
To study the kinetics of oxidation, conventional Uv-vis spectroscopic 
technique was used using Shimadzu (UV-1800) UV-vis spectrophotometer. The 
temperature in the reaction cell was controlled by circulating water by using Lauda 
thermostat within a temperature fluctuation of 0.05
o
C. The reactions were performed 
under pseudo-first-order conditions by keeping excess of the isoniazid with respect to 
CTADC. The rate of disappearance of the Cr(VI) species was followed 
spectrophotometrically by monitoring the absorption band at 380 nm in the absence of 
acid and 450 nm in presence of acetic acid.  The first-order rate constant, kobs, was 
obtained from the linear plot of log [CTADC] against time for up to 75% completion 
of the reaction. The values reported are the average of at least triplicate runs and were 
reproducible within 6% error. The solvent kinetic isotope effect was investigated 
using 1:1 mixtures of H2O-acetonitrile, D2O-acetonitrile instead of chloroform in 
presence of 2% acetic acid.  
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4.2.4 Stoichiometry 
The stoichiometry of the reaction was determined by performing the 
experiment at 298 K, under the conditions of [CTADC] >> [isoniazid] ([CTADC] = 
1.75 x 10
-4 
to 8.73 x 10
-4
 and [Isoniazid] = 4.36 x 10
-5
 to 1.1 x 10
-4
) at varying 
isoniazid concentrations. The disappearance of Cr(VI) was followed until the 
absorbance values became constant. The [CTADC] was estimated after 48 h. A 
stoichiometry ratio, Δ[CTADC]/Δ[Isoniazid] = 0.7, was observed, which confirmed a 
1:1.5 CTADC/isoniazid relationship. 
4.3     RESULTS AND DISCUSSION 
The reaction mixture consisting of CTADC and isoniazid in chloroform 
become green after six hours under reflux condition. The oxidation product was 
isolated using chromatographic separation techniques. From the CHNS, IR and NMR 
spectral analysis, the product was found to be isonicotinic acid. In presence of 10% 
acetic acid the oxidation reaction was found to complete after about three hours 
giving rise to the same product.  
Stoichiometric analysis reveals the reaction of 1 mole equivalent of CTADC 
with 1.5 mole equivalent of isoniazid. The green coloration of the product mixture 
due to the absorption maxima around 550-580 nm supports the formation of reduced 
Cr(III).
54 
One electron oxidation giving rise to free radicals may not be possible for 
the present reaction due to the following factors (i) oxidation of isoniazid, in an 
atmosphere of nitrogen, failed to induce polymerization of acrylonitrile
55 
(ii) the 
addition of acrylonitrile did not affect the rate of oxidation reaction
56 
and (iii) absence 
of signal in the EPR spectrum. Further, following the procedure of Braslau et al.
37 
the 
reaction was carried out in presence of 2,2,6,6-Tetramethylpiperidinyloxy (TEMPO), 
a stable nitroxyl radical. Absence of any acyloxyamine products may confirm the 
absence of isonicotinoyl radical in the reaction process. Thus, it may be proposed that, 
during the oxidation process Cr(VI) is reduced to Cr(IV), which further changes to 
Cr(III)   by a disproportionation reaction in a sequential manner. Using the result, the 
stoichiometric equation may be formulated as in equation 1. 
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2 (CTA
+
)2 Cr2O7
--
  +  3 Isoniazid   + 4 H
+ 
 
          3 Isonicotinic acid + 3 N2 + 5 H2O + 4 CTA
+
 + 4 Cr(III)               (1) 
For the mechanistic analysis of the oxidation reaction of isoniazid by CTADC, 
the reaction kinetics was investigated using UV-vis spectroscopic technique. The rates 
of reactions were monitored by observing the rate of depletion of absorption peak at 
450 nm. The observed rate constants, kobs at varying concentration of the substrates 
involved were calculated maintaining pseudo first order condition and tabulated in 
Table 4.1. 
4.3.1 Effect of acetic acid concentration 
The observed rate constant of the reaction increases linearly with increase in 
the concentration of acetic acid indicating protonation of dichromate which facilitates 
the oxidation reaction. The plot of log rate vs. log [acetic acid] depicts a fractional 
order (i.e. 0.5) dependency with respect to acid. The fractional order dependency with 
respect to acetic acid is ascribed to the protonation of isoniazid.  In the presence of 
acetic acid, there may be a decrease in the rate of attack of protonated substrate and 
protonated oxidant affecting the reaction order with respect to acetic acid. The kobs 
obey the following relationship with [acetic acid].  
kobs = k0 + kcat [acetic acid] 
Where, kcat refers to the rate constant for the acid catalyzed oxidation of isoniazid and 
k0 refers to uncatalyzed rate constant and found to be 2.7 x 10
-3
 s
-1
 indicating an 
appreciable oxidation of isoniazid with CTADC in the absence of acid. Thus to have 
more insight into the reaction mechanism, the reaction was studied both in the 
absence and in the presence of acetic acid. 
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Table 4.1 Effect of [Isoniazid], [CTADC] and [Acetic Acid] on the Oxidation of 
Isoniazid by CTADC in Chloroform at 298 K 
[CTADC] x 10
4
 M [Isoniazid] x 10
4 
M [Acetic acid] M kobs x 10
3
 s
-1 
0.44 11 -- 1.81 ± 0.05 
0.88 11 -- 2.06 ± 0.06 
1.31 11 -- 2.28  ± 0.07 
2.18 11 -- 2.69  ± 0.07 
2.64 11 -- 2.48  ± 0.08 
3.05 11 -- 2.26  ± 0.08 
0.44 11 0.79 6.62  ± 0.27 
0.88 11 0.79 6.02  ± 0.24 
1.31 11 0.79 5.55  ± 0.22 
2.18 11 0.79 4.82  ± 0.17 
2.64 11 0.79 4.66  ± 0.17 
3.05 11 0.79 4.51  ± 0.16 
0.44 1.1 -- 1.09  ± 0.03 
0.44 2.2 -- 1.43  ± 0.04 
0.44 2.73 -- 1.50  ± 0.03 
0.44 3.27 -- 1.56  ± 0.04 
0.44 3.82 -- 1.62  ± 0.05 
0.44 4.36 -- 1.65  ± 0.06 
0.44 4.91 -- 1.68  ± 0.06 
0.44 5.45 -- 1.72  ± 0.05 
0.44 8.18 -- 1.78  ±0.07 
0.44 11.0 -- 1.81  ± 0.05 
   
Continued… 
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[CTADC] x 10
4
 M [Isoniazid] x 10
4 
M [Acetic acid] M kobs x 10
3
 s
-1 
0.44 2.2 0.79 4.37  ± 0.16 
0.44 2.73 0.79 4.69  ± 0.17 
0.44 3.27 0.79 5.02  ± 0.20 
0.44 3.82 0.79 5.31  ± 0.21 
0.44 4.36 0.79 5.54  ± 0.21 
0.44 4.91 0.79 5.73  ± 0.23 
0.44 5.45 0.79 5.92  ± 0.23 
0.44 8.18 0.79 6.40  ± 0.24 
0.44 11.0 0.79 6.62  ± 0.26 
2.18 11 0.79 4.82  ± 0.17 
2.18 11 0.32 3.34  ± 0.12 
2.18 11 0.48 3.90  ± 0.13 
2.18 11 0.64 4.38  ± 0.15 
2.18 11 0.79 4.82  ± 0.17 
2.18 11 0.95 5.12  ± 0.20 
2.18 11 1.11 5.34  ± 0.20 
2.18 11 1.27 5.76  ± 0.23 
2.18 11 1.43 6.25  ± 0.25 
2.18 11 1.59 6.52  ± 0.25 
2.18 11 1.75 6.83  ± 0.27 
2.18 11 1.91 7.55  ± 0.28 
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4.3.2 Effect of isoniazid concentration 
The observed rate constant determined in the absence of acetic acid was found 
to increase asymptotically with increasing concentration of isoniazid, approaching its 
maximum value of 1.8 x 10
-3
 s
-1
 (Figure 4.4A). Thus a Michaelis-Menten type 
kinetics is proposed i.e. the reaction involves the binding of oxidant to the substrate to 
form a complex prior to the rate determining step. The complex subsequently 
decomposes to the products (equation 2 and 3).  
 
 
Figure 4.4 (A) Plot of 10
3 
x
 
kobs versus 10
4 
x [isoniazid] and (B) Plot of 1/(10
3 
x
 
kobs) 
versus 1/(10
4 
x [isoniazid]) for the oxidation reaction of isoniazid with CTADC in 
chloroform at 298 K.  
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By applying steady-state approximation to equation 2 and 3 the rate 
expression is obtained (equation 4).
57 
1
kobs
=
1
k2K Isoniazid 
+
1
k2
                                                                                  (4) 
The steady-state dissociation constant of the oxidant-substrate complex known 
as the Michaelis-Menten constant, Km(= (k-1+ k2)/k+1), was calculated to be 0.9 x 10
-4
 
M. Km is the substrate concentration at which the reaction rate falls to half-maximum, 
and is an inverse measure of the substrate's affinity for the catalyst (enzyme). Smaller 
is the Km, higher is the affinity of the catalyst toward the substrate. Km values for the 
oxidation reaction of CTADC with different alcoholic substrates are compared with 
that of isoniazid (Table 4.2). Though in each of the three alcoholic substrates, 
chromate ester intermediate is formed with the bonding of hard donor –OH with hard 
accepter Cr(VI), Km for cholesterol is much lower than that of cyclohexanol and 
benzylalcohol. The lower Km and higher affinity for cholesterol may be attributed to 
the hydrophobic interaction with the non-polar tail of the lipophilic oxidant.
51 
Though 
isoniazid has less hydrophobicity and softer bonding (-NH2) site, the lower Km values 
compared to the above alcoholic substrates show higher affinity of CTADC towards 
isoniazid. This may be explained through the proximity of carbonyl oxygen and 
chromium in the oxidant substrate complex which provides additional stabilization.  
Table 4.2  Km values for the oxidation of organic substrates by CTADC 
Substrate Km (Without acid) Km (acid catalyzed) Refs 
Cholesterol -- 2.4 x 10
-4
 M 51 
Benzyl alcohol -- 0.1 M 58 
Cyclohexanol -- 0.2M 59 
Isoniazid 0.9 x 10
-4
 M 1.7 x 10
-4
 M Present study 
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From the Lineweaver-Burk double reciprocal plot (Figure 4.4B) k2 and K    
(=k+1/k-1) were calculated to be 1.99 x 10
-3
 s
-1
 and 11181 dm
3
 mol
-1
 respectively. 
Using Km, k2 and K values  k+1 and k-1 were found to be 3.5 x 10
3
 dm
3
mol
-1
s
-1
 and 
3.15 x 10
-1 
s
-1
 respectively. In the oxidation of isoniazid to isonicotinic acid by the 
enzyme catalase-peroxidase from Mycobacterium tuberculosis, Johnsson et al.
18 
have 
reported similar order of kcat and Km i.e. 4.5 x 10
-2
 s
-1
 and 1.98 x 10
-4 
M respectively.  
The acid catalyzed process also follows the same trend with change in 
[substrate]. The corresponding Km, k2, K, k+1 and k-1  are found to be 1.7 x 10
-4 
M, 
7.69 x 10
-3
 s
-1
, 5909 dm
3 
mol
-1
, 10000 dm
3
 mol
-1 
s
-1
 and 1.69  s
-1
 respectively. Lower 
binding affinity of oxidant and substrate in acid catalyzed process may be attributed to 
the (i) higher polarity of the medium where solvation of isoniazid will be higher 
leading to a decrease in the interaction of isoniazid and CTADC or (ii) protonation of 
isoniazid, which reduces the interaction of protonated isoniazid with CTADC. As the 
actual oxidant is anionic, higher binding affinity of oxidant and protonated isoniazid 
is expected. However, presence of contact ionpair between dichromate and CTA
+ 
in 
nonpolar medium may decrease the binding affinity due to the repulsion between 
protonated isoniazid and CTA
+
.  
Consistent with the above observations, the reaction mechanisms for oxidation 
of isoniazid with CTADC without acid (Scheme 4.3) and in the presence of acetic 
acid (Scheme 4.4) have been proposed where dichromate ion forms an N-substituted 
acid hydrazide intermediate complex with isoniazid. The complex subsequently 
decomposes into products namely isonicotinic acid, diazene and Cr(IV) by a slow 
rate-determining process, where  chromate oxygen attacks  to the carbonyl carbon 
through the formation of a cyclic five membered transition state. Diazene further 
oxidizes to dinitrogen and water with another mole of Cr(VI). Yalgudre et al.
60
 while 
investigating the oxidation of isoniazid by bromate in aqueous hydrochloric acid 
medium, demonstrated the formation dinitrogen and water from diazene intermediate. 
The formation of diazene intermediate in the oxidation of isoniazid has also been 
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reported by Bodiguel et al.
61 
Karimi et al.
62 
have described the formation of dinitrogen 
in the electro-catalytic dehydrogenative oxidation of isoniazid to isonicotinic acid via 
acyldiazene intermediate 4. 
HN=NH + Cr(VI) N2   +  H2 O + Cr(IV)
fast
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R C
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(Scheme 4.4) 
Comparing kobs, k2 and K values of both without acid and acid catalyzed 
oxidation processes, it is found that the rate of the reaction is dependent mostly on the 
rate of decomposition of the complex (C). A higher rate of reaction in presence of 
acid is thus due to higher rate of decomposition of the complex, though the binding 
affinity of oxidant and substrate is higher in the absence of acid. In the presence of 
acid, the carbonyl carbon acquires a partial positive charge due to the polarization of 
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the carbonyl bond owing to the protonation of the carbonyl oxygen. The higher rate of 
decomposition is thus attributed to the higher electrophilicity of the carbonyl carbon 
due to which the reactivity of hydroxyl oxygen towards carbonyl carbon increases, 
which leads to an increase in the overall rate of the reaction. To get further support for 
the proposed mechanism, effect of temperature, and solvent kinetic isotope effect 
(k(H2O)/k(D2O)) have been investigated.  
4.3.3 Effect of temperature 
  The observed rate constant increases linearly with increase in temperature. 
The thermodynamic parameters such as H‡, S‡ and G‡ were calculated from the 
plot of ln (k/T) vs. 1/T using Eyring equation and are tabulated in Table 4.3. The 
high-negative entropy of activations is indicative of the formation of a forced, more 
ordered and extensively solvated transition state than the reactants in the rate-
determining step in both the cases.
63,64 
Table 4.3 Observed rate constants and activation parameters for the oxidation of 
isoniazid by CTADC in the absence of acid and in presence of acetic acid. [Isoniazid] 
= 1.1 x 10
-3
M, [CTADC] = 2.18 x 10
-4 
M. 
[Acetic acid] 
10
3
 kobs  s
-1
 
H‡ 
kJ mol
-1
 
S‡ 
J K
-1
 mol
-1
 
G‡ 
kJ mol
-1
 
293K 298 K 303K 308K 
-- 
1.82 
(±0.04) 
2.69 
(±0.07) 
3.7 
(±0.15) 
4.65 
(±0.19) 
44.6 -145 87.7 
0.79 M 
4.26 
(±0.15) 
4.82 
(±0.17) 
5.56 
(±0.21) 
6.1 
(±0.23) 
15.8 -159 63.2 
4.3.4 Determination of solvent kinetic isotope effect 
To obtain the solvent kinetic isotope effect (k(H2O)/k(D2O)), the reaction was 
carried out in 1:1 mixture of H2O-acetonitrile and in 1:1 mixture of D2O-acetonitrile 
in presence of 2% acetic acid. Acetic acid was equilibrated with H2O and D2O for 3 h 
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before its use in the reaction process. The solvent isotope effect k(H2O)/k(D2O) was 
found to be ((3.3×10
−3
)/(4.84×10
−3
)) =0.68. The acid catalyzed rate is faster in D2O 
than in H2O, when a pre-equilibrium protonation is involved.
65-67 
The inverse solvent 
kinetic isotope effect i.e.  k(D2O) >k(H2O), indicates that the NH2 group is not 
involved in the rate-determining step and thus supports the formation of complex “C” 
in the reaction process. Due to immiscibility of chloroform-water binary mixture and 
improper solubility of reactants in aqueous medium, the solvent kinetic isotope effect 
is measured in a different solvent medium other than chloroform. Thus it may be 
anticipated that the reaction mechanism in both the cases differ. The validity of 
isokinetic relationship (equation 5) for a series of solvents including chloroform and 
acetonitrile-water mixture was verified from the linear plot of H‡ vs. S‡ (Figure 4.5) 
and demonstrated the same mechanism for whole solvent series.
68 
The isokinetic 
temperature,  for the present oxidation process in presence of acetic acid is found to 
be 314 K, where the rate of every member of the series is same. 
H‡  = S‡ + c         (5) 
 
Figure 4.5 Plot of H‡ versus S‡ for the oxidation reaction of isoniazid with 
CTADC in presence of acetic acid for a series of solvents.  
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4.3.5 Effect of CTADC concentration 
With an increase in [CTADC] in the absence of acid, the rate constants are 
found to increase up to [CTADC] = 2.18 x 10
-4
 M and then decreases (Figure 4.6A). 
However, in the presence of acetic acid, direct decrease in rate constant is observed 
with increase in [CTADC] (Figure 4.6B). These facts demonstrate probable formation 
of reverse micelles as discussed in previous chapters. The concentration of CTADC at 
which the decrease in the rate constant begins, differs in the two processes. In 
presence of acid it starts before 4.4 x 10
-5
 M whereas without acid it is approximately 
at 2.18 x 10
-4
M. The presence of acetic acid starts the aggregation at a lower 
concentration. Amphiphilic molecules form reversed micelle in the non-polar solvents 
either in presence of water or in presence of non-aqueous polar solvents.
69
 The 
presence of acetic acid triggers the formation of reverse micellar aggregates of 
CTADC in chloroform and thus the aggregation starts at lower concentration.  
Based on the above results, it is proposed that the mechanism of oxidation of 
isoniazid by CTADC stems on the following; 
(i) rate of depletion of complex (C1 or C2)  by forward reaction, k2 
(ii) stability of transition state 
(iii) the partition of the oxidant and substrate in two micro-heterogeneous 
domains due to the formation of reverse micelles. 
To obtain a clear picture on these aspects, the effect of different surfactants (with 
varied charge) and the effect of various solvents (with varied hydrophobicity and 
polarity) on the reactivity were investigated.  
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Figure 4.6 Plot of 10
3 
x
 
kobs versus 10
4 
x
 
[CTADC] in the oxidation reaction of 
isoniazid with CTADC in chloroform at 298 K. A: Without acid B: in presence of 
0.79M acetic acid.  [Isoniazid] = 1.1 x 10
-3 
M 
 
4.3.6 Effect of surfactant 
To study the effect of surfactant on the reaction rate CTAB (cationic 
surfactant), SDS (anionic surfactant) and TX-100 (nonionic Surfactant) were used. All 
the three surfactants can form reverse micelles in non-polar medium,
 70-73
 mixed 
micelle with various ionic and nonionic surfactants
74-78 
and also
 
with CTADC. If the 
rate decrease with increase in [CTADC] is only because of the partition of oxidant 
and substrate in two different micro-heterogeneous media, consequently a more or 
less decrease in rate would have been expected upon addition of surfactants to the 
reaction mixture.  
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In the absence of acid, a sharp decrease in rate constant was observed on 
addition of CTAB and SDS which supports the formation of reverse micellar 
aggregates (Figure 4.7). However, on addition of TX-100 the rate constant initially 
increased up to a concentration of 1.16 x 10
-2 
M and then decreased sharply (Figure 
4.8).  Above 3.5 x 10
-2
 M of TX-100 the rate constant almost became stable around 
1.2 x 10
-3
 s
-1
. The increase is explained through a greater attractive interaction of oxy-
ethylene units of TX-100 with the cationic head group of CTADC and repulsive 
interaction with that of anionic oxygen of the complex increasing the rate of 
decomposition of the complex. At high concentration of TX-100 the partition factor 
may become more important than the electronic factor in the reverse micellar 
aggregates of the nonionic surfactant. Assuming the rate decrease at high [surfactant] 
is due only to the partition effect, for complete entrapment of a CTADC it requires a 
composition of 1:160 of CTADC/TX-100 and 1:16 of CTADC/SDS in the reaction 
mixture. 
 
 
Figure 4.7 Effect of [CTAB] and [SDS] on the rate constant in the oxidation of 
isoniazid by CTADC in chloroform at 398K. [Isoniazid] = 1.1 x 10
-3
M, [CTADC]= 
2.18 x 10
-4 
M.
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Figure 4.8 Effect of [TX-100] on the rate constant in the oxidation of isoniazid by 
CTADC in chloroform at 398K. [Isoniazid] = 1.1 x 10
-3
M, [CTADC]= 2.18 x 10
-4 
M. 
In the presence of acetic acid, the three surfactants influence the rate 
differently.  When CTAB was added to the reaction medium, a decrease in the rate 
constant was observed while addition of SDS increased it (Figure 4.9). The addition 
of nonionic surfactant TX-100 has no significant effect on the reaction rate in acidic 
medium. CTAB forms reverse micelle with a cationic interface and thus in presence 
of acetic acid, apart from the partition factor the decrease in rate constant may be 
attributed to the following factors (i) decrease in the effective concentration of H
+ 
on 
cationic interface of CTAB, (ii) slow formation of the active protonated dichromate 
and (iii) decrease in the electrophilicity of the carbonyl carbon by reducing the 
protonation of the carbonyl oxygen on the cationic interface. In contrast to CTAB, the 
increase in the rate constant in presence of anionic surfactant SDS is explained 
through (i) an increase in the effective concentration of H
+
 on the anionic interface of 
SDS, (ii) the rapid formation of the active protonated dichromate and (iii) increase in 
the protonation of carbonyl group thus increasing the electrophilicity of the carbonyl 
carbon on the anionic interface of SDS reverse micelles. In case of TX-100 the 
increase in the rate constant due to accumulation of H
+ 
on the polar oxyethylene 
interface is compensated by the decrease in the rate constant due to partition of 
reactants in different phases. 
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Figure 4.9 Effect of [surfactant] on rate constant in the oxidation of isoniazid by 
CTADC in presence of acetic acid in chloroform at 398K. [Isoniazid] = 1.1 x 10
-3
M, 
[CTADC] = 2.18 x10
-4 
M, [Acetic acid] = 0.79M 
4.3.7 Effect of solvent polarity 
In the present investigation, twelve different solvents were used having non-
polar and dipolar aprotic characteristics. The solvent effect was investigated only in 
the presence of acid due to poor solubility of reactants in most of the solvents.  The 
observed rate constant shows significant solvent sensitivity (Table 4.4). Herein, we 
have made an attempt to correlate the solvent induced change in reactivity termed as 
“solvatoreactivity” with the solvent polarity parameters such as π∗, β, A, B, A+B, log 
P, ε, μ, η, ρ and γ. The plots of kobs with various polarity parameters exhibit some 
interesting results.  
The plot of kobs versus polarity parameter π∗ exhibits (Figure 4.10) a negative 
slope (with benzene, toluene, chloroform and dioxane as outliers), indicating a rate 
retardation due to an increase in the polarity of the solvents. Further, the plot of 
dielectric constant (ε) values with kobs (Figure 4.11) shows a sharp rate increase in the 
lower side (ε : 0 to 9) followed by significant rate decrease in the higher side (ε : 6 to 
47). The increase in the rate is due to the solvents like benzene, toluene, chloroform 
and dioxane, while the rate decrease is due to the solvents DMSO, DMF, acetone, 
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acetonitrile and nitrobenzene with ethyl acetate, THF and dichloromethane being 
common in both the cases. The plot of kobs versus Dipole moment (μ) demonstrates 
similar increasing and decreasing trends (Figure 4.12) in the lower and higher side 
respectively.  
 
Table 4.4 Observed rate constants for the oxidation of isoniazid by CTADC in 
various organic solvents in presence of acetic acid at 298K. [Isoniazid] = 1.1 x 10
-3
M, 
[CTADC]= 2.18 x 10
-4 
M, [Acetic acid]=0.79 M
 
 Sl. No. Solvents 10
3
 x kobs  s
-1
 
1 Toluene 2.63  ± 0.09 
2 Benzene 2.37  ± 0.09 
3 Chloroform 4.82  ± 0.17 
4 Dichloromethane 5.74  ± 0.23 
5 Dioxane 4.78  ± 0.20 
6 Nitrobenzene 3.86  ± 0.14 
7 Tetrahydrofuran 7.23  ± 0.29 
8 Acetonitrile 5.08  ± 0.18 
9 Ethyl acetate 7.89  ± 0.32 
10 Acetone 5.70  ± 0.22 
11 Dimethylsulfoxide 1.75  ± 0.05 
12 N,N-Dimethylformamide 3.72  ± 0.13 
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Figure 4.10 Plot of 10
3 
x
 
kobs versus π∗ of the solvents in the oxidation reaction of 
isoniazid with CTADC at 298 K. 
 
Figure 4.11 Plot of 10
3
kobs versus dielectric constant (ε) of the solvents in the 
oxidation reaction of isoniazid with CTADC at 298 K. 
 
Figure 4.12 Plot of 10
3
kobs versus Dipole moment (μ) of the solvents in the oxidation 
reaction of isoniazid with CTADC at 298 K. 
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The above results clearly envisage the division of these solvents into two 
groups, first group for high polar solvents while the second group for apolar solvents. 
Low polar solvents such as ethylacetate and THF are common for both the groups. 
For the former polar group, rate of the reaction decreases with increase in polarity, 
whereas for the later nonpolar and low polar solvent group rate acceleration with 
polarity is observed. The opposite trends in these two groups of solvents suggest a 
complex mechanism with varied contribution of these solvents towards the reaction 
mechanism through the above said three factors.  
The negative contribution of polarity towards the reaction rate for the polar 
solvents suggests a relatively less polar transition state than the reactants. The degree 
of solvation of polar reactants and the complex (C1 and C2) is more in the polar 
solvents compared to the transition state. Thus the rate of association of reactants to 
form complex and also the rate of decomposition of complex (k2) decreases, leading 
to overall rate retardation. This proposition of less polar transition state in the reaction 
mechanism is also supported by high negative entropy of activation which suggests a 
cyclic transition state where the charge is more dispersed. Further, if the change in 
rate constants with change in solvent polarity is only due to the stability of reactants 
or transition state, then the rate constant should also increase with decrease in polarity 
for the nonpolar and less polar solvents. However, the opposite trend in this case 
proposes the existence of reverse micellar aggregation of CTADC in non-polar 
solvents. Quaternary ammonium and phosphonium salts, exist as ion pairs or an 
aggregation of ion pairs in nonaqueous medium.
79 
The degree of aggregation of these 
salts in a non-polar solvent is inversely proportional to the polarity of the medium.
80
 
With increase in non-polarity of the solvents, reverse micellization increases which 
results in higher partition of oxidant and substrate into two different phases imparting 
a rate decrease.   
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The above analysis may lead to the following proposition; (i) for the polar 
group of solvents, polarity (or hydrophilicity) is predominant due to solvation of 
reactants and transition state through polar-polar specific and nonspecific solute 
solvent interactions; and (ii) for the second group of solvents, non-polarity or 
hydrophobicity is predominant due to the formation of reverse micellar aggregates.  
To confirm this proposition of differential contribution, the reactivity was 
correlated with log P (the logarithm of partition coefficient of the substrate between 
octanol and water). It has the inherent characteristics of both hydrophilicity (partition 
from or to water) and hydrophobicity (partition from or to octanol).
81 
The bilinear plot 
of kobs versus log P of the solvents (Figure 4.13), indicates balanced contribution from 
both the factors. A maximum at ethylacetate (log P = 0.73) in the plot indicates a 
hydrophobic switch, which balances the polarity and hydrophobic contributions of the 
solvents. In the lower side of log P values (<0.82), increasing hydrophobicity has a 
rate acceleration, whereas with higher log P values (> 0.73) rate retardation is 
observed. Solvents with log P values less than 0.73 solvate the reactants and the 
transition state through polar interactions (hydrophilicity) and the solvents with log P 
values more than 0.82 solvate through apolar interactions (hydrophobicity), whereas 
the common solvents ethylacetate and THF solvate through both polar and apolar 
interactions. This type of polarity switch (at log P = 0.88) has also been reported in 
the literature in the study of solvation of p-nitroaniline in alcohol-dioxane binary 
solvent mixtures and attributed the observation to the differential contribution of 
hydrophilic and hydrophobic parts of the solvents leading to preferential solvation.
82 
Panigrahi et al.
83 
have reported similar reversal in solvatochromism of some 
hydrophobic styrylpyridinium dyes and explained the fact through structural transition 
of the solvation shell with change in nature and polarity of the solvents. 
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Figure 4.13 Plot of 10
3 
x
 
kobs versus log P of the solvents in the oxidation reaction of 
isoniazid with CTADC at 298 K. (Dotted lines are drawn manually to show 
variations) 
For the polar group of solvents, an increase in both anion solvating power (A) 
and cation solvating power (B) (Figure 4.14) of the solvents have adverse effect on 
the rate constant delineating less ionic and nonpolar transition state. These results also 
support the formation of cyclic transition state with charge delocalization in the rate-
determining step. With increase in A and B, solvation of the complex increases 
through specific solvation of the respective ionic part by the solvents and thus the 
reactivity decreases. 
 
Figure 4.14 Plot of 10
3 
x
 
kobs versus A and B of the solvents in the oxidation reaction 
of isoniazid with CTADC at 298 K. 
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Similar to the mechanism described by Amos et. al.
45
 for the oxidation of 
isoniazid, other mechanisms may also be proposed as in Scheme 4.5. Possibility of 
route 1 leading to isonicotinoyl radical is ruled out due to the reasons mentioned 
earlier. Route 2, shows the cleavage of C-N bond to form free isonicotinoyl cation, 
diazene and Cr(VI). However, the results from effect of solvents and effect of 
temperature on rate constants precluded route 2. Thus, it may be proposed that in 
nonpolar environment, the breaking of C-N bond to form isonicotinoyl cation and 
attack of chromate hydroxyl group to the electrophilic isonicotinoyl cation are 
simultaneous leading to a nonpolar cyclic transition state, solvated and  stabilized by 
nonpolar medium (route 3).  Any change in the functionality of the oxidant-substrate 
complex which increases the nucleophilicity of the hydroxyl group, electrophilicity of 
acyl carbon and hydrophobicity of the reaction center leads to increase in the rate of 
nucleophilic acyl substitution through route 3.  
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R C HN NH
Cr
OCrO2O
-CTA+HO
OH
O
O
Cr(V)
++
Route 2
R C+
HN NH
Cr
OCrO2O
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O-
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O +
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H
N
H
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C Cr
H
OO
O
OCrO2O
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OH
R
Nucleophilic
acyl substitution
Route3
Oxidant-Substrate 
      Complex
 
(Scheme 4.5) 
Our results may assist in understanding why a single Ser315Thr mutation in the 
KatG enzyme in Mycobacterium tuberculosis results in an enzyme without the ability 
to activate isoniazid.
24,84
 The change from a serine with a primary alcoholic side chain  
to a threonine with secondary hydroxyl group in the substrate access channel of heme 
active site,
23-24,85
 increases the nucleophilicity of oxygen functionality and also 
hydrophobicity in the active site.  This change may favor the simultaneous acyl 
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nucleophilic substitution in preference to radical mechanism and therefore, the altered 
catalase-peroxidase confers resistance to isoniazid.  
4.4     CONCLUSION 
In conclusion, the oxidant (CTADC) oxidizes isoniazid to isonicotinic acid 
following Michaelis-Menten kinetics, the first step of which is a very fast formation 
of association complex between isoniazid and CTADC, followed by a second rate-
determining dissociation of the complex proceeding via a less ionic and less polar 
transition state. CTADC assembles to form reverse micelle in non-polar solvents with 
cations at the interface providing different residing sides for the reactants thus, 
mimicking enzyme activity. The substrate and oxidant are partitioned into two 
different types of environments and, accordingly the reaction is controlled. The 
outcome from solvent effect illustrates the presence of reversal in “solvatoreactivity” 
with a polarity/hydrophobic switch (at log P = 0.73), due to differential contribution 
from nonpolar and polar solvents. Nonpolar solvents contribute more to the reverse 
micellization whereas polar solvents contribute to the stability of reactants and 
transition state.  CTADC provides Cr(VI) for oxidation of substrate as well as it 
provides reverse micellar aggregates resembling that of lipid cell membrane. In this 
hydrophobic environment isoniazid is oxidized to isonicotinic acid.  As a result of 
these investigations we speculate that the resistance conferred by the Ser315Thr 
mutant KatG is because of the preference of acyl nucleophilic substitution over the 
formation of acyl radical in hydrophobic environment, hindering the formation of 
INH-NAD adduct (3).  An understanding of the mechanism of drug resistance may 
provide new directions in the development of more effective antibiotics for MDR-TB. 
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5.1 INTRODUCTION 
Carbamazepine (CBZ) is an active pharmaceutical ingredient, chemically 
known as 5H-dibenzo[b,f]azepine-5-carboxamide. It is widely used as anticonvulsant, 
antiepileptic, and mood-stabilizing drug.
1-3 
It is also used in the treatment of other 
diseases such as resistant schizophrenia, ethanol withdrawal, neuropathic pain, 
restless leg syndrome, psychotic behaviour associated with dementia, and post-
traumatic stress disorders.
4-7 
Although CBZ is one of the most widely used drug all 
over the world, its use is associated with a range of adverse reactions mainly skin 
rash, blood disorders, hepatitis, and hematological disorders.
8-14 
Albeit the mechanism 
of carbamazepine-induced adverse reactions is not clear, it is believed to be due to the 
formation of different chemically reactive oxidative metabolites and their subsequent 
covalent binding to cellular proteins.
15-18 
Thus a brief idea about CBZ oxidative 
metabolism in diverse environment is desirable to get invaluable information on the 
mechanistic pathway, cause, and the condition for oxidative instability. The most 
important pathway in CBZ metabolism is the cytochrome P450 (CYP3A4) catalyzed 
formation of carbamazepine-10,11-epoxide (CBZ-EP), which is further hydrolyzed to 
10,11-dihydro-10,11-dihydroxy carbamazepine (CBZ-DiOH) and under suitable 
conditions oxidized to dicarboyl products.
19,20
 Various biomimetic models are 
developed to mimic the function of cytochrome P450 to provide information 
regarding production of drug metabolites and to understand the mechanism of 
biological transformation in CBZ oxidation. Some examples include Fe(II) and 
Mn(II) complexes of rigid crossed- bridged tetraazamacrocycles along with oxidants 
H2O2 and KHSO5,
21 
metalloporphyrin complexes along with a variety of oxidants such 
as ClO
-
, HSO5
-
, m-chloroperoxybenzoic acid, H2O2,
 22-24
 and Jacobsen catalyst.
25
 
In case of the major human CYP isoform, that is, CYP3A4, the major 
interaction with substrates arises from hydrophobic interaction as evident from 
structure activity relationship (SAR) studies and available data on CYP3A4 crystal 
structure.
26-28 
The large active site of CYP3A4 is unique among CYP isozymes 
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containing seven phenylalanine residues stacking against each other forming a 
hydrophobic core.
26-28  
Objectives: Owing to the importance of hydrophobic forces in the substrate binding in 
the cytochrome-mediated oxidative metabolism in CBZ oxidation, and selectivity of 
cetyltrimethylammonium permanganate CTAP toward the oxidation of olefinic 
double bonds in nonpolar medium,
29
 herein we have made an attempt to look into the 
mechanism of oxidative metabolism of CBZ by CTAP in a surfactant-generated 
hydrophobic and biomimetic environment and to answer the following pertinent 
questions. 
 Will CTAP act as a selective oxidant for carbamazepine ?  
 If so, what may be the reason of selectivity, hydrophobicity associated with CTA 
group or the selectivity of permanganate for double bonds? 
 What will be the mechanism of the oxidation reaction? 
To achieve the above objectives and to answer the above hypothesis, oxidation 
products have been analyzed, reaction kinetics has been studied studied and a suitable 
mechanism for the reaction has been proposed. 
 
5.2 EXPERIMENTAL 
5.2.1 Materials 
CBZ was purchased from Sigma-Aldrich (Mumbai, India) and used without 
further purification. The organic solvents were purified by standard methods. The 
surfactants CTAB and SDS (Merck, India) were purified by recrystallization from 
aqueous ethanol. TX-100 was purchased from Merck (India) and used without further 
purification. 
5.2.2 Synthesis of cetyltrimethylammonium permanganate (CTAP) 
Cetyltrimethylammonium permanganate (CTAP) was prepared as reported 
earlier
29
 by adding aqueous solution of potassium permanganate (2 g, 0.06M) the 
aqueous solution of cetyltrimethylammonium bromide (0.84 g, 0.01M) with 
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continuous stirring using a teflon coated magnetic bar at room temperature. A violet 
coloured compound appeared immediately. Stirring was continued for 15 minutes 
more after completion of the addition of the permanganate solution. The resulting 
violet product was then filtered off and washed with water several times till no 
bromide and permanganate were detected in the filtrate. It was vacuum dried and kept 
in a desiccator in the dark. M.P. 225 
0
C (decomposed), Yield: 98%, and its purity was 
checked from its NMR spectral data.  
5.2.3 Kinetic Measurements 
The kinetics of oxidation of CBZ by CTAP was studied 
spectrophotometrically using a double beam Shimadzu UV-vis spectrophotometer 
(UV-1800). The temperature in the reaction cell was controlled by circulating water 
by using Lauda thermostat within a temperature fluctuation of 0.05
o
C. CTAP stock 
solution was prepared in acetonitrile because of considerable stability in this solvent. 
The reactions were performed under pseudo-first-order conditions by keeping excess 
of the CBZ (10 times or more) with respect to CTAP. The rate of disappearance of the 
Mn(VII) species was followed by monitoring the depletion of absorption band at 530 
nm. The first-order rate constants kobs were obtained from the linear plot of log 
[CTAP] against time for up to 75% completion of the reaction. The values reported 
are the average of at least triplicate runs and were reproducible within 6% error.  
5.2.4 Stoichiometry 
The stoichiometry of the reaction was determined by performing the 
experiment at 298 K, under the condition of [CTAP] > [CBZ] at varying 
carbamazepine concentration. The disappearance of Mn(VII) was followed, until the 
absorbance values become constant. The CTAP was estimated after 7 h. The 
stoichiometric ratio was found to be 2:1 CTAP to CBZ, respectively.  
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5.2.5 Product analysis 
The reaction mixture containing CTAP (160 mg, 1M) and CBZ (94 mg, 1M) 
in DCM was stirred and refluxed for 30 minutes. The completion of the reaction was 
monitored by TLC. The solvent was evaporated, and the reaction mixture was 
subjected to column chromatography by taking hexane-ethylacetate (8:2) mixture as 
an eluent. The orange coloured solid product thus obtained (48 mg, yield 51%, M. Pt. 
>300°C) was characterized from 
1
H NMR, 
13
C NMR, and mass spectral analysis. 
1
H 
NMR (400 MHz, DMSO-d6): δ/ppm 10.748 (1H, S) for the -NH proton, 7.8 (2H,q) 
for 4,4
’
 proton, 7.67 (2H, m) for 2,2
’
 proton, 7.5 (2H, d) for 3,3
’
 proton, 7.17 (2H, m) 
for 1,1
’
proton (Figure 5.1). 
13
C NMR (100 MHz, DMSO-d6): δ/ppm 120.34, 120.73, 
122.25, 130.57, 135.18, 141.33, 188.59 (Figure 5.2). MS (ESI, positive mode): m/z 
(relative intensity) 246 ([M + Na]
+
, 100), 469 ([2M + Na]
+
, 80) MS (ESI, negative 
mode): m/z (relative intensity) 222 ([M – H]+, 100). NMR and Mass spectral analysis 
of the product confirmed the formation of 1H-dibenzo[b,f] azepine-4,5-dione.  
5.3 RESULTS AND DISCUSSION 
The reaction mixture consisting of CTAP and CBZ in DCM was stirred and 
refluxed for 30 minute. The completion of the reaction was monitored using TLC. 
The mixture turned brown, indicating the formation of reduced Mn(IV). The product 
was obtained from the reaction mixture as an orange solid, which was characterized 
by its NMR and Mass spectral data as 1H-dibenzo[b, f]azepine-4,5-dione (1) (Scheme 
5.1). 
1' 1
22'
33'
44'
1H-dibenzo[b,f] azepine-4,5-dione
N
O NH2
CTAP
DCM
N
H
O O
1  
(Scheme 5.1) 
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From the stoichiometric analysis, it has been found that 1 mole equiv of CBZ 
reacts with 2 mole equiv of CTAP. A free radical pathway may be ruled out for the 
present reaction as (i) oxidation of CBZ by CTAP, in an atmosphere of nitrogen, 
failed to induce polymerization of acrylonitrile
30
 and (ii) the rate of the reaction was 
unaffected by the addition of acrylonitrile.
31
 Thus, Mn(VII) may be reduced to 
Mn(III) and Mn(V) and further changed to Mn(IV) by a disproportionation reaction in 
a sequential manner (Scheme 5.2). The formation of Mn(IV) in the oxidation of 
various organic substrates by Mn(VII) is also well known in the literature.
32 
2 Mn(VII) + Carbamazepine 1H-dibenzo[b,f]-azepine-4,5-dione + Mn(III) + Mn(V)
Mn(III) + Mn(V) 2 Mn(IV)
Hence,       2Mn(VII) 2 Mn(IV)  
(Scheme 5.2) 
In the oxidative transformation of CBZ, using Mn(VII) as an oxidizing 
system, Hu et al. detected 12 different intermediates and products, whereas using 
Fe(VI) as an oxidizing system they have detected 6 products.
33 
They proposed that 
reactions are initiated by electrophilic attack at the olefinic double bond on the central 
heterocyclic ring by Mn(VII) or Fe(VI). Rao et al. have detected 14 intermediates and 
products by using WO3 suspension and proposed an electrophilic attack of radicals at 
the olefinic double bond in the central heterocyclic ring, leading to a ring-opening and 
formation of various products.
34 
In the present oxidizing system, a single product was 
detected and isolated in neutral medium, indicating the mildness and chemoselectivity 
of the oxidizing system. Further, similar to biological system, it is oxidized at the 
double bond to form the dicarbonyl product which indicates the biomimetic 
characteristics of the oxidizing system.  For the mechanistic analysis of this selective 
oxidative transformation, the rates of reaction were monitored by observing the rate of 
depletion of Mn(VII) at 530 nm under pseudo-first order condition keeping [CBZ] 
more than 10-fold excess relative to the [oxidant]. The observed rate constants (kobs) 
were calculated from the linear plots of log [CTAP] versus time and presented in 
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Table 5.1. Rates of the reaction at various concentrations of the oxidant and substrate 
were also calculated by multiplying [oxidant] with that of the corresponding kobs.  
5.3.1  Effect of reactant concentration 
The observed rate constant was found to increase with an increase in [CBZ], 
whereas it was found to be almost constant with the change in the [CTAP]. The log 
(rate) values obtained at different conditions (Table 5.1) were subjected to multiple 
regression analysis and were correlated with the parameters of the reaction condition, 
i.e. [substrate] and [oxidant], to examine the interdependency of reactant 
concentrations towards the rate of the reaction. The regression model, thus obtained, 
is presented in equation 1. The linear plot (R
2
 = 0.997) of observed rate versus 
predicted rate (Figure 5.3) supports the regression model. Using equation 1, the rate 
expression can be written as in equation 2. From the rate expression, it may be 
predicted that, the order of the reaction is 1 with respect to CTAP and 0.86 with 
respect to CBZ.  
Log (rate) = -0.997(±0.070) + 0.984(±0.017) log [CTAP] + 0.856 (±0.023) log  
[Carbamazepine]             (1) 
R
2
 = 0.998, F = 2977 n = 12       
Rate= 0.1 [CTAP]
 0.98
 [Carbamazepine]
 0.86
                                                             (2) 
 
Figure 5.3 Plot of observed rate versus calculated rate of the reaction for the 
oxidation reaction of carbamazepine with CTAP in dichloromethane at 298 K. 
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Table 5.1 Effect of [carbamazepine] and [CTAP] on the oxidation of carbamazepine 
by CTAP in DCM at 298K 
[CTAP]  
in mM 
[Carbamazepine] 
in mM 
10
4 
x kobs    
s
-1
 
10
4
 x Rate   (mM s
-1
) 
Observed Calculated
a
 
0.047 4.5 11.46 ± 0.37 0.54 0.54 
0.135 4.5 11.5 ± 0.51 1.55 1.54 
0.269 4.5 11.28 ± 0.57 3.03 3.03 
0.338 4.5 10.86 ± 0.38 3.67 3.79 
0.471 4.5 10.92 ± 0.46 5.14 5.25 
0.338 2.7 7.84 ± 0.25 2.65 2.47 
0.338 4.5 10.86 ± 0.38
b 
3.67 3.79 
0.338 6.4 14.66 ± 0.41 4.96 5.09 
0.338 8.0 18.20 ± 0.30 6.15 6.21 
0.338 10 21.80 ± 0.49 7.37 7.50 
0.338 12 26.45 ± 0.78 8.94 8.77 
0.338 13 29.00 ± 0.84 9.80 9.39 
a
Calculated using Eq (1) 
b
kobs 10
4 
at 293, 303, and 308 K are obtained to be 8.6 ± 0.25, 13.7 ± 0.42, and     
17.24 ± 0.59 s
−1
 respectively. 
 
The order of the reaction with respect to each reactant were also calculated 
from the slopes of linear plots of log (rate) versus log [reactant] using equation 3 and 
4 and were found to be same. 
Rate = k2 [CTAP]
a
  [Carbamazepine]
b
      (3) 
Log (rate) = log k2 + a log [CTAP] + b log [carbamazepine]                (4) 
where a and b are orders with respect to CTAP and carbamazepine. 
   
Chapter 5 
152 
 
The magnitude of a has been calculated from slope of the linear plot of log 
(rate) vs. log [CTAP] at constant concentration of carbamazepine (Figure 5.4). 
Similarly, magnitude of b can be calculated from the linear plot of log (rate) vs. log 
[carbamazepine] at constant CTAP concentration (Figure 5.5). The oxidation process 
is calculated to be first-order with respect to CTAP, while it is fractional order (0.84) 
with respect to carbamazepine. 
 
Figure 5.4 Plot of log (rate) versus log [CTAP] for the oxidation reaction of 
carbamazepine with CTAP in dichloromethane at 298 K. 
 
Figure 5.5 Plot of log (rate) versus log [carbamazepine] for the oxidation reaction of 
carbamazepine with CTAP in dichloromethane at 298 K. 
Lee and Brownridge,
 35 
in the oxidation of cinnamic acid by permanganate ion, 
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absorption maximum at 415 nm in the electronic spectrum.  In the present case, the 
development of a broad shoulder at 400-430 nm in the UV-vis spectrum (Figure 5.6) 
during the reaction also indicates the formation of Mn(V)-ester intermediate, which 
decomposes to Mn(III) and the products. 
 
Figure 5.6 UV-vis spectra of reaction mixture consisting of CTAP and 
carbamazepine in DCM at different time interval.   
The permanganate ion oxidation of alkenes is proposed to proceed through an 
initial π-complex formation between electropositive metal and electron-rich alkene, 
followed by the slow rate-determining cycloaddition to form Mn(V)-ester 
intermediate (2).
36-37 
The fate of the Mn(V)-ester intermediate is entirely dependent 
upon the reaction condition.
32
 In acidic medium it cleaves to two carbonyl compounds 
while in basic condition it hydrolyses to diol. Furthermore, if the medium is neutral or 
slightly basic, it converts to -hydroxycarbonyl compound (Scheme 5.3).32, 38-40 
For the present oxidation reaction of CBZ by CTAP, a similar mechanistic 
path has been proposed (Scheme 5.4), where the first step involves a reversible 
formation of π-complex between CBZ and CTAP followed by a rate-determining syn 
addition of permanganate to the double bond of the CBZ, resulting in the formation of 
a cyclic hypomanganate ester intermediate (3). The possibilities of two paths, i.e. the 
hydrolysis of the intermediate to diol and cleavage of the intermediate to carbonyls 
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may be precluded for the present case as the medium is neither acidic nor basic and 
also devoid of water. Utilizing an additional permanganate ion, 3 may decompose to 
give the dicarbonyl product (5) and a molecule of water probably through an 
intermediate (4).
32, 38-40 
The oxidation of 4 to 5 may go through removal of hydride ion 
with simultaneous reduction of Mn(VII) to Mn(V).
41
 5 then hydrolyses to give the 
final product 1 utilizing a molecule of water generated during the oxidation process. 
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(Scheme 5.3) 
N
H H
O NH2
N
H H
O NH2
O
Mn
O
O O-CTA+
3
N
H
O NH2
O-CTA+O
4
DCM
+ Mn(III)
MnO4
-CTA+
N
O NH2
OO
5
+ 2 Mn(IV) + H2O
N
H
OO
5
 H2O
1
RDS
+
MnO4
-CTA+
N
H H
O NH2
Mn
O O
O O
Slow
CTA+
N
H
O NH2
OO
Mn
O
O
O-CTA+
O-CTA+
+ Mn(III)
+ NH2COOH
 
(Scheme 5.4) 
   
Chapter 5 
155 
 
5.3.2    Effect of solvent polarity  
The effect of solvent on the reaction rate gives invaluable information 
regarding the reaction mechanism, nature of the transition states, and intermediates. 
The change in the rate with change in the nature of the solvents or the polarity of the 
solvents is mainly due to differential solvation of the starting material and transition 
state by the solvents. To see the effect of solvent polarity on the rate of reaction for 
the present investigation, eight different solvents were used having nonpolar and 
dipolar aprotic characteristics. The observed rate constants are tabulated in Table 5.2 
and correlated with various solvent polarity parameters such as dielectric constant, π* , 
dipole moment, anion-solvating power (A), cation-solvating power (B), and 
hydrophobicity (log P).  
Table 5.2 Values of observed rate constants for the oxidation of carbamazepine by 
CTAP in different solvents at 298K. [CTAP] =0.338 mM [carbamazepine] = 4.5 mM 
Solvents 10
4
 x kobs  
 
in s
-1
 
Toluene 36.24 ± 1.13 
Benzene 32.62 ± 0.77 
Chloroform 25.43 ± 1.13 
Dichloromethane 10.86 ± 0.38 
Acetonitrile 1.58 ± 0.07 
Acetone 1.54 ± 0.05 
Tetrahydrofuran 4.84 ± 0.16 
Ethylacetate 11.46 ± 0.34 
The plots of kobs with A and B exhibit scattered points, indicating that no 
definite relationship exists between the ion-solvating power of the solvent and the 
reactivity. The plot of kobs versus dielectric constant (Figure 5.6) shows an asymptotic 
decrease in the rate constant with an increase in polarity of the medium. There is a 
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sharp decrease in rate constant from 36.2 x 10
-4
 to 4.82 x 10
-4
 s
-1
 in the lower side of 
dielectric constant (<10), whereas in the higher side (10-40) it remains almost 
constant. A similar increasing trend with an increase in hydrophobicity is observed 
from the plot of kobs versus log P of the solvents (Figure 5.7). These facts can be 
explained through the formation of a less polar cyclic transition state than the 
reactants and the differential solvation of reactants and the transition state. As shown 
in Scheme 5.5, the negative charge of the MnO4
-
 is well dispersed in the transition 
state within the C=C and the permanganate moiety. In high polar solvents (with high 
dielectric constant), there is extensive solvation of the ionic reactant (MnO4
-
) leading 
to a decrease in the rate of attack of the permanganate toward CBZ. On the other 
hand, less polar solvents solvate the less polar transition state more extensively than 
the reactants leading to a higher rate of reaction. 
N
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(Scheme 5.5) 
 
Figure 5.6 Plot of kobs versus dielectric constant of the solvents in the oxidation 
reaction of carbamazepine by CTAP at 298 K. (The dotted lines are drawn manually 
to indicate the variations)  
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Figure 5.7 Plot of kobs versus log P of the solvents in the oxidation reaction of 
carbamazepine by CTAP at 298 K. (The dotted lines are drawn manually to indicate 
the variations)  
 
5.3.3  Effect of temperature 
With an increase in temperature, the rate constant increases linearly (Table 
5.1). Using Arrhenius and Eyring equation, thermodynamic parameters such as 
activation energy (Ea), enthalpy of activation (H
‡
), free energy of activation (G‡) 
and entropy of activation (S‡) were calculated and were found to be 34.7, 32.2, 89.9 
kJ mol
-1
 and -194 J mol
-1
 K
-1
 respectively. The lower energy of activation and high 
free energy of activation support the formation of highly solvated transition state. As 
the present reaction was undertaken in nonpolar solvents like DCM, greater solvation 
of the proposed nonpolar transition state compared to that of the reactants is expected. 
Furthermore, if the transition state is more extensively solvated than the reactants, ΔS‡ 
assumes a larger negative value due to appreciable increase in ordering in the 
solvation shell.
42 
These results support the formation of a nonpolar cyclic transition 
state in the rate-determining step. 
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5.3.4  Effect of surfactant 
Lipophilic oxidants having long-chain quaternary ammonium counterion are 
known to form contact ion pairs in nonpolar solvents. As discussed in Chapter 1, these 
surfactants can form reverse micelles in nonpolar solvents, and mixed reverse 
micelles with various ionic and nonionic surfactants. The selectivity and mildness of 
these oxidants are proposed to be mainly because of the contact ion pair formation 
and formation of organized assemblies. To see the compatibility of CTAP in the 
formation of mixed aggregates with other surfactants and the effect of these 
aggregations on the reactivity and mechanism of CBZ oxidation, the effect of 
[surfactant] on the reaction rate was evaluated by using a cationic (CTAB), an anionic 
(SDS) and a non-ionic (TX-100) surfactant. With an increase in the concentration of 
surfactants, keeping the concentrations of all reactants constant, the rate of the 
reaction was found to increase in case of the ionic surfactants CTAB and SDS (Figure 
5.8 and 5.9). The addition of TX-100 did not exhibit any significant change in the rate 
constant. 
 
Figure 5.8 Effect of [CTAB] on the observed rate constants in the oxidation reaction 
of carbamazepine by CTAP at 298 K.  (The dotted lines are drawn manually to 
indicate the variations). 
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Figure 5.9 Effect of [SDS] on the observed rate constants in the oxidation reaction of 
carbamazepine by CTAP at 298 K. (The dotted lines are drawn manually to indicate 
the variations). 
As shown in Figure 5.8 and 5.9, a bilinear increase in the rate constant was 
observed with an increase in the concentration of each of the surfactant with break 
points at around 0.2 and 4 mM for CTAB and SDS, respectively. With an increase in 
the concentration of CTAB from 0 to 0.2 mM, the rate constant increased sharply 
from 11 x 10
-4
 to 15 x 10
-4
s
-1
. Beyond the concentration of 0.2 mM, it is found to 
increase slowly. In case of SDS, the increasing trend is opposite to that of the CTAB. 
Here, there is a slow increase in the rate constant initially at low concentration of SDS 
(up to 2.8 mM), beyond that a sharp increase is observed. The break point in the plots 
demonstrates the formation of mixed aggregates. The catalyzing effect of these 
surfactants can thus be explained through the greater partition of CBZ to the 
interfacial region, and hence the effective concentration of CBZ in the vicinity of 
MnO4
-
 becomes higher resulting in an increase in rate. This phenomenon is 
represented schematically in Scheme 5.6. As compared to CTAB, in the presence of 
SDS, the rate constant is found to be higher in the higher concentration range. In the 
SDS-CTAP reverse micellar aggregate, cationic CTA
+
 interacts with anionic 
dodecylsulphate. Owing to this interaction, the contactness between CTA
+
 and MnO4
- 
may decrease and the permanganate ion become free and thus is more available to the 
CBZ with a higher reactivity. 
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5.4  CONCLUSION 
CTAP oxidizes carbamazepine in DCM medium to produce a selective 
product 1H-dibenzo[b, f]azepine-4,5-dione. From the kinetic analysis, the reaction is 
found to be first order with respect to CTAP and fractional order with respect to CBZ. 
A suitable mechanism is proposed consisting of a first rate-determining syn addition 
of permanganate to the C=C double bond of CBZ to form Mn(V)-ester intermediate 
through a nonpolar cyclic transition state. The intermediate was further decomposed 
and hydrolyzed to the dicarbonyl product. The proposed mechanism is also supported 
from the effect of medium and effect of temperature on reaction rate. Ionic surfactants 
are found to catalyze the reaction due to the formation of mixed reverse micellar 
aggregates with CTAP.  
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6.1   INTRODUCTION 
Norfloxacin [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-
quinoline carboxylic acid] is a representative member of   fluoroquinolone family  and 
widely used as a first choice of drug for the treatment of bacterial infections of the 
urinary, biliary, and respiratory tracts.
1,2 
The antibacterial activity of fluoroquinolones 
arises due to the inhibition of growth of DNA gyrase (a critical enzyme to bacterial 
chromosome replication) of gram-positive and gram-negative bacteria through the 
formation of a ternary complex between the drug, the enzyme and bound DNA 
segment.
3-7 
Carbonyl and carboxyl moiety of norfloxacin bind with DNA, break the 
DNA-gyrase complex and are responsible for the antibacterial activity. Fluorine (F) at 
6
th
 position and piperazine substituent at 7
th
 position involve in binding interaction 
with enzyme, giving extra stabilization to the drug-enzyme-DNA ternary complex, 
and thus responsible for the increase in the effectiveness and potency of the 
antibacterial.
3-7 
Norfloxacin is poorly metabolized in the body. 26-32% of the 
administered dose remained as such and excreted by renal excretion while only 5-8% 
of the drug is metabolized mainly to six active metabolites of lesser antimicrobial 
potency.
8
 As studied in human and fungi, the drug is primarily metabolized in the 
liver by P450 enzymes via N-formylation/acetylation, oxidation and breakdown of the 
piperazine ring resulting in decreased antimicrobial activity.
9-12 
Further, the 
bioavailability and thus the antibacterial activity of fluoroquinolones drastically 
decreased by the presence of multivalent metal containing compounds (such as 
magnesium or aluminium antacid, vitamins or minerals) at gastric pH and is attributed 
to the formation of metal-chelate complex and alternations in dissolutions.
13-14
 In view 
of potential pharmaceutical importance of norfloxacin and presence of few literatures 
on the mechanism of oxidation of this drug
15-17  
there is a need to understand the mode 
of interaction with the oxidizing agents and mechanism of oxidative metabolism of 
this drug in biomimetic medium.  
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Objectives: In view of the above, the present investigation is an attempt to utilize 
CTAP to look into the mechanism of the oxidative cleavage of norfloxacin and to 
investigate the following hypothesis. 
 Will CTAP be used as mild, selective and biomimetic oxidants for the oxidative 
metabolism of norfloxacin? 
 If so, what will be the reason of selectivity?  
 What will be mechanism of this oxidative degradation? Are there any similarities 
with that of other biomimetic oxidations of norfloxacin in terms of mechanism? 
 What will be the effect if any of different parameters such as reaction temperature, 
solvent polarity/hydrophobicity etc. on the overall rate and mechanism of the 
oxidative metabolism? 
Kinetic method was used to study the mechanism. Basing on the kinetic data a 
rate expression and a plausible mechanism have been proposed.  Effect of solvent on 
the reaction rate has been analyzed in media of varied polarities to suggest a suitable 
solvation model. 
6.2 EXPERIMENTAL 
6.2.1 Materials 
Cetyltrimethylammonium permanganate (CTAP) was synthesized by 
following the reported procedure
18
 as discussed in Chapter 5. Norfloxacin was 
purchased from Sigma-Aldrich, India and was used without further purification. 
Acetonitrile (Merck, India) was purified by standard method.  Acetic acid (Merck, 
India) was used as source of hydrogen ions and was also used as such. D2O (Sigma-
Aldrich) used is of NMR grade with 99.8% D.  
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6.2.2 Kinetic measurements 
The oxidation kinetics of norfloxacin by CTAP in acetonitrile-water solvent 
mixture in presence of acetic acid was investigated by monitoring the decrease in 
optical density (OD) of Mn(VII) at an analytical wavelength of 530 nm using 
Shimadzu UV-vis spectrophotometer (UV-1800) fitted with thermostatic cell holders. 
The temperature in the reaction cell was controlled by circulating water by using a 
Lauda thermostat within a temperature fluctuation of ±0.05 
o
C. All the kinetic runs 
were performed under pseudo-first-order conditions by keeping excess of the 
Norfloxacin (10 times or more) with respect to [CTAP]. The observed rate constants 
(kobs), were obtained from the linear plots (R
2
 = 0.99) of log [CTAP] against time for 
up to 75% completion of the reaction. The effect of the variation of [CTAP], [acid], 
and [norfloxacin] on the rate constant was investigated by varying the concentration 
of the desired constituent in the reaction mixture and the values reported are the 
average of at least triplicate runs and were reproducible within 6% error. The solvent 
isotope effect (k(H2O)/k(D2O)) was investigated using mixtures of H2O-acetonitrile 
and D2O-acetonitrile separately in presence of acetic acid at the mole fraction ratio of 
H2O (or D2O) : Acetonitrile: Acetic acid as 0.71:0.25:0.04.  
6.2.3 Product analysis 
The reaction mixture containing norfloxacin (64 mg, 1M) and CTAP (80 mg, 
1M) in acetonitrile-water medium was stirred and refluxed for 15 minutes in the 
presence of 5% acetic acid. The reaction mixture turned brown, indicating the 
formation of reduced Mn(IV).
19 
The completion of the reaction was monitored by 
TLC. The brown colored precipitate was separated from the reaction mixture by 
filtration and the filtrate was subjected to column chromatographic separation using 
chloroform and methanol as solvent. The pale yellow solid product thus obtained 
(Yield: 49 mg, 98%; M. Pt. 230°C) was characterized by NMR and mass spectral 
analysis. 
1
H and 
13
C NMR spectrum were recorded on a Bruker 400 MHz NMR 
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spectrometer.  Mass data were obtained on a Perkin Elmer, Flexar SQ 300 MS 
Detector ESI Mass Spectrometer using acetonitrile as mobile phase at a flow rate of 
10 ml/min. 
1
H NMR (400 MHz, DMSO-d6): δ/ppm 15.75 (1H, S, -COOH ), 8.85 
(1H, S, C2-H ), 7.8 (1H, d,  C5-H), 7.1 (1H, d, C8-H), 6.649 (2H, S, –NH2 proton), 4.4 
(2H, m,  –CH2 ), 1.426 (3H, t, –CH3) (Figure 6.1); 
13
C NMR (100 MHz, DMSO-d6): 
δ/ppm 176.47, 166.96, 151.25, 148.81, 144.32, 138.50, 115.31, 110.42, 106.69, 
100.24, 49.45, 14.54 (Figure 6.2); MS (ESI, positive mode): m/z (relative intensity) 
251 ([M+H]
+
, 100). NMR and   ESI-MS spectral analysis of the product agreed well 
with that of 7-amino-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. 
From TLC spot analysis, formaldehyde was found to be one of the degraded products. 
It was also confirmed by comparing the melting point of 2,4-dinitrophenylhydrazone 
derivative (M. Pt. 150 
o
C)  with the literature value (M. Pt 156
o
C).  
6.2.4 Stoichiometry  
The stoichiometry of the reaction was determined by performing the 
experiment at 298 K, under the condition of [CTAP] > [norfloxacin] at varying 
norfloxacin concentration keeping all other conditions constant. After 1 h, the 
concentration of remaining Mn(VII) was measured by monitoring the absorbance at 
530 nm. A stoichiometry ratio of Norfloxacin/CTAP = 0.75, was observed. The 
stoichiometry of the reaction was also determined by limiting logarithmic method.
20
 
In this method, two different sets of experiments were done. In the first set of 
experiment, the norfloxacin concentration was varied (3.27 x 10
-6
 to 3.25 x 10
-5
 M) at 
a fixed CTAP concentration (0.9 x 10
-3
 M) and in the second set of experiment the 
CTAP concentration was varied (5.45 x 10
-4
  to 1.45 x 10
-3
M) at a fixed norfloxacin 
concentration (3.27 x 10
-6
M). The absorbances of Mn(VII) at 530 nm were recorded 
after 1 h of addition of reactants. The logarithms of the obtained absorbances were 
plotted against log [norfloxacin] and log [CTAP] in the first and the second set of 
experiments respectively. The slopes of the fitting line in both sets of experiments 
were calculated and found to be 0.433 and 0.574, respectively (Figure 6.3). Thus, the 
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molar reactivity of the reaction is 0.433/0.574, i.e. the reaction proceeds in the ratio of 
around 0.76:1 with respect to norfloxacin and CTAP.  
 
Figure 6.3 Limiting logarithmic plot for the calculation of the stoichiometric ratio 
between Norfloxacin and CTAP: (a) log absorbance vs. log [Norfloxacin] and (b) log 
absorbance vs. log [CTAP]. 
6.3 RESULTS AND DISCUSSION 
The reaction mixture consisting of CTAP and norfloxacin in acetonitrile-water 
mixture in the presence of acetic acid became brown after 15 minutes under reflux 
condition.  The main reaction products were identified as Mn(IV), 7-amino-1-ethyl-6-
fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, ammonia, and formaldehyde.  
The product, 7-amino-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid  
was isolated with the help of column chromatographic separation technique and 
characterized by ESI-MS, 
1
H NMR and 
13
C NMR spectral analysis. Evolution of 
ammonia during the reaction was detected by its characteristic smell and litmus test.  
Presence of brown colored precipitate settled on the bottom of the flask after 
completion of the reaction indicated the formation of reduced Mn(IV). Formation of 
formaldehyde as one of the degraded product was confirmed by TLC spot test and 
comparing the melting point of the 2,4-dinitrophenylhydrazone derivative with that of 
the authentic sample.  
Stoichiometry analysis revealed the reaction of 1 mol of CTAP with that of 
0.75 mol of norfloxacin. The possibility of free radical mechanism may be ruled out 
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for the present reaction as (i) oxidation of norfloxacin, in an atmosphere of nitrogen, 
failed to induce polymerization of acrylonitrile
21 
and (ii) the addition of acrylonitrile 
did not affect the rate of oxidation reaction.
20 
Thus it may be proposed that, during the 
oxidation process, Mn(VII) is reduced to Mn(V), and finally converted to Mn(IV) by 
a disproportionation reaction in a sequential manner.
22
 The stoichiometric equation is 
formulated as in Equation 1. 
NN
HN
OH
O O
+ 4 MnO4
- + 4  H2O + 4 H
+
NH2N
OH
O O
+ 12 CH2O + 3 NH3 + 4 MnO2
F
F
3
3
Norfloxacin
7-amino-1-ethyl-6-fluoro-1,4-dihydro-4-
oxoquinoline-3-carboxylic acid
(1)
1
2
34
7
5
6
8
 
In the oxidative transformation of norfloxacin using alkaline KMnO4, Naik et 
al. have reported the insertion of OH radical at C2 of the quinolone ring to form 1-
ethyl-6-fluoro-2-hydroxy-4-oxo-7-piperazin-1-yl-1,4-hydro-quinoline-3-carboxylic 
acid as the main reaction product.
17 
Srivastava et al., in the oxidative  degradation  of 
norfloxacin  by the oxidant  chloramine-T in aqueous micellar medium, reported the 
cleavage of C2-C3 bond to form 3-fluoro-4-piperazinoyl-6-N-
ethylaminophenylglyoxalic acid as the main reaction product.
16 
Similar oxidation 
product of norfloxacin have also been isolated by Nanda et al. using N-
chlorosuccinimide as oxidant in acidic medium.
15 
Though norfloxacin has many 
reaction sites, by using the  present oxidizing system, it is converted to a single 
product. Similar to biological oxidant (P450), in the present oxidizing system, 
norfloxacin is attacked and metabolized selectively at the piperazinyl ring. This 
indicates the mildness, chemoselectivity and biomimetic characteristic of the 
oxidizing system toward the oxidation of norfloxacin. 
For the mechanistic analysis of the oxidation reaction of norfloxacin by 
CTAP, the reaction kinetics was investigated using UV-vis spectroscopic technique. 
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Pseudo-first-order conditions were maintained by keeping excess of Norfloxacin with 
respect to [CTAP] unless otherwise stated. The rates of reactions were monitored by 
observing the rate of depletion of the absorbance peak at 530 nm (Figure 6.4). All 
reactions obeyed first-order kinetics. The observed rate constants (kobs) were 
calculated from the linear plots of log [CTAP] versus time and presented in Table 6.1. 
Rates of the reaction at varying concentration of the oxidant, substrate and acetic acid 
were also calculated by multiplying [oxidant] with that of the corresponding kobs. 
Table 6.1 Effect of [Norfloxacin], [CTAP], and [Acetic acid] on the oxidation of 
norfloxacin by CTAP in acetonitrile-water mixture (mole fraction ratio 0.65:0.3) at 
298K.  
[CTAP] x 10
4
 M [Norfloxacin] x 10
3
 M [Acetic acid] M 10
4 
x kobs s
-1
 
0.1 1.8 1.27 19.60 ± 0.65 
0.2 1.8 1.27 20.20 ± 0.68 
0.4 1.8 1.27 19.23 ± 0.63 
0.7 1.8 1.27 19.64±0.65 
1.1 1.8 1.27 18.73 ± 0.6 
1.8 1.8 1.27 19.00 ± 0.6 
1.8 0.6 1.27 7.92 ± 0.34 
1.8 3.7 1.27 39.62 ± 1.31 
1.8 5.5 1.27 53.00 ± 2.19 
1.8 7.3 1.27 58.46 ± 2.20 
1.8 9.0 1.27 60.95 ± 2.35 
1.8 10.2 1.27 65.70 ± 2.84 
1.8 13.8 1.27 68.00 ± 3.34 
1.8 1.8 0.16 5.50 ± 0.24 
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1.8 1.8 0.32 7.80 ± 0.31 
1.8 1.8 0.63 13.50 ± 0.58 
1.8 1.8 0.95 17.31± 0.75 
1.8 1.8 1.58 19.54 ± 0.71 
1.8 1.8 1.90 21.23± 0.70 
 
 
Figure 6.4 Successive scan of UV-vis absorption of the reaction mixture consisting of 
CTAP and norfloxacin in acetonitrile-water mixture in the presence of acetic acid at a 
time interval of 1 min.  (* represents the peak taken for the calculation of kobs ). 
6.3.1 Effect of reactant concentration 
To observe the effect of CTAP concentration on the rate of the reaction, CTAP 
concentration was varied in the range of 1.1 x 10
-5
 to 5.45 x 10
-4
 mol dm
-3
, at constant 
concentration of norfloxacin (1.8 x 10
-3
 mol dm
-3
) and acetic acid (1.27 mol dm
-3
). 
The linear plots of log (absorbance) versus time for different concentrations of CTAP 
indicated a first-order dependency with respect to CTAP. Further, the constant values 
of kobs with change in [CTAP] also confirmed the reaction to be first-order with 
respect to CTAP (Table 6.1). 
 
0
0.1
0.2
0.3
0.4
0.5
400 450 500 550 600 650
A
b
so
rb
an
ce
Wavelength in nm 
1min
2min
3min
4min
5min
6min
7min
8min
9min
10min
*
   
Chapter 6 
173 
 
The individual reaction orders with respect to the norfloxacin and acetic acid 
were determined from the slopes of log (rate) versus log (concentration) plots 
constructed by varying the concentrations of respective reactants and were found to be 
0.7 and 0.6 respectively.  Further, the log (rate) values obtained at different conditions 
(Table 6.1) were subjected to multiple regression analysis, and were correlated with 
the parameters of the reaction condition, i.e. [CTAP], [norfloxacin] and [acetic acid] 
to examine the interdependency of reactant concentrations toward the rate of the 
reaction. The linear plot (R
2
 = 0.99) of log (observed rate) versus log (predicted rate) 
(Figure 6.5) supported the regression model (equation 2). Using the coefficients 
obtained from equation 2, the rate expression can be obtained as in equation 3. The 
regression model confirmed the reaction to be first-order with respect to CTAP and 
fractional order with respect to norfloxacin and acetic acid.  
Log (rate) = -0.82(±0.13) + 0.99(±0.03) log [CTAP] + 0.73 (±0.03) log [Norfloxacin]     
+ 0.59 (±0.04) log [Acetic acid]      (2) 
R
2
 = 0.99, F = 741, n = 21       
Rate= 0.15 [CTAP]
 0.99
 [Norfloxacin]
 0.73 
[Acetic acid] 
0.59
    (3) 
 
Figure 6.5 Plot of log (observed rate) versus log (predicted rate) for the oxidation 
reaction of norfloxacin with CTAP in acetonitrile-water mixture in the presence of 
acetic acid at 298 K. 
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The observed rate constant was found to increase with an increase in the      
[acetic acid] with almost no reaction in the absence of acid and tended toward a 
limiting value at higher acidities. It indicates the involvement of protonation of 
permanganate and existence of a rapid equilibrium with the protonated form in the 
oxidation process.
23
 The protonation may be due to an exchange of CTA
+
 with H
+
 in 
the acetonitrile-H2O-acetic acid medium. At higher acidities, protonation is almost 
complete leading to a limiting rate.  
With an increase in concentrations of norfloxacin, the observed rate constant 
was found to increase asymptotically approaching its maximum value at higher 
concentrations (Figure 6.6A). Thus, a Michaelis-Menten type kinetics was proposed 
for the oxidation reaction(equation 4 and 5) i.e. the reaction involves the binding of 
oxidant and substrate to form a complex prior to the rate-determining step which 
subsequently decomposes to the products. Applying steady-state approximation to 
equation 4 and 5, the rate expression can be written as in equation 6.  
Norfloxacin + Oxidant
k+1
k−1
 Complex      (4) 
 Complex 
k2
rds
 Product       (5) 
1
kobs
=
1
k2 K[Norfloxacin]
+
1
k2
                                                                              (6) 
 
From the Lineweaver-Burk double reciprocal plot (Figure 6.6 B) k2, K (=k+1/k-
1) and Km were calculated to be 10.5 x 10
-3
 s
-1
, 147.3 dm
3 
M
-1
, and 6.8 x 10
-3 
M dm
-3
 
respectively. The Michaelis-Menten constant Km (steady-state dissociation constant of 
the oxidant-substrate complex) is an inverse measure of the substrate's affinity for the 
catalyst (enzyme). Smaller the Km, higher is the affinity of the catalyst for the 
substrate. To measure the substrate affinity for the oxidant, Km values were measured 
at different acid concentration at constant oxidant concentration. With the variation in 
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acetic acid concentration, no significant change in Km values was observed, 
delineating no effect of acetic acid concentration either in the complex formation or in 
the decomposition of the complex.  
 
 
Figure 6.6 (A) Plot of 10
4 
x
 
kobs versus 10
3 
x
 
[norfloxacin] and (B) Plot of 1/(10
4 
x
 
kobs) versus 1/(10
3 
x [norfloxacin]) in the oxidation reaction of norfloxacin by CTAP 
in acetic acid-acetonitrile-water medium (0.05:0.65:0.3) at 298 K.  
In view of these experimental findings, a plausible mechanism can be 
proposed as in Scheme 6.1, wherein the first step involves the protonation of CTAP 
followed by formation of a complex with norfloxacin in a second equilibrium step. In 
a slow rate-determining step, the complex then decomposes to form Mn(V) and the 
intermediate iminium cation (2). The intermediate undergoes hydrolysis in a further 
fast step to form formaldehyde and another intermediate (3). 3 subsequently reacts 
with the another mole of Mn(VII) in a similar manner followed by the hydrolysis of 
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the corresponding iminium cation to  form the final product 7-amino-1-ethyl-6-fluoro-
1,4-dihydro-4-oxoquinoline-3-carboxylic acid along with  ammonia and 
formaldehyde. 
The oxidant-substrate complex is formed through the interaction between 
electronegative nitrogen (N1) of the piperazine ring and electropositive manganese of 
the permanganate. Though N4 nitrogen of piperazine ring has higher electron density 
than N1 of norfloxacin, it is not expected to take part in the complex formation since 
it exists in protonated form in acidic pH.
24
 
+ H
+    +   CTA+Mn
O
O
O
-OCTA+
Mn
O
O
O
HO
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Mn
O
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O
HO
+
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(Scheme 6.1) 
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6.3.2 Effect of solvent polarity 
Investigation of effects of solvent on reactivity always plays a crucial role in 
determining the nature of the transition state and the mechanism of the reaction. In the 
light of the transition-state theory, the change in the rate of a reaction with change in 
the nature of the solvents or the polarity of the solvents is mainly due to difference in 
solvation pattern and relative stabilization of the starting material and the 
corresponding activated complex by the solvents.
25,26 
Increase in solvent polarity 
either increases or decreases the reaction rate, depending on whether the activated 
complex is more or less dipolar than the initial state. Further, a change in solvent 
polarity has a negligible effect on the rates of reactions that involve little or no change 
in the charge density on going from reactants to the activated complex.
25,26
 
In the present investigation, the oxidation reaction was carried out in solutions 
containing varying proportions of acetonitrile (dipolar aprotic solvent) and water 
(polar protic solvent) in the presence of a fixed amount of acetic acid (5%). The 
observed rate constant was found to show significant solvent sensitivity (Table 6.2). 
To analyze the solvent induced change in reactivity, kobs were correlated with different 
solvent parameters such as ε (dielectric constant),27 π* (solvent polarity),28 β 
(hydrogen bond acceptor basicity),
29  (hydrogen bond donor acidity), 29 A (anion 
solvating power of the solvent),
30
 B (cation solvating power of the solvent),
30
 and A+ 
B (solvent polarity).
30 
The polarity parameters for the solvent mixtures have been 
estimated approximately from the polarity parameters of the pure solvents. 
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Table 6.2 Observed rate constants for the oxidation of norfloxacin by CTAP in the 
acetonitrile- water solvent mixture in the presence of acetic acid at 298 K.       
[CTAP]= 1.8 x 10
-4
 M, [Norfloxacin] = 1.8 x 10
-3
 M, [Acetic acid] = 1.27 M. 
Mole 
fraction 
(CH3CN) 
Mole 
fraction 
(water) 
Mole 
fraction 
(acetic acid) 
   A
 
B
 α β 
10
4
x kobs  
(S
-1
) 
8+ln kobs 
(S
-1
) 
0.80 0.14 0.06 41.50 0.49 0.84 0.35 0.27 125.50 ± 5.44 3.62 
0.72 0.23 0.06 44.96 0.54 0.85 0.43 0.26 45.42 ± 1.80 2.61 
0.65 0.30 0.05 48.04 0.59 0.86 0.49 0.25 19.00 ±0.60 1.73 
0.62 0.33 0.05 49.45 0.61 0.87 0.52 0.25 14.32 ±0.55 1.45 
0.59 0.36 0.05 50.79 0.63 0.87 0.55 0.25 9.75 ± 0.32 1.07 
0.56 0.39 0.05 52.05 0.65 0.88 0.58 0.24 7.60 ± 0.33 0.82 
0.43 0.52 0.04 57.52 0.72 0.90 0.70 0.23 6.50 ± 0.28 0.66 
0.33 0.63 0.04 61.87 0.79 0.92 0.80 0.22 5.90± 0.35 0.56 
0.25 0.71 0.04 65.41 0.84 0.93 0.88 0.21 5.72 ± 0.34 0.53 
With an increase in dielectric constant of the medium, kobs was found to 
decrease suggesting a relatively less polar transition state with smaller charge density 
than the reactants (Figure 6.7).
33
 On increasing the dielectric constant of the medium 
from 41 to 52, a sharp decrease in rate constant is observed. On the other hand, in the 
region of higher dielectric constant (>52) the rate constant is virtually independent of 
the composition. This kind of non-ideal decrease demonstrates preferential solvation 
of reactants and transition state by either of the solvents through specific and non-
specific solute-solvent interaction such as hydrogen bonding.
31
 The change of trend in 
the reactivity with change in solvent composition may also be due to a change in the 
mechanism. However, the validity of isokinetic relationship for the whole series of 
solvent composition in the present case with an isokinetic temperature of 236  17 K 
confirms that the bilinear decreasing trend with change in solvent composition is not 
due to a change in the reaction mechanism.
32
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Figure 6.7 Plot of 10
4
 x kobs versus dielectric constant of the medium () for the 
oxidation of norfloxacin by CTAP in the presence of acetic acid (1.27 M) in 
acetonitrile-water solvent mixtures. 
The decrease in rate constant with an increase in ion solvating power (A+B) of 
the medium depicts the involvement of ions in the rate-determining step. Further, with 
the increase in both A and B, similar decreasing trend is observed, which may propose 
the presence of both cation and anion in the complex C and the transition state in the 
rate-determining step.  
Based on all these experimental observations, it may be proposed that in the 
rate determining step the complex C decomposes to the products through a less polar 
transition state as represented in Scheme 6.2. The transition state is expected to be less 
polar than the complex C due to delocalization of the negative charge.  
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Figure 6.8 demonstrates a bilinear decrease in ln k with change in solvent 
composition. The rate constants are found to be higher in the higher mole fraction of 
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acetonitrile, decreased sharply with further increase in water content in the mixture 
and became constant at higher mole fraction of water (mole fraction > 0.4). This kind 
of bilinear decrease may be ascribed to the differential solvation of the complex C and 
the transition state (4) through specific and nonspecific solute solvent interaction.  
 
Figure 6.8 Plot of 8 + ln kobs versus mole fraction of water in the oxidation of 
norfloxacin by CTAP in presence of acetic acid (1.27 M) in acetonitrile-water solvent 
mixtures. 
Higher rate of reaction in the larger acetonitrile domain can be explained by 
greater solvation of less polar transition state (TS) by less polar acetonitrile compared 
to that of water.  The positive charges in the transition state are localized on both the 
nitrogens while the negative charge is delocalized through the piperazine ring and 
manganate moiety. Accordingly, the transition state 4 might behave more as a cation 
than an anion. Being dipolar aprotic and due to the presence of nonbonding electrons, 
acetonitrile acts as a good cation solvator (B= 0.86),
26,30  
and it can strongly solvate 
the TS through ion-dipole and dispersive interactions leading to greater stabilization 
of the TS. In contrast, being a poor anion solvator (A = 0.37),
26,30
 it will not be able to 
solvate the complex C so extensively compared to that of the less polar TS. 
Consequently, stability of the complex will be less in acetonitrile domain, which will 
increase the rate of decomposition. On the other hand, being polar protic and having 
greater anion solvating power (A =1),
38 
water solvates the complex C more 
extensively than the TS. Thus, stability of complex C will be more in water rich 
domain which will decrease the rate of the reaction.  
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For reactions involving ions and dipolar molecules, ln k is related to the 
dielectric constant of the medium () as per equation 7, where k0 refers to rate 
constant in the medium of unit dielectric constant, rand r
≠ 
refer to radii of the reacting 
species and the activated complex respectively.
26
 
     𝑙𝑛𝑘 = 𝑙𝑛𝑘0 +  
𝑁𝑍2𝑒2
2𝑅𝑇
 
1
𝑟
−
1
𝑟≠
                                                          (7)
 As per the above equation, ln k is linearly dependent on 1/. The slope of the 
line depends on the radii (r and r
≠
) of the reactants and the transition states and 
accordingly the rate of the reaction will either increase or decrease with the increase 
in solvent polarity. If the activated complex is highly solvated than the reactants, r
≠
 
will be greater than r and the slope increases with the increase in solvation. On the 
other hand, if the reactant is highly solvated than the value of r will increase leading 
to a decrease in the magnitude of the slope. The bilinearity in the plot of ln k versus 
1/ (Figure 6.9) confirmed the validity of the equation for the present investigation in 
both the acetonitrile rich domain (ln k = 577(1/) -10. 26: R2 = 0.999) and water rich 
domain (ln k = 75(1/) -0.62: R2 = 0.983). Greater sensitivity of the rate constant with 
higher positive slope in the acetonitrile rich domain supports the presence of highly 
solvated activated complex than the reactants.
26 
In water rich domain (mole fraction of 
water > 0.39), however, the reactant is preferentially solvated by water through ion-
dipole interaction and hydrogen bonding.  
 
Figure 6.9 Plot of 8 + ln k versus. 1/ in the oxidation of norfloxacin by CTAP in the 
presence of acetic acid (1.27 M) in acetonitrile-water binary solvent mixtures. 
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With the increase in β (HBA ability) value and decrease in α (HBD ability) 
value of the medium, ln k was found to increase (Figure 6.10). These facts illustrate 
the involvement of hydrogen bonding between the solute (reactant and/or transition 
state) and solvent molecules, which leads to preferential solvation. Water, being a 
polar protic solvent can act as a strong hydrogen bond donor as well as hydrogen 
bond acceptor.
33-35  
It can form hydrogen bonds with N-H protons of the piperazine 
moiety as HBA as well as with manganate anion as HBD solvent. On the other hand, 
acetonitrile being a non HBD and a weak HBA solvent, it may forms only weak 
hydrogen bond with N-H proton of the piperazine moiety. As a result of which strong 
intramolecular hydrogen bonding between manganate anion and NH
+
 of piperazine 
moiety may prevail. As a result in the oxidant-substrate complex (C), two types of 
hydrogen bonding causing difference in rate are expected (i) strong intermolecular 
hydrogen bonding between manganate anion and water in water rich domain and (ii) 
strong intramolecular hydrogen bonding between manganate anion and NH
+
 of 
piperazine moiety in acetonitrile rich domain (Scheme 6.3). 
 
Figure 6.10 Plot of 8 + ln k versus  and  of the solvent mixture in the oxidation of 
norfloxacin by CTAP in the presence of acetic acid (1.27 M) in acetonitrile-water 
medium at 298K. 
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(Scheme 6.3) 
As shown in Scheme 6.3, stronger intramolecular hydrogen bonding in the 
oxidant-substrate complex leads to higher rate of hydrogen abstraction from 
piperazine moiety and thus the rate of the reaction is higher. Due to strong HBD 
ability water can preferentially solvate the oxidant-substrate complex and stabilize the 
complex through intermolecular hydrogen bonding, which leads to a slower rate of 
decomposition of the complex. 
6.3.3 Effect of temperature 
The proposed mechanism was further supported by the effect of temperature 
on the rate of the reaction. With the increase in temperature from 293 to 313 K, the 
rate constant was found to increase linearly (Table 6.3). The thermodynamic 
parameters were calculated using Arrhenius and Eyring equation (Table 6.3). The 
lower energy of activation and high free energy of activation support the formation of 
highly solvated transition state.
36
 The high negative entropy of activation is also 
indicative of an extensively solvated and highly ordered activated complex than the 
reactants.
 
It also supports the existence of a cyclic or a forced transition state during 
abstraction of N-H proton by permanganate anion and subsequent breaking of C-C 
bond of the complex C in the rate determining step (Scheme 6.2).
37 
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Table 6.3 Rate constants at three different temperatures and activation parameters for 
the oxidation of norfloxacin by CTAP in acetonitrile-water solvent mixture in the 
presence of acetic acid. [CTAP]= 1.8 x 10
-4
 M, [Norfloxacin] = 1.8 x 10
-3
 M, [Acetic 
acid] = 1.27 M 
Mole 
fraction  
(CH3CN)   
X1   
Mole 
fraction 
(water) 
X2   
10
4
 kobs ( s
-1
) 
Ea 
kJ mol
-1
 
ΔH≠ 
kJ mol
-1
 
ΔG≠ 
kJ mol
-1
 
ΔS≠ 
J mol
-1 
K
-1
 298K 303K 313K 
0.80 0.14 125.5 140 151 9.1 6.5 85.1 -259 
0.72 0.23 45.42 52.2 59 13 10.5 87.54 -254 
0.65 0.30 19 22.6 26.8 17.2 14.67 89.76 -248 
0.62 0.33 14.32 17.27 21.11 19.5 16.96 90.49 -242 
0.59 0.36 9.75 10.75 19.96 38.59 36.04 91.28 -182 
0.56 0.39 7.6 8.44 16.54 41.89 39.35 91.87 -173 
0.43 0.52 6.5 7.53 14.75 43.77 41.22 92.2 -168 
0.33 0.63 5.9 6.4 13.6 45.31 42.77 92.6 -164 
0.25 0.71 5.72 6.14 13.6 47.13 44.6 92.6 -158 
To further support the above proposal, activation parameters were calculated 
at different solvent composition (Table 6.3). The energy of activation (Ea) was found 
to be smaller in the acetonitrile rich domain and was also found to increase 
systematically with the increase in the water content of the solvent mixture. These 
facts further supported the following; (i) Stronger is the intramolecular hydrogen 
bonding lesser is the Ea for  hydrogen abstraction and higher is the rate of reaction (ii) 
stronger is the intermolecular hydrogen bonding with water,  higher is the stability of  
oxidant-substrate complex and slower is the rate of decomposition. Further high polar 
nature of water may destabilize the nonpolar transition state compared to that of 
acetonitrile. This phenomenon is presented graphically in Scheme 6.4. The lower the 
temperature, the stronger is the preferential solvation of the probe molecule by the 
solvents.
38 
An increase in temperature results in increased kinetic energy of 
molecules, and thereby the interaction between molecules connected with preferential 
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solvation becomes weaker. The hydrogen bonding between the reactants and solvents 
also weakens resulting in an increase in the rate of reaction.   
X1 = 0.8; X2 = 0.14
Water rich domain
Ea = 9 kJ/mol Ea = 47 kJ/mol
TS
Reactants
Reactants
TS
Acetonitrile rich domain
X1 = 0.25; X2 = 0.71
 
(Scheme 6.4) 
With an increase in the mole fraction of water from 0.14 to 0.71, the entropy 
of activation (ΔS≠) was found to increase from -259 to -158 J K-1 mol-1. The values of 
ΔS≠ are generally influenced by the degree of solvation and solvent polarity. If the 
transition state is more extensively solvated than the reactants, ΔS≠ assumes a larger 
negative value due to an appreciable increase in ordering in the solvation shell.
39 
Thus, the higher negative value of ΔS≠ in acetonitrile rich domain as compared to 
water rich domain may be attributed to the greater solvation of the nonpolar transition 
state in the less polar solvent. 
6.3.4 Determination of solvent kinetic isotope effect 
Isotopic labeling on solvents influences the rate of the reaction and gives 
useful information regarding the reaction mechanism. To obtain the solvent kinetic 
isotope effect (k(H2O)/k(D2O)), the reaction was carried out in the mixture of H2O-
acetonitrile and D2O-acetonitrile separately. The solvent kinetic isotope effect, k 
(H2O)/k (D2O), was found to be 1.18(± 0.05).  The magnitude of the isotope effect, in 
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this case, is similar to that of a secondary isotope effect and may be due to the 
following factors.
35 
(i) A secondary isotope effect is observed if the easily exchangeable protons of the 
reactants are replaced by deuterium, but the deuterium-containing bonds are not 
broken during the rate-determining step of the reaction. 
(ii) Secondly, secondary isotope effect is observed if the solvent (water in the present 
case) performs a nucleophilic attack in the rate-determining step. 
(iii) With isotopic substitution, the physical characteristics of the solvent also change. 
Consequently, the solute-solvent interaction will be somewhat different, altering 
the strength of H-bonds or nucleophilicity of the reactants resulting in secondary 
kinetic isotope effect.  
In the preset case, the observed secondary solvent kinetic isotope effect  can 
be explained through the difference in solute-solvent interaction due to isotopic 
substitution as the hydrogen bond strength is higher in D2O compared to that of 
water.
40
 Thus, it is expected that, the oxidant substrate complex forms stronger 
hydrogen bonds with D2O compared to water leading to increase in the energy of 
activation. Consequently, the solvent kinetic isotope effect is greater than one though 
considerably smaller. 
6.4       CONCLUSION 
Norfloxacin was metabolized by CTAP in aqueous acetonitrile medium in the 
presence of acetic acid to produce 7-amino-1-ethyl-6-fluoro-1,4-dihydro-4-
oxoquinoline-3-carboxylic acid, formaldehyde and ammonia through selective attack 
at the piperazine ring. From the kinetic analysis, the reaction was found to be first 
order with respect to CTAP and fractional order with respect to norfloxacin and acetic 
acid. A suitable reaction mechanism was proposed, the first step of which is a very 
fast formation of association complex between oxidant and substrate, followed by a 
rate determining dissociation of the complex proceeding via a less polar cyclic 
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transition state.  The proposed mechanism is supported by the effect of solvent, 
solvent kinetic isotope effect and from the effect of temperature on the reaction rate. 
The outcome of solvent effect illustrates the presence of a differential contribution 
from dipolar aprotic and polar protic solvents toward the reaction through specific and 
nonspecific solute-solvent interaction. The study could through some light on the fate 
of this drug in the presence of the oxidant like Mn(VII) in  biological systems.  
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7.1       SUMMARY  
Oxidative transformations by lipopathic Cr(VI) and Mn(VII) containing 
quaternary ammonium ions are widely explored in synthetic organic chemistry and 
also a topic of current interest for the versatility as well as selectivity in oxidation of 
organic substrates in organic solvents. With appropriate alkyl groups in the quaternary 
ammonium groups, the salts assemble in both aqueous and nonaqueous media to form 
organized assemblies mimicking bioaggregates like protein, lipids, and nucleic acids. 
In this context the present thesis is an attempt to establish two lipopathic oxidants, 
CTADC and CTAP (containing long chain amphiphilic cetyltrimethylammonium ion 
as counter ions for dichromate and permanganate respectively) and to answer the 
following questions.  
(i) Can these oxidants be used as mild, selective oxidants in the oxidation of 
multifunctional organic substrates? 
(ii) Can these oxidants be used as biomimetic oxidants for the oxidation of 
biologically important organic substrates? 
(iii)If so, can these be used as metal based non-enzymatic chemical models to study 
the mechanism of oxidative metabolism and to synthesize selective metabolites 
in sufficient amounts? 
    For the purpose, the oxidative metabolism of some established drugs (such as 
acetaminophen, epinephrine, isoniazid, carbamazepine and norfloxacin having 
multifunctional groups) have been investigated in nonaqueous medium. A brief 
summary of the findings are presented as follows. 
 Formation of single, chemoselective and biomimetic products in the oxidation of 
above substrates demonstrates the mildness and selectivity of these oxidizing 
systems.  
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 These lipopathic oxidants containing long chain CTA counterions are found to be 
more advantageous than other classical and non-classical lipopathic oxidants of 
Cr(VI) and Mn(VII). 
 The uniqueness in terms of reactivity, selectivity and difference with that of other 
classical and non-classical oxidants is attributed to the presence of CTA
+ 
which 
tunes the reactivity of the anionic oxidizing counterpart through tight ion pair 
formation in nonpolar medium.  
 Kinetic analysis of the above oxidative conversions reveals similar mechanistic 
path for all reactions. Fractional order dependencies with respect to the drugs 
demonstrates the initiation of the reaction through the reversible binding between 
the oxidant and the substrate at selective site to form a complex which then 
decomposes to the product through subsequent reaction steps (Scheme 7.1).   
 
Oxidant  +  Substrate                       Oxidant-Substrate 
                                                                    Complex
Oxidant-Substrate 
         Complex
Products
Step 1
Step 2
 
(Scheme 7.1) 
 
 Similar to that of enzyme catalysed reaction, these oxidants provide suitable 
residing/binding sites for proper orientation of the substrates as well as active 
site/catalytic site for reaction (Scheme 7.2). The oxidative conversion takes place 
predominantly at the interfacial region of the reverse micellar aggregates. Nature 
of solvents and the polarity of the solvents have been found to play significant 
roles in controlling the rate of the reaction either through controlling the 
aggregation process or by differential solvation of reactants and transition states 
through specific and non-specific solute-solvent interaction.  
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(Scheme 7.2) 
 These oxidants may serve as a non-enzymatic, chemical oxidation model 
primarily to synthesize the selective metabolites of drug candidates in the course 
of drug discovery and development.  
 Elucidation of probable mechanistic pathway of drug oxidation using these 
oxidants in presence of artificial organised assemblies may serve as a reasonable 
model to enlighten the complex biological reactions occurring at the lipid–
solution interface in the living system and give valuable information for finding 
more suitable drug candidate to fight with oxidative stress and to combat drug 
resistance.   
 
 
 
   
Summary and future scope  
192 
 
7.2  FUTURE SCOPE 
In view of the success of the strategy to utilize long chain amphiphilic CTA 
ion as onium counter ion for the synthesis of lipopathic Cr(VI) and Mn(VII) oxidants 
for mild, selective and biomimetic oxidations, it can be extended to synthesize  novel 
lipopathic Fe(III), Ru(VII), Mo(VI) and W(VI)  oxidants for possible application in 
selective oxidative functional group transformations.  
Due to the insolubility or poor solubility in aqueous medium these oxidants 
can be utilized as heterogeneous oxidizing system for treatment of contaminated 
stream or possible degradation and removal of xenobiotics.  
Kinetic and spectrophotometric determination of drug in pharmaceutical 
formulations has been the subject of interest to many investigators due to their 
sensitivity, selectivity, simplicity and accuracy. In these methods the drug is oxidized 
using the metal ion oxidant and thus the amount of drug has been estimated. But in 
most of the methods high concentration of strong acid, high temperature and longer 
reaction time is required for the process. However, CTAP and CTADC oxidize many 
oxidizable functional groups in milder conditions as compared to other conventional 
oxidants. Further, due to the suitable reactivity of these oxidants, the kinetics of the 
reaction can be studied properly. Owing to the selectivity, sensitivity and accuracy of 
kinetic methods and due to the mildness of the oxidizing method, the oxidation 
kinetics of drug by these lipopathic oxidants can be a better alternative to the available 
methods for the determination of drug in pharmaceutical formulations. 
In the development of new pharmaceuticals, one crucial task is to elucidate the 
metabolic fate of the drug candidate that need to be studied at early stages. Cell-based 
metabolism studies of active compounds using enzymes liver microsomes, 
hepatocytes or micro-fungi present several advantages but the difficulty of isolation 
from the biological medium and small quantities of the metabolites are severe 
drawbacks. Thus many non-enzymatic chemical models have been proposed as 
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biomimetic alternative approach to the cell-based metabolism study of bioactive 
compounds. In this regard, these oxidants may serve as a biomimetic, non-enzymatic, 
chemical oxidation model primarily to synthesize selective metabolites of drug 
candidates in the course of drug discovery and development. Further, elucidation of 
probable mechanistic pathway of drug oxidation using these oxidants in presence of 
artificial organized assemblies can serve as a reasonable model to enlighten the 
complex biological reactions occurring at the lipid–solution interfaces in the living 
system. 
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